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Abstract 
The work described here is an investigation of the molecular mechanism of pH 
dependent immunoglobulin G (IgG) binding by the neonatal Fe receptor (FeRn). FeRn 
binds IgG at acidic, but not alkaline pHs, in two important physiological processes. These 
processes are the acquisition of passive immunity by the fetus or newborn and protecting 
IgG from a default degradative pathway. 
A biosensor assay is used to characterize the interaction of a soluble form of FeRn 
with IgG. Immobilization of FeRn on the biosensor surface reproduces the high affinity 
IgG binding observed for membrane bound FeRn, whereas immobilization of IgG results 
in lower affinity binding similar to that of the FcRn/IgG interaction in solution. The 
statistical method of cross-validation is used to show that there are two classes of non-
interacting binding sites. The IgG binding interaction is characterized for several mutant 
FeRns with designed amino acid substitutions. These mutations map the functional IgG 
binding site on FeRn. 
The structure of FeRn at an alkaline pH is described. This structure determination 
reveals an extensive carbohydrate mediated interaction between the dimer related FeRn 
molecules. The physiological relevance of this interaction is discussed in the context of the 
FeRn dimerization literature. A further refined structure of FeRn at an acidic pH is 
described that includes additional carbohydrate structure. These structures are compared 
with specific attention to the pH dependence of FeRn stability and IgG affinity. Finally, a 
mechanism for pH dependent antibody binding to FeRn is proposed based on these 
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THE ACQUISITION OF MATERNAL IgG: 
A review of research on the neonatal Fe receptor 
Daniel E. Vaughn 
After encountering a disease, the immune system can specifically recognize the 
foreign antigens that characterize it. This recognition enables specific immunity to be 
developed for the disease. Thus, once we have had a disease such as chicken pox, we 
develop resistance to it. Presumably as a result of the importance of specific immunity, 
vertebrates have evolved multiple recognition mechanisms. For example, there is a cell-
mediated specific immunity in which specialized cells of the immune system, T-cells, 
recognize antigenic peptides presented by MHC molecules (Figure 1a; reviewed in 
Bjorkman, 1997). There is also a humoral specific immunity in which antibodies 
recognize specific complementary three-dimensional surfaces such as an intact protein 
(Figure 1b). The most prevalent of these antibodies, immunoglobulin G (IgG) molecules, 
have two identical copies of an antigen binding domain (Fab) and a single constant 
domain (Fe). The genes that code for antibodies undergo a process of DNA 
recombination that results in the generation of billions of different IgG molecules, each 
cell producing an antibody with a different specificity. Under certain conditions (e.g., an 
infection), the capacity to make those IgG molecules that have the relevant specificities is 
increased. 
Unfortunately, specific immunity generally requires previous exposure to some 
form of the disease bearing organism. One exception to the general requirement of 
previous exposure occurs in newborns. Mothers transfer some of their IgG molecules to 
their offspring. Because individual antibodies last in the bloodstream for only a few 
weeks , this passively acquired immunity is only temporary. It does, however, provide 
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powerful specific immune recognition during the critical period before the baby is fully 
capable of its own specific immune recognition. 
The acquisition of maternal antibodies is critical to the survival of mammals in 
general. A recent study is particularly illustrative (Gustafsson et al., 1994). Some of the 
mice used in this study have a deletion in the gene coding for Ig J..l chain that is necessary 
for antibody production (W). Although W mothers (mated with either wild type or w 
fathers) were able to complete pregnancy and deliver nonnal litter sizes, all of their 
babies died1. In contrast, all babies born to antibody-producing mothers survived (Figure 
2). Therefore, infant survival depended only on whether the mother could produce 
antibodies and not on the infant's ability to produce antibodies. 
The offspring born to antibody-deficient mothers could be rescued by nursing 
from antibody-producing foster mothers. Although the young had no antibodies at birth, 
at days 6 and 12 their antibody levels were nonnal. Thus the foster mothers were able to 
promote infant survival presumably by transferring antibodies to the infants through their 
milk. 
Mice born to antibody-producing mothers but nursed by antibody-deficient foster 
mothers, survived well initially (90% survival at day 10, more than 3 times the survival 
rate of babies born to and nursed by antibody-deficient mothers), but often died by day 25 
(> 85% mortality rate). In this case, the antibody levels were normal at birth but 
decreased thereafter. In nonnal offspring, antibody levels increase after birth. These data 
indicate that in mice, mothers also transfer antibodies to their offspring prenatally, and 
that this too promotes infant survival. 
This experiment is one clear example of the importance of maternal transfer of 
antibodies for infant survival. Mice that were able to acquire antibodies from the milk of 
Jg ~deficient mice are bred and raised in special sterile environments, and adull Ig ~deficient 
mice can survive adequately in the normal laboratory conditions used in this experiment. 
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biological or foster mothers survived until weaning while babies that nursed from 
antibody deficient mothers usually died. Similarly, babies that were able to receive 
maternal antibodies prenatally had a survival advantage especially during their first week 
of life. The genetic manipulations used to construct antibody deficient mice allowed a 
direct test of the importance of antibody transfer. Although these manipulations can not 
be performed in humans or most other mammals, the importance of maternal antibody 
acquisition to neonatal survival has been well documented across a wide range of 
mammalian species beginning with the pioneering work of Paul Erlich in the late 19th 
century (Junghans, 1997). 
Evolution of antibody transmission 
In the 1950s and 1960s, Brambell and coworkers studied the transmission of 
immunity from mother to young (Brambell, 1970). The animals that they studied 
included representatives from diverse branches of amniotic evolution. For each of these 
species they measured the developmental time and the route of antibody transmission. 
Interpretation of these results requires an appreciation of the differences in embryonic 
structures that evolved as vertebrates adapted to terrestrial existence. 
Amphibians, although capable of living on land, must return to the water to 
reproduce. Their offspring develop rapidly using maternal nourishment that is provided 
by way of the egg yolk. These embryos enclose the yolk within an embryonic membrane. 
This yolk sac develops an extensive network of blood vessels that connect to the 
developing embryos circulatory system, the vitelline network. The principle function of 
the yolk sac is to allow the developing embryo to make use of the nutrients that the 
mother deposits in the yolk. 
For embryos to develop on land, certain new embryonic organs were required to 
provide a protected aqueous micro-environment, gas exchange, and waste disposal. The 
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cleidoic egg (i.e., enclosed in a shell and self sufficient except for gas exchange) 
characteristic of most reptiles and monotremes (egg laying mammals, e.g., duck-billed 
platypus) provides this environment by evolving structures derived from embryonic 
tissues (Figure 3, left panel). These structures, four membranous sacs, are also conserved 
in placental mammals (Figure 3, right panel). The yolk sac is the homolog of the fish and 
amphibian yolk sac, and it serves the same nutrient procurement function. The allantois 
forms from hindgut tissue and serves initially as an excretory reservoir, homologous to 
the amphibians' urinary bladder. Later in embryonic development an expanded and 
extensively vascularized allantois also serves a respiratory function. The amnion 
surrounds the embryo and provides an aqueous micro-environment. The chorion (also 
called serosa in reptiles) encloses all other embryonically-derived tissues. 
With the evolution of mammals, two new mechanisms were developed to provide 
nourishment to the young. All mammals provide nourishment to their young by secreting 
milk from mammary glands. The viviparious mammals (bear their young live) also have 
placentas to provide nourishment to the young in utero. Although, marsupials (e.g., 
opossum and kangaroo) only have a very rudimentary placenta. 
The evolution of more developed placentas are characteristic of eutherial2 
mammals. Many ungulates, including the pig and horse, have the simplest kind of 
placenta. These placentas are diffuse (Figure 4a) because the villi that contribute to the 
placenta are scattered over the entire chorion. In ruminants (e.g., cattle, goats, and sheep) 
the placenta is cotyledonary (Figure 4b), meaning that the villi cluster into patches that 
are distributed over the chorion. In all ungulates, the maternal epithelium remains intact 
(epithelialchorial placenta) and the nutrients must pass over several layers to reach the 
embryo from the maternal circulation. Carnivores have a more complicated placenta. 
The villi cluster in a characteristic band about the center of the chorion; this arrangement 
2 Euthcrians arc traditionally described as placental mammals. This is somewhat misleading 
because marsupials have placentas but are not classified as euthcrian. 
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is zonal (Figure 4c). The carnivore's uterine wall breaks down to make a more intimate 
placental connection, although the endothelial tissues of the blood vessels remain intact 
(an endothiliochorial placenta). Lagomorphs (rabbits and related species) and rodents 
have well-developed placentae. They are discoid (the villi localize to a single patch; 
Figure 4D) and heamochorial (the maternal blood circulates directly over the embryonic 
chorion). Humans and other primates also have a placenta classified as haemochorial and 
discoid, but the morphology, lacunar, is unique. 
The mechanisms of antibody transmission have coevolved with reproductive 
strategies. Brambell and collegues characterized the developmental time and route of 
antibody transmission for a wide range of amniotes (Table 1). 
Species Prenatal Transmission Postnatal Transmission 
Route Route Window 
Birds Egg yolk Egg yolk < 5 days 
Wallaby None Gut 180 days 
Horse None Gut 1 day 
Pig None Gut 1-2 days 
Ruminants None Gut 1 day 
Dog, Cat U ncharacterized Gut 1-2 days 
Rabbit Yolk-sac None 
Rat, Mouse Yolk-sac Gut 20, 16 days 
Guinneapig Yolk-sac None 
Hedgehog U ncharacterized Gut 40 days 
Human, Monkey Placenta None 
Table 1. IgG transmission in several species. Dogs, cats and hedgehogs have significant 
prenatal transmission; although the route of this transmission remains uncharacterized. 
Ruminants tested include cattle, sheep and goats. Birds tested include chicken, pigeon, 
dove, sparrow, crow, and swallow. (Ref. Brambell 1970.) 
The transmission of passive immunity is not limited to mammals. Birds and other 
reptiles have an antibody, IgY, which is the homologue of both mammalian IgG (which is 
transmitted from mother to young) and IgE (which is not). In these species the young 
develops in ovo with all maternal contributions present in the egg. Antibody transmission 
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is well characterized in the chicken. Maternal IgY is secreted by the ovarian follicle into 
the developing egg yolk. Endodermal cells of the yolk sac absorb the IgY and vitteline 
vessels transport it to the developing chick's circulation. Mammalian IgG injected into 
the egg yolk is not effectively transmitted (Brierley and Hemmings, 1956). IgY is also 
transmitted through the egg yolk in the tortoise (Maung, 1963). In Brambell's work, there 
is no mention of amphibians transmitting passive immunity. It is possible that the 
transmission of immunity from mother to young also occurs in amphibians since they 
have both IgY and a yolk sac. There is evidence for monomeric antibodies in teliosts 
(bony fish), and even elasmobranches (rays, primitive sharks, etc.), although the nature of 
these antibodies is more controversial (Warr, 1994). 
Mammals with the most primitive placentas obtain maternal antibodies 
postnatally. In the wallaby, a species of kangaroo, antibody transmission occurs through 
the milk during the entire period when the young reside in the pouch. This is the 
functional route of antibody transmission (Waring, personal communication cited in 
Brambel, 1970). As with all viviparous mammals, marsupial embryos do not derive 
significant nutrients from the egg yolk. If antibody transmission occurs through the egg 
yolk, it is insufficient to transmit immunity, and it should be considered vestigial 
(Bramble, 1970). Ungulates are born much more fully developed, and they receive all of 
their maternal antibodies immediately after birth from the colostrum (milk that is 
especially high in antibody and other proteins secreted for a day or two after birth). 
Postnatal antibody transmission occurs by maternal secretion of IgG into the 
colostrum and milk, and acquisition by the neonate through its gut. The mechanism by 
which antibodies are secreted into the milk is unknown, although antibodies are 
transferred from the mother's blood stream in an at least somewhat specific manner 
(Jordan and Morgan, 1967). Therefore, new antibody synthesis in the mammary glands if 
it occurs, can not be the only mechanism of transmission. In the newborn, endocytic cells 
that line portions of the nursing infants' small intestines (primarily the jejunum but also a 
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proximal region of the ileum) transport antibodies from the gut to their blood stream, a 
process called transcytosis . 
With the evolution of more devolped zonary placentas, mammals also evolved 
prenatal antibody transmission. Carnivores such as dogs and cats, are born with partial 
maternally derived immunity although the route of transmission has not been 
characterized. Most of their passive immunity is transmitted just after birth by way of the 
colostrum. Lagomorphs on the other hand, receive all of their antibodies prenatally. 
The route of lagomorph prenatal antibody transmission was convincingly 
demonstrated in the rabbit by Brambell and collegues. In the final arrangement of the 
rabbit embryonic membranes , the chorion only partially encloses the rest of the 
embryonic tissue (Figure 5a), and the yolk sac endoderm is directly exposed to the lumen 
of the uterus. Antibodies are secreted from the maternal circulation into the lumen of the 
uterus where they are absorbed by a vascularized structure of the yolk sac, the 
splanchnopleur, and transported by the vitteline network to the foetus (Brambell et al., 
1949). The critical evidence was provided by surgically constricting the yolk sac stock 
containing the vitteline vein (Figure 5b). Fetuses treated in this way were not able to 
aquire antibodies either produced by the mother, injected into the mother's circulation, or 
injected into the intestinal lumen. Untreated littermates acquired both antibodies and 
immunity from each of the antibody sources (Brambell et al., 1949). 
Some rodents also receive all of their maternally derived immunity prenatally, 
e.g., the guinea pig, while others, e.g., mice and rats, receive the majority of their 
maternal antibodies postnatally and only a fraction prenatally. Unlike carnivores, 
postnatal transmission, when it occurs in the rodent, continues throughout the majority of 
the nursing period. One difference between rodents that do and those that do not acquire 
maternal antibodies postnatally, is that rats and mice are born less fully developed (-3 
week gestation period) than are guinea pigs ( -10 week gestation period). The hedgehog 
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is an insectivore3 and, like rats and mice, has a haemochorial discoid placenta, a 
relatively short gestation period (31 days), and receives antibodies both prenatally and for 
an extended postnatal period. 
Humans and other primates also have a haemochorial discoid placenta, but, like 
rabbits and guinea pigs, they have a relatively long gestation period and only receive 
antibodies prenatally. The transmission of immunity in these species occurs by a 
different route. In contrast to rodent's, the primate chorion encircles the developing 
embryo, isolating it from the uterine lumen, and the yolk sac is small and rudimentary 
throughout development, never positioned to absorb immunoglobulins directly from the 
exterior (Brambell, 1970). Instead, fetal cells selectively transport IgG, present in the 
maternal blood that bathes the chorionic villi, to the allantoic circulatory network. 
Extended postnatal antibody transmission is seen in the earliest viviparous 
mammals, marsupials, and (along with some prenatal transmission) in rats, mice and 
hedgehogs. This mechanism of transmission appears and disappears throughout 
mammalian evolution, and its presence coincides with offspring that are born less mature. 
Other than this exception, the route of maternal lgG transmission seems to have evolved 
sequentially. Initially this transmission was via the egg yolk, as in reptiles. The 
evolution of mammals introduced the process of nursing, and this advance provided a 
route of postnatal antibody transmission. Ungulates consolidated this transmission to the 
colostrum presumably because their young are born with a more developed immune 
system obviating the need for the extended antibody transmission required of marsupials. 
Carnivores evolved a prenatal mechanism of transmission; although, the route of this 
transmission has never been characterized, and fewer antibodies are transmitted 
prenatally than posnatally. The routes of prenatal transmission for rabbits, rats, and mice 
are well characterized and are similar. However, while rabbits use prenatal transmission 
3 Insectivores are a class of mammals that diverged relatively early from the rodent/lcgomorph line. 
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exclusively, rats and mice transmit most of their immunity postnatally. The route of 
antibody transmission in humans and monkeys is different from that of rabbits and 
rodents. In rabbits and rodents, antibodies are secreted into the uterine lumen, and 
acquired in utero by transcytosis across endocytic cells in the yolk sac. In primates, 
antibodies are contained in the maternal blood that bathes the placental villi, and acquired 
in utero by trancytosis across endocytic cells in these villi. 
Antibody acquisition by any of these routes is accompanied by significant 
antibody degradation. Labelled antibodies fed to neonatal rats are both transmitted intact 
to the infant's circulation and digested (Halliday, 1957; Brambell et al., 1961). Transport 
across the rabbit yolk sac and the human placenta also include considerable antibody 
degradation (Brambell 1970). A set of early in vitro experiments allowed accurate 
quantitation of this process (Bamford, 1966). The small intestine of neonatal rats is 
turned inside out, cut into appropriate lengths, and the ends are tied off. These tissues 
remained viable for several hours (many cycles of antibody transport). A large volume of 
fluid outside these "sausages" maintains an approximately constant antibody 
concentration, and at the conclusion of these experiments the intact antibodies can be 
completely recovered. These and subsequent experiments have consistently shown that 
selective lgG transcytosis is accompanied by significant JgG degradation. 
The neonatal Fe receptor 
Three characteristics of antibody transmission: saturation, selectivity, and 
inhibition, led Brambell and colleagues to hypothesize that a receptor was responsible for 
prenatal and neonatal antibody acquisition. Using a procedure that allowed quantitative 
delivery of antibodies to the newborn's stomach, Halliday demonstrated that antibody 
transcytosis was saturatable (Halliday, 1957). That is, for modest quantities of antibody, 
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the amount of antibody reaching the neonate's blood stream is proportional to the amount 
administered, but for doses above a certain level, the amount of antibody transferred is 
constant regardless of the dose. Halliday further showed that antibody transmission was 
specific; i.e., antibodies from different species were transferred with different efficiency4 
(Halliday, 1955). Morris demonstrated that the transfer of an antibody with any given 
specificity could be inhibited by whole IgG molecules with a different specificity 
(Morris, 1957) or the Fe portion of an antibody (Morris, 1963). It was soon recognized 
that these properties (saturation, selectivity, and inhibition) suggest that a specific 
receptor is responsible for antibody transmission (Brambell, Halliday and Morris 1958). 
Indeed a receptor that recognizes IgG through its Fe region was isolated from 
neonatal rat intestine (Jones & Waldman, 1972), and is thus known as the neonatal Fe 
receptor (FeRn). The isolated receptor binds IgG under slightly acidic conditions (pH 6) 
but not under slightly alkaline conditions (pH 7.4; Jones & Waldman, 1972). It was later 
shown that this pH dependent binding of IgG, or its Fe portion, occurs in the neonatal 
intestine as well as the isolated receptor (Rodewald, 1976; Wallace & Rees, 1980). The 
DNA sequence that codes for rat FeRn was identified and was found to be homologous to 
class I MHC molecules whose three-dimensional structures are known (reviewed in 
Bjorkman and Parham, 1990). Both MHC class I molecules and FeRn are composed of a 
common soluble light chain, ~2-microglobulin (~2m), and a homologous transmembrane 
heavy chain (Simister and Rees, 1985). 
Transgenic mice were created that do not produce ~2m which is necessary for 
FeRn function (Zijlstra et al., 1989). These mice lack the FeRn surface expression in the 
neonatal intestine that is observed in wild type mice, and do not transport maternal lgG 
(Zijlstra et al., 1989; Israel et al., 1995). The adult ~2m- mice have IgG levels that are 
4 Halliday's work also first demonstrated that some classes of antibodies are transferred more readily 
than others (Halliday and Kekwick 1960). This study found that the neonate's gut was more permeable to 
hyperimmune sera than serum taken shortly after primary immunization. In retrospect, this is consistent 
with IgG being transmitted and IgM being impermeable. 
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1/10th those of normal mice (Israel et al., 1995). The interpretation of these results is 
complicated because P2m is a component not only of FeRn, but also class I MHC 
molecules and several other proteins with homology to class I MHC molecules. 
Nonetheless, the observation of low IgG levels in the adult transgenic mice coupled with 
observations of widespread FeRn expression in adult rats (Simister and Mostov, 1989), 
lead several groups to reconsider Brambell's proposal of a second FeRn function 
(reviewed in Junghans, 1997). 
In the mid 1960s, Brambell recognized that features of the IgG catabolism in the 
blood stream were similar to those of maternal antibody transmission. It was discovered 
that the rate of degradation of IgG in healthy adult mice increases with increased 
concentrations of IgG (Fahey and Robinson, 1963). This effect is selective for the Fe 
portion of IgG. Elevated concentrations of either IgG or its Fe portion, but not of either 
the Fab portion of IgG or of other classes of immunoglobulins (IgM or IgA), increase the 
rate of catabolism of IgG. Brambell and colleagues immediately recognized that the 
same receptor that they hypothesized transports immunity from mother to young could 
also be working to specifically recognize IgG and rescue it from an otherwise degradative 
fate (Brambell et al., 1964; Brambell, 1966). 
Indeed in the year following the initial report of P2m- mice having decreased IgG 
levels (Israel et al., 1995), three groups independently found that the low IgG levels were 
due to increased catabolism resulting from impairment of the normal IgG protection 
mechanism (Ghetie et al., 1996; Junghans and Anderson, 1996; Israel et al., 1996). 
Careful quantitation of this effect shows that in normal mice, the rate of IgG catabolism is 
seven-fold greater than the rate of catabolism of a representative serum protein, albumin 
(Junghans and Anderson, 1996). In contrast, the rate of IgG degradation is the same as 
that of albumin in P2m- mice (Junghans and Anderson, 1996). In the same study, the IgG 
level was measured to be eight-fold higher in wild-type mice than in the transgenic mice. 
Thus, within experimental error, the difference in IgG concentration and rate of 
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catabolism are the same in normal and B2m knockout mice (Junghans and Anderson, 
1996). The FeRn heavy chain is expressed in diverse tissues of the adult, including the 
vascular epithelium where most serum protein degradation is believed to occur (Sirnister 
and Mostov, 1989; Story et al., 1994). In addition to the prenatal and neonatal acquisition 
of maternal IgG, these studies strongly implicate a second FeRn function: the protection 
of IgG from a default degradative pathway. 
The expression of a soluble form of FeRn (Gastinel et al., 1992) has facilitated 
structural and mechanistic studies of the FcRn-IgG interaction (reviewed in Raghavan 
and Bjorkman, 1996). Soluble FeRn exhibits the same pH dependent binding of IgG 
seen for isolated FeRn or intact neonatal intestine (Gastinel et al., 1992). Under the 
slightly acidic conditions that permit tight IgG binding, soluble FeRn denatures at a 
higher temperature and the dissociation rate of heavy and light chains is an order of 
magnitude slower than under the slightly alkaline conditions for which no IgG binding is 
observed (Raghavan et al., 1993). A biosensor based assay was developed to characterize 
the interaction of IgG and FeRn (Raghavan et al., 1994). This assay was used to 
quantitate the pH dependent binding of IgG to FeRn immobilized on a biosensor chip 
(Raghavan et al., 1995a). The affinity for IgG decreases by at least two orders of 
magnitude from pH 6.0 to 7 .0. This steep pH dependence is unusual for protein 
interactions. From a Hill plot of the binding constant as a function of pH, a Hill 
coefficient of 2.6 was derived (for mlgG2a) suggesting that at least 3 residues are titrating 
each with a pKa of about 6.6-6.7. Solvent exposed histidine residues generally have a 
pKa in this range due to the deprotonization of the imidizole side chain (Fersht, 1977). 
Two histidine residues on the Fe ligand (His 310 and His 433) as well as one or both of 
two consecutive histidines on the receptor (His 250 and/or His 251) are important in the 
pH dependence of FcRn-IgG binding (Raghavan et al., 1995a). 
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The structure of soluble FeRn was determined to 2.2 A resolution by X-Ray 
crystallography (Burmeister et al., 1994a). The overall fold of FeRn is very similar to 
class I MHC molecules (Figure 6). The a.l and a.2 domains of the heavy chain form a 
platform composed of an eight {3-strand anti-parallel sheet and two long a.-helices. The 
a.3 domain of the heavy chain and the light chain, {32m, are Ig-like domains of the Cl-set. 
The major structural difference relative to class I MHC molecules is that the long helix of 
the a.2 domain is bent in FeRn with theN-terminal portion of the helix and the outer two 
{3-strands displaced as a unit. This displacement effectively closes the peptide binding 
groove present in class I MHC molecules. At the position where the helix bends, there is 
a proline residue that is conserved among the three known FeRn sequences but is a valine 
in class I MHC molecules. Since proline residues are substituted on their amino group 
they are unable to make one of the two hydrogen bonds characteristic of residues in an a.-
helix. Research is underway to examine the effect of substituting the FeRn proline with 
the class I valine (J. Lebron, ... , PJB). 
In each of three crystal forms used in the FeRn structure determination, the same 
dimer of FeRn molecules was observed (Figure 7; Burmeister et al. 1994a). Because the 
binding of FeRn and IgG occurs with a stoichiometry of 2:1 FcRn:IgG (Huber et al., 
1993), it was postulated that this dimer could be functionally important for IgG binding 
(Burmeister et al., 1994a,b). The role of FeRn dimerization in IgG binding was directly 
tested by introducing cysteines at positions that either facilitated or hindered receptor 
dimerization when FeRn was coupled through these cysteines to a biosensor chip 
(Raghavan et al., 1995b). High affinity binding was observed when FeRn was coupled in 
the orientation facilitating dimerization. Binding affinity was reduced more than tOO-
fold when receptor dimerization was hindered. Thus, the high affinity IgG binding 
observed in vivo requires FeRn dimerization in order to be reconstituted in vitro. 
A low (-6 A) resolution crystal structure was determined for FeRn complexed 
with the Fe portion from a mixture of rat IgGs (Burmeister et al., 1994b). These crystals 
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have a stoichiometry of 2:1 FcRn:IgG, with one FeRn molecule and one half of an Fe 
molecule in the asymetric unit (Huber et al., 1993). In this case the FeRn dimer and the 
Fe monomer are related by different crystallographic symmetry operators (Figure 8). In 
addition to the FeRn structure described above, the structure of an Fe portion of IgG was 
also known from a previous crystallographic analysis (Deisenhofer, 1981). Electron 
density for the FeRn molecule and C3 domain of Fe allowed these known structures to be 
positioned accurately. Because there was little or no electron density for the C2 domain, 
this domain's position is less well determined (Burmeister et al., 1994b). Nonetheless, 
this structure was used to identify the site on Fe that interacts with FeRn as the interface 
of the C2 and C3 domains (Figure 8). This is the same portion of Fe that binds fragment 
B of protein A (Deisenhofer, 1981 ). It had previously been shown that a genetically 
engineered analog of fragment B competitively inhibits FeRn binding to Fe (Raghavan et 
al. , 1994), and that protein A-IgG complexes have a shorter serum persistence than 
uncomplexed IgG (Dima et al., 1983). The principle Fe binding site on FeRn is in the a2 
domain (amino acids 113-119 and 131-137), although the N-terminus of ~2m and some 
epitopes on the a3 domain of the dimer related FeRn molecule could also be involved 
(Burmeister et al., 1994b). Mutation of FeRn residues in a3 domain (either residues 219-
224 or the consecutive histidine residues 250 and 251) to the corresponding residues in 
class I MHC molecules reduces the affinity for IgG slightly ( -2-fold and 6- to 7-fold 
respectively; Raghavan et. al., 1994). Each of these mutations are at positions that would 
not directly affect IgG binding to an FeRn monomer, but could effect the interaction of 
IgG with the dimer related FeRn molecule. Taken together the low resolution FcRn-Fc 
complex structure and these biochemical studies have provided the crude structural 
epitopes for the binding of FeRn to IgG. 
Site directed mutagenesis of the Fe region has identified functionally important 
epitopes for inhibition of FeRn binding, neonatal and prenatal transcytosis, and protection 
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from a default degradative pathway. For murine IgG1 (mlgG1), mutants 1253A5 or 
H310A have greatly reduced interaction with FeRn (Table 2). Either of these mutations 
reduces fetal transmission of IgG, inhibition of neonatal transmission of lgG, inhibition 
Neonatal Fetal Plasma 
Mutation FeRn Affinity Transcytosis Transcytosis clearance 
A. inhibition inhibition transmission t112 P-phase 
(%) (%) (%) (hr) 
mJgG1-Fc 68 46 1.7 83 
H285A 66 45 1.4 76 
1253A 12 4 0.4 20 
H310A 4 6 0.2 17 
H433A 52 34 1.4 115 
N434A 48 40 1.3 115 
N434Q 115 
H435A 5 12 0.1 17 
H436A 16 25 1.5 46 
B. inhibition inhibition transmission t112 P-phase 
(%) (%) (%) (hr) 
migG1-Fc 67 55 2.8 120 
1253A 31 20 0.2 26 
H310A,Q311N 26 9 0.2 18 
H433A,N434Q 54 44 0.7 50 





M252G ,I253G,S254G 1700 
L309G,H310G,Q311G 1900 
Table 2: Site directed Fe mutants effect on FeRn funcction. This table summarizes the 
results of several studies which have examined the role of specific amino acid subtitution 
of the Fe ligan on the various FeRn functions. These studies are Medesan et al., 1997 
(part A.); Kim et al., 1994a,b and Medesan et al., 1996 (part B.); and Raghavan et al., 
1995 (part C.). Parts A. and B. summarize the interaction of murine FeRn with murine 
Fe, while part C. *The mutant labelled as 310-311/433-434 has the H310A,Q311N and 
H433A,N434Q mutations. 
of IgG binding to FeRn, and have an increased rate of catabolism relative to wild type Fe 
5 Throughout this chapter site directed mutants will be abreviated by the one Jetter amino acid 
symbol of the wild-type residue, the amino acid sequence number, and the mutant residue. Thus I253A is 
isoleucine 253 mutated to alanine. 
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(Medesan et al., 1997). These results are entirely consistent with previous reports on 
mutations in migG1 (Kim et al., 1994a,b; Medesan et al., 1996) and human IgG4 (hlgG4; 
Raghavan et al., 1995). But mutation H435A and to a lesser extent H436A but not 
H433A, N434Q, nor N434A reduces the interaction of the Fe fragment of mlgG 1 with 
FeRn (Medesan et al., 1997). These results apparently contradict previous reports from 
the same laboratory that the double migG 1 mutant H433A,N434Q inhibits the interaction 
with FeRn (Kim et al., 1994a,b; Medesan et al., 1996) and from our laboratory that 
mutation H435R in higG4 has a negligible effect on the interaction with FeRn 
(Raghavan et al., 1995). Regarding the conflict with their previous results, the authors 
suggest that "The most plausible explanation for the observed effects of mutation of both 
H433 and N434 is that simultaneous mutation of these two amino acids causes a local 
perturbation in the orientation of the adjacent histidine (H435), which, in contrast to 
H433 and N434, plays a critical role in the FcRn-mlgG 1 interaction" (Medesan et al., 
1997). Presumably mutations H433A, N434A, and N434Q are insufficient to cause this 
local perturbation. Similarly, regarding the hlgG4 result, the authors say "it is 
conceivable that in the context of differences in the sequences of surrounding residues, 
the relative roles of H433 and H435 are distinct in different isotypes" (Medesan et al., 
1997). 
The work described in the subsequent chapters is an investigation of the 
molecular mechanism through which FeRn binds IgG at acidic but not alkaline pHs. In 
Chapter 1, I describe the method that I use to characterize the interaction of IgG with 
FeRn and report the finding that immobilized FeRn binds IgG with higher affinity than 
soluble FeRn. Chapter 2 describes amino acid substitutions to FeRn and their effect on 
IgG affinity. This investigation provides the most detailed experimental map of the IgG 
binding site on FeRn. In Chapter 3, I describe the structure of FeRn at an alkaline pH and 
an additionally refined structure of FeRn at an acidic pH. These structures include an 
17 
extensive carbohydrate structure that is necessary for the dimerization of FeRn. These 
structures provide the basis upon which I propose a mechanism for the pH dependent IgG 
binding to FeRn. In the final chapter, I summarize our current understanding of the 
FcRn-IgG molecular interaction and speculate on the cellular mechanism through which 
FeRn mediates the acquisition of passive immunity and the protection from degradation. 
Acknowledgments 
I would like to thank my father for extensive editorial work, Pamela Bjorkman for 




Ahouse JJ, Hagerman CL, Mittal P, Gilbert DJ, Copeland NG, Jenkins NA, Simister 
NE. 1993. Mouse MHC class-! like Fe receptor encoded outside the MHC. J. Jmmunol. 
151: 6076-6088 
Arey, LB. 1954. Developmental Anatomy, 6th ed. Saunders, Philadelphia. 
Balinsky, Bl. 1981. An Introduction to Embryology, 5th ed. CBS College Publishing, 
New York. 
Bamford DR. 1966. Studies in vitro of the passage of serum proteins across the intestinal 
wall of young rats. Proc. R. Soc. B. 166: 30-45. 
Bjorkman PJ, Parham P. 1990. Structure, function and diversity of class I major 
histocompatibility complex molecules. Ann. Rev. Biochem. 90: 253-88. 
Bjorkman PJ. 1997. MHC Restriction in three dimensions: A view of T cell 
receptor/ligand interactions. Cell. 89: 167-170. 
Blumberg RS, Koss T, Story CM, Barisani D, Polischuk J, Lipin A, Pablo L, Green 
R, Simister NE. 1995. A major histocompatibility complex class !-related Fe receptor for 
IgG on rat hepatocytes. J. Clin. Invest. 95: 2397-2402. 
Brambell FWR, Hemmings WA, Henderson M, Parry HJ, Rowlands WT. 1949 The 
route of antibodies in the stomach contents of foetal rabbits. Proc. R. Soc .. B. 136: 131-
144. 
Brambell FWR, Halliday R, Morris IG. 1958. Interference by human and bovine serum 
and serum protein fractions with the absorption of antibodies by suckling rats and mice. 
Proc. R. Soc .. B. 149: 1-11. 
Brambell FWR, Halliday R, Hemmings WA. 1961. Changes in 132J-labelled immune 
bovine "(-globulin during transmission to the circulation after oral administration to the 
young rat. Proc. R. Soc .. B. 153: 477-489. 
Brambell FWR, Hemmings WA, Morris IG. 1964. A theoretical model of g-globulin 
catabolism. Nature. 137: 1352-1355. 
Brambell FWR. 1966. The transmission of immunity from mother to young and the 
catabolism of immunoglobulins. Lancet. ii: 1087-1093. 
Brambell FWR. 1970. The transmission of passive immunity from mother to young. 
North-Holland Publishing Co., Amsterdam. 
' 
Brierley J, Hemmings W A. 1956. The selective transport of antibodies from the yolk sac 
to the circulation of th echick. J Embryol. exp. Morph. 4: 34-41. 
Burmeister WP, Gastinel LN, Simister NE, Blum ML, Bjorkman PJ. 1994a. The 2.2 
A crystal structure of the MHC-related neonatal Fe receptor. Nature 372: 379-383 
19 
Burmeister WP, Huber AH, Bjorkman PJ. 1994b. Crystal structure of the complex 
between the rat neonatal Fe receptor and Fe. Nature 372: 336-343 
Davies DR, Metzger H. 1983. Structural basis of antibody function. Annu. Rev. 
Jmmunol. 1: 87-117 
Deisenhofer J. 1981. Crystallographic refinement and atomic models of a human Fe 
fragment and its complex with fragment B of protein A from Staphylococcus aureus at 
2.9- and 2.8-A resolution. Biochemistry 20: 2361-2370 
Fahey JL, Robinson AG. 1963. Factors controlling serum y-globulin concentration. J. 
Exp. Med. 118: 845-868. 
Fersht A. 1977. Enzyme structure and mechanism. WH Freeman and Co., New York. 
Gastinel LN, Sirnister NE, Bjorkman PJ. 1992. Expression and crystallization of a 
soluble and functional form of an Fe receptor related to class I histocompatibility 
molecules. Proc. Natl. Acad. Sci. USA 89: 638-642 
Ghetie V. Hubbard JG, Kim JK, Ysen MF, Lee Y, Ward ES. 1996. Abnormally short 
serum half-lives of IgG in P2-microglobulin-deficient mice. Eur. J. Immunol. 26: 690-
696. 
Gustafsson E, Mattsson A, Holmdahl R, Mattsson R. 1994. Pregnancy in B-cell-deficient 
mice--postpartum transfer of immunoglobulins prevents neonatal runting and death. Bioi 
Reprod. 51: 1173-1180. 
Halliday R. 1955. The absorption of antibody from immune sera by the gut of the young 
rat. Proc. R. Soc., B. 143: 408-413. 
Halliday R. 1957. The absorption of antibody from immune sera and from mixtures of 
sera by the gut of the young rat. Proc. R. Soc., B. 148: 92-103. 
Huber AH, Kelley RF, Gastinel LN, Bjorkman PJ. 1993. Crystallization and 
stoichiometry of binding of a complex between a rat intestinal Fe receptor and Fe. J. 
Mol. Bioi. 230: 1077-1083 
Isreal EJ, Patel VK, Taylor SF, Marshak-Rothstein A, Simister NE. 1995. Requirement 
for a P2-microglobulin-associated Fe receptor for acquisition of maternal IgG by fetal and 
neonatal mice. J. Tmmunol. 154: 6246-6251. 
Isreal EJ, Wilsker DF, Hayes KC, Schoenfield D, Simister NE. 1996. Increased clearance 
of IgG in mice that lack P2-microglobulin: possible protective role of FeRn. 
Immunology 
Jones EA, Waldmann TA. 1972. The mechanism of intestinal uptake and transcellular 
transport of IgG in the neonatal rat. J. Clin. Invest. 51: 2916-2927. 
Jordan SM, Morganv EH. 1967, Albumin, transferrin, and gamma-globulin metabolism 
during lactation in the rat. 0 . Jl. exp. Physiol. 52: 422-429. 
20 
Junghans RP. 1997. Finally! The Brambell receptor (FcRB). Mediator of transmission of 
immunity and protection from catabolism for IgG. lmmun. Res. 16: 29-57. 
Junghans RP, Anderson CL. 1996. The protection receptor for IgG catabolism is the p2 
microglobulin-containing intestinal transport receptor. Proc. Natl. Acad. Sci. 93: 5512-
5516. 
Kim J-K, Tsen M-F, Ghetie V, Ward ES. 1994. Identifying amino acid residues that 
influence plasma clearance of murine IgG 1 fragments by site-directed mutagenesis. Eur. 
J. Immunol. 24: 542-548. 
Kim J-K, Tsen M-F, Ghetie V, Ward ES. 1994. Localization of the site of the murine 
IgG 1 molecule that is involved in binding to the murine intestinal Fe receptor. Eur. J. 
Tmmunol. 24: 2429-2434 
Mackenzie NM, Morris B, Morris R. 1983. Protein binding to the brush borders of 
enterocytes from the jejunum of the neonatal rat. Biochim. Biophys. Acta 755: 204-209 
Maung, R. T. 1963. Immunity in the tortoise, Testudo ibera. J. Path. Bact. 85: 51-66. 
Medesan C, Radu C, Kim J-K, Ghetie V, Ward ES. 1996. Localization of the site of the 
IgG molecule that regulates maternofetal tranmission in mice. Eur. J. Immuno. 26: 2533-
2536. 
Medesan C, Matesoi D, Radu C, Ghetie V, Ward ES. 1997. Delineation of the amino acid 
residues involved in transcytosis and catabolism of mouse IgGI. J Immunol. 158:2213-
2217. 
Morris IG. 1957. The effects of heterologous sera on the uptake of rabbit antibody from 
the gut of young mice. Proc. R. Soc., B. 148: 84-91. 
Morris IG. 1963. Interference with the uptake of quinea-pig agglutinins in mice due to 
fractions of papain hydrolyzed rabbit y-globulin. Proc. R. Soc .. B. 157: 160-169. 
Popov S, Hubbard JG, Kim J-K, Ober B, Ghetie V, Ward ES. 1996. The 
stoichiometry and affinity of murine Fe fragments with the MHC class !-related receptor, 
FeRn. Mol. Immunol. 33: 521-529. 
Raghavan M, Gastinel LN, Bjorkman PJ. 1993. The Class I MHC-related Fe receptor 
shows pH Dependent stability differences correlating with immunoglobulin binding and 
release. Biochemistry 32: 8654-8660 
Raghavan M, Chen MY, Gastinel LN, Bjorkman PJ. 1994.ldentification of interaction 
sites in the class I MHC-related Fe receptor/immunoglobulin G complex. Immunity 1: 
303-315 
Raghavan M, Bonagura VR, Morrison SL, Bjorkman PJ. 1995a. Analysis of the pH 
dependence of the neonatal Fe receptor/Immunoglobulin G interaction using antibody 
and receptor variants. Biochemistry 34: 14649-14657 
Raghavan M, Wang Y, Bjorkman PJ. 1995b. Effects of receptor dimerization on the 
interaction between the class I MHC related Fe receptor and immunoglobulin G. Proc. 
Natl. Acad. Sci. USA 92: 11200-11204 
21 
Raghavan M, and Bjorkman PJ . 1996. Fe receptors and their interactions with 
immunoglobulins. Annu. Rev. Cell Dev. Bioi. 12: 181-220. 
Roberts DM, Guenthert M, Rodewald R. 1990. Isolation and characterization of the Fe 
receptor from fetal yolk sac of the rat. J. Cell Bioi. 111: 1867-1876 
Rodewald R. 1973. Intestinal transport of antibodies in the newborn rat. J. Cell Bioi. 58: 
189-211 
Rodewald R. 1976. pH-dependent binding of immunoglobulins to intestinal cells of the 
neonatal rat. J. Cell Bioi. 71: 666-670. 
Rodewald R, Kraehenbuhl J-P. 1984. Receptor-mediated transport oflgG. J. Cell Bioi. 
99: 159s-164s 
Simister NE, Mostov KE. 1989a. Cloning and expression of the neonatal rat intestinal Fe 
receptor, a major histocompatibility complex class I antigen homolog. Cold Spring 
Harbor Symposia on Quantitative Bioi LIV: 571-580 
Simister NE, Mostov KE. 1989b. An Fe receptor structurally related to MHC class I 
antigens. Nature 337: 184-187 
Simister NE, Rees AR. 1985. Isolation and characterization of an Fe receptor from 
neonatal rat small intestine. Eur. J. Immunol. 15: 733-738 
Simister NE, Story CM. 1996. Fey receptors in human placenta. In Human JgG Fe 
Receptors, ed. J. G. J. van de Winkel and P. J. A. Capel, 25-38. R. G. Landes Company 
Story CM, Mikulska JE, Simister NE. 1994. MHC class !-like Fe receptor cloned from 
human placenta. J. Exp. Med. 180: 2377-2381 
Wallace KH, Rees AR. 1980. Studies on the immunoglobulin G Fe fragment receptor 
from neonatal rat small intestine. Biochem. J 188: 9-16 
Warr GW. 1994. A review of antibodies and immunoglobulin genes in vertebrates. 
Developmental and Comparative Immunology. 18: S39. 
Williams AF, Barclay AN. 1988. The immunoglobulin superfamily- Domains for cell 
surface recognition. Annu. Rev. Immunol. 6: 381-405 
Zijlstra M, LiE, Sajjadi F, Subramani S, Jaenisch R. 1989. Germ-line transmission of a 
disrupted J32-microglobulin gene produced by homologous recombination in embryonic 
stem cells. Nature 342: 435-438. 
Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH. 1990. J32-microglobulin deficient 
mice lack CD4-s+ cytolitic T cells. Nature 344: 742-746. 
22 
Figure]. Antigen Recognition. A) An MHC class I molecule (light grey) is shown 
presenting an antigenic peptide (black) to the variable portion of aT-cell receptor (dark 
grey). B) An antibody (with its heavy chain in light grey and it light chain in grey) is 
shown binding two copies of a protein antigen (light grey) through its two Fab domains. 





















Death == >90% Dead by Day 10 
Survival == >90% Alive at Day 20 
Figure 2. The importance of passive immunity--Male mice negative (left diagram) or 
positive (right) for lgG production were mated with female mice either negative (left 
mouse in each diagram) or positive (right) for IgG production. Offspring born and nursed 
by IgG producing mothers survived normally throughout the nursing period, whether or 
not the offspring themselves were able to produce IgG. Offspring born and raised by 
antibody deficient mothers suffered high mortality rates(> 90%) again whether or not the 
offspring could produce IgG. Offspring born to antibody deficient mothers, but nursed 
from birth by lgG producing foster mothers survived normally throughout the nursing 
period. Offspring born the lgG producing mothers, but nursed from birth were initially 
healthy, but suffered poor growth and intermediate mortality during the later stages of 
nursing. 
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Figure 3. Embryonic Membranes--typical of a bird (left) and mammal (right). Based on 













Figure 5. Ligature studies of the rabbit uterous. A) A scematic diagram showing the 
major embryonic membranes. The arrow points to the area that is operated on to ligate 
the vitrial vein. B) The stalk of the yolk sac is tied off and returned to the uterus so that 
the acquisition of maternal IgG by the developing fetus can be tested. Based on a similar 
figure by Brambell ( 1970). 
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MHCI 
Figure 6. Ribbon diagrams of show the similar structures of FeRn and a class I MHC 
molecule. 
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Figure 7. Two FeRn molecules pair to form a dimer observed in crystals of FeRn alone 
and in complex with Fe. Residues identified by site directed mutagenesis to slightly 





Figure 8. Complex of Fe (top) with the FeRn dimer (bottom). 
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ABSTRAcr: The neonatal Fe receptor (FeRn) binds maternal immunoglobulin G (IgG) during the acquisition 
of passive immunity by the fetus or newborn. In adult mammals, FeRn also binds IgG and returns it to 
the bloodstream, thus protecting IgG from a default degradative pathway. Biosensor assays have been 
used to characterize the interaction of a soluble form of FeRn with IgG. We use the statistical method 
of cross-validation to show that there are two classes of noninteracting binding sites, and these are sufficient 
to account for previously observed nonlinear Scatchard plots of FcRn/IgG binding data. We demonstrate 
that immobilization of FeRn on the biosensor surface reproduces the high-affinity IgG binding observed 
for membrane-bound FeRn, whereas immobilization of IgG results in lower affinity binding similar to 
that of the FcRn/IgG interaction in solution. The dependence of FcRnllgG binding affinity on the coupled 
molecule provides further evidence in suppon of the previously hypothesized model that an FeRn dimer 
forms the high-affinity IgG binding site. 
The neonatal Fe receptor (FcRn)1 binds immunoglobulin 
G (IgG) in two important physiological processes: the 
transfer of IgG from mother to fetus or newborn and the 
protection of IgG from a default degradative pathway 
(reviewed in ref 1 ). FeRn is structurally similar to class I 
MHC molecules, consisting of a homologous membrane-
bound heavy chain and the class I MHC light chain, {32-
m.icroglobulin (2, 3). A soluble form of FeRn, a heterodimer 
composed of the extracellular domains of the heavy chain 
complexed to /32-microglobulin, was previously shown to be 
functionally active (4), retaining its high-affinity IgG binding 
at pH 6.0 with a sharp drop· in affinity at pH values above 
7 (4-6). 
Our laboratory has used a biosensor assay to characterize 
the binding of soluble FeRn to lgG (6-8). Biosensors utilize 
a surface plasmon resonance (SPR) based assay that allows 
the formation of a protein-protein complex to be monitored 
several times per second (9-1 1). In this system, one 
molecule is immobilized at the sensor chip surface, and 
binding of the second molecule is monitored as it is passed 
over the chip. Scatchard and lcinetic analyses of the binding 
between FeRn and IgG were used to calculate binding 
affinities (6- 8). These characterizations were complicated 
by nonlinearity of the Scatchard plots, suggesting the 
presence of multiple classes of binding sites. 
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Here, we demonstrate that the interaction of lgG with 
immobilized FeRn can best be modeled as IgG binding to 
two classes of noninteracting sites on FeRn, and describe a 
method to derive accurate binding constants for each class. 
Using this method, we show that the affinities of FeRn for 
different IgGs are systematically higher when FeRn, rather 
than the IgG, is immobilized. The affinities of immobilized 
FeRn for IgG are comparable to those observed in binding 
assays using membrane-bound FeRn (7, 12), suggesting that 
immobilization of FeRn on a biosensor chip mimics the 
physiological situation. These results are interpreted with 
reference to previous work demonstrating that FeRn dimer-
ization is required for high-affinity binding of IgG (8). 
MATERIALS AND METHODS 
Proteins and R~ag~nts. Secreted rat FeRn (a heterodimer 
composed of residues 1-269 of the rat FeRn heavy chain 
associated with rat {32m) was purified from supernatants of 
transfected Chinese hamster ovary cells using pH-dependent 
binding to rat IgG affinity columns (4). IB5 and 3F4 are 
murine IgG 1 monoclonal antibodies against human Zn-a2-
glycoprotein (13). They were purified from ascites fluid by 
thiophillic adsorption on a T-gel column according to the 
manufacturer's protocol (Pierce Chemical Co.) and by FeRn 
affinity chromatography (14). Monoclonal mouse and rat 
antibodies of the specified subtypes were purchased from 
Pharmingen. Anti-CD4, a rat lgG2a, was purchased from 
Boehringer Mannheim. Polyclonal human lgG and Fe 
fragments (Hu IgG and Hu Fe; mixture of IgG I, IgG2, IgG3, 
and IgG4 subtypes) and polyclonal rat IgG and Fe fragments 
(mixture of IgG I, IgG2a, IgG2b, and IgG2c subtypes) were 
purchased from Jackson lmmunoResearch. 
Protein concentrations were determined spectrophotometri-
cally using extinction coefficients at 280 nm of 216 000 M-1 
em-• [IgG; (15)] and 84 900 M-1 em-• (FeRn). The 
extinction coefficient for FeRn in aqueous solution was 
determined after measurement of the absorbance of the same 
Cl 1997 American Chemical Society 
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concentration of protein in 6 M GuHCI and phosphate 
buffered saline (L. M. Sanchez and P.J.B., unpublished 
results). The reference solution's FeRn concentration was 
determined from the A280 in GuHCI and the theoretical 
extinction coefficient [valid only for denatured proteins; 
calculated from the amino acid sequence according to (16)]. 
Immobilization of lgG and FeRn on Biosensor Chips. A 
BIAcore biosensor system (Pharmacia LKB Biotechnology 
Incorporated) was used for real time binding experiments. 
This system includes a biosensor element with a dextran-
coated gold surface to which FeRn or IgG was coupled using 
standard amine coupling chemistry as described in the 
BIAcore manual. Immobilization of soluble FeRn and IgG 
proteins using amine coupling chemistry was previously 
described (6-8). 
Interpretation of Biosensor Data. Binding of soluble IgG 
or FeRn to the other molecule immobilized on the biosensor 
chip results in changes in the SPR signal that are directly 
proportional to the amount of bound protein, and read out 
in real time as resonance units (RU) (9, 10). Affinities were 
derived at pH 6.0 by analysis of data obtained from room 
temperature injections of different concentrations of injected 
protein in 50 mM phosphate, 150 mM NaCI. Each injection 
onto an FeRn- or lgG-coupled flowcell was followed by an 
identical injection onto a blank flowcell of the same chip in 
order to subtract out significant nonspecific responses. 
Two methods were used to derive the equilibrium dis-
sociation constant (K0). In the first [a Scatchard analysis 
(17)], the slope of the plot of Reql[ligand] versus Req is equal 
to -liKe (where Req is the equilibrium biosensor response 
and ligand refers to the injected protein). In the second, Req 
was plotted versus the log of the concentration of the ligand. 
Nonlinear regression analysis (18) was used to fit these data 
to a binding model and to derive values for the K0 and the 
binding response at infinite concentration of ligand (Rmu). 
The fit of the data to the following binding models was 
examined: 
(i) A single class of noninteracting binding sites. Req is 
represented as 
Req = Rmu([ligand]/K0 )/(l + [ligand]/K0 ) ( I) 
(ii) A somewhat more complicated model employing a 
Hill constant (H) to represent the cooperativity of a class of 
interacting binding sites. R.q is represented as 
A Hill constant greater than I indicates positive cooperativity; 
i.e., the binding of one ligand facilitates the binding of 
additional ligands. A Hill constant less than I indicates 
negative cooperativity; i.e., the presence of a ligand hampers 
the binding of additional ligands. 
(iii) Multiple classes of noninteracting binding sites. Req 
is represented as 
Req = RmuLtfi{([ligand]/K0 )/(l + [ligand]/K0 )} (3) 
where /1 denotes the fraction of total binding sites in each 
class and L/1 = I. (iv) Multiple classes of interacting sites. 
Req is represented using eq 3 with the incorporation of Hill 
coefficients as in eq 2. 
For comparison of the models, three statistical parameters 
were calculated. The correlation coefficient, r, is defined 
as [L(xl - (x))(y1 - (y))]2/(l;;{x1 - {x))2l:;{y1 - (y))2]. The 
1-2 
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rmsd is defined as the root mean square difference between 
observed and predicted responses for all concentrations 
tested. The free rrnsd was calculated as follows: Data points 
were omitted one at a time, and a best fit of the model to 
the remaining data was calculated. For each best fit model, 
the difference was calculated between the predicted and 
observed responses for each omitted concentration. The free 
rmsd is the root mean square of these differences. 
For calculation of kinetic constants, the B IAevaluation 2.1 
software package was used to fit dissociation curves using 
a single-exponential dissociation rate equation (y = Roe-t-'; 
where R0 is the observed response at the start of the 
dissociation and kd is the dissociation rate constant) or a hi-
exponential dissociation rate equation [y = Ro(/1e-t._,, + 
f~-to.:l), where Jc.s.1 and k.s.2 represent fast and slow dissocia-
tion rate constants and f, and f2 correspond to the fraction 
of complexes dissociating with each rate constant]. Using 
the BIAevaluation 2.1 software, an F-test-based comparison 
between derived x2 values for the single-exponential or two-
exponential fits yielded an estimated probability for each 
dissociation curve of which model produced the best fit to 
the data. In all cases for which two k.J values are reported, 
the probability that the biexponential model is valid was 
greater than 0.99. The possibility that the second dissociating 
population arises from mass transfer effects was ruled out 
by showing that the dissociation behavior showed no 
dependence on flow rate (data not shown). 
RESULTS 
lgG Binding to Immobilized FeRn Fits a Model for Two 
Noninteracting Classes of Binding Sites. We immobilized 
FeRn on a biosensor chip and measured the biosensor 
response at equilibrium (Req) for the binding of a series of 
concentrations of a monoclonal IgG. Since large amounts 
oflgG were needed for injections at high concentrations (and 
polyclonal rat and mouse IgG bind to rat FeRn with 
approximately equal affinities (/9)], we used a mouse 
monoclonal IgG I antibody available in the laboratory (I B5 
(/3)]. 
Ko's are typically derived from biosensor data using a 
Scatchard plot. in which the slope of the plot of Reql[injected 
protein] versus Req is equal to -1/Ko. Determination of 
binding constants by this method is straightforward for a 
single class of identical independent sites. However, if there 
are multiple classes of independent sites or cooperative 
interactions between sites, the resulting function is nonlinear, 
and the interpretation is far more complicated. The Scatchard 
plot for the interaction between immobilized FeRn and the 
IB5 IgG shows marked nonlinearity (Figure lA), as also 
observed for the FeRn interaction with other IgGs [data not 
shown; discussed in (6, 8)]. In the previous work, only the 
data points that correspond to the high-affinity interaction 
were considered for calculation of the high-affinity Ko. 
An alternative method of analysis involves a plot of the 
equilibrium biosensor response as a function of the log of 
lgG concentration, and nonlinear regression fitting of these 
data to a binding model (Figure IB). This method is 
preferred over Scatchard analysis for the derivation of 
binding affinities because (i) the affinity constant is derived 
using concentrations of protein that bracket the Ko, whereas 
an affinity can be extrapolated using an inappropriate 
concentration range in a Scatchard analysis, and (ii) less 
propagation of experimental error leads to more accurate 
calculated affinities (20). 
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800 1000 
Best Frt Parameters Quality of Rt 
Model Ko,t Ht It Ko,2 Hz 12 Ko.3 Ia r2 rmsd Free rmsd 
nM ')(, jiM ')(, jiM ')(, RU RU 
t-Site <10 tOO 0.92 59 7t 
t-al 77 0.49 tOO 0.994 1<1 20 
2-Site t6 63 1.2 37 0.9997 3 4 
2-Hil ts t.Ot 60 1.2 0.88 40 0.9997 3 7 
3-Site t5 60 1.6 30 0.25 9 0.9998 2 4 
fiGURE I: Comparison of Scat chard and nonlinear regression analyses for determining the affinity of IgG binding to immobili:ted FeRn. 
FeRn was coupled to a density of 2200 RU (for the experiment shown, and with similar results to densities from 2000 to 4000 RU, data 
no1 shown), and I_B5 IgG was injected at the concentrations indicated on the right panel. The same equilibrium binding data are plotted for 
Scatchard analysis (panel A) and directly as function of IgG concentration (panel B). The Scatchard plot is distinctly nonlinear. The five 
data points shown as open squares (which correspond to the five lowest IgG concentrations) were used to deterrnine a best fit line from 
which a high-affinity Ko of 14 nM was derived. The data were also fit using nonlinear regression analysis to five potential binding models. 
The best fit lines for three of the models are shown; the two most complicated models superimpose closely upon the ''Two Sites" model 
and were omitted for clarity. The best fit parameters and measures of the quality of fit for each of the models, as defined under Materials 
and Methods, are shown below the plots. The two-site model is the best representation because it is the simplest model that fully accounts 
for the data. 
The binding data were fit to models assuming one, two, 
or three noninteracting sites and one or two interacting sites. 
As shown in Figure lB. the assumption of a single class of 
binding sites results in a relatively poor fit to the experimental 
data as judged by the correlation coefficient and rmsd. 
Adding a Hill coefficient to account for cooperativity among 
a single class of binding sites improves the fit to the data, 
but the cooperativity model does not fit the experimental 
data points as well as a model assuming two classes of 
noninteracting binding sites. This model predicts the pres-
ence of a second lower affinity class of binding sites which 
are not saturated unless high concentrations of lgG are 
injected. 
More complicated models (three classes of noninteracting 
binding sites and two classes of cooperative binding sites) 
also fit the experimental data well. Addition of parameters 
to a model will usually improve the best fit to the data, 
therefore resulting in a lower rmsd, but carries the risk of 
overfilling, i.e., modeling the noise. A model that accurately 
reproduces the experimental signal should also fit well to 
data which are excluded while fitting the model parameters 
(the statistical principle of cross-validation). Using the cross-
validation method of testing statistical models (21), we 
calculated a "free rmsd" for each model. The two nonin-
teracting sites model produced both a lower rmsd and a free 
rmsd than either of the one-site models, demonstrating that 
the two site model more fully accounts for the data. When 
two Hill coefficients are included in the two-site model, the 
rmsd stays the same, but the free rmsd increases slightly, an 
example of overfitting the data. Addition of a third class of 
sites yields a slightly lower rmsd compared to the two 
noninteracting sites model, but a comparable free rmsd, and 
thus does not significantly improve the fit of the model to 
the data. 
The preceding analyses demonstrate that the interaction 
of IgG with immobilized FeRn is best represented as two 
independent classes of IgG binding sites. The class of 
receptor binding sites with high affinity for lgG is populated 
at lower lgG concentrations. The derived binding affinity 
for the high-affinity class of binding sites (Ko.l = 16 nM) 
corresponds to the Ko calculated from a Scatchard analysis 
when only the points corresponding to the high-affinity 
interaction are considered [Ko = 14 nM; Figure lA, and 
see ref (6, 8)], but the identification of these points is 
somewhat arbitrary. The second class of binding sites is 
populated at higher concentrations of lgG. An accurate 
estimate of the binding affinity of this class of binding sites 
can only be derived when the concentration range of ligand 
brackets the K0 , which requires large amounts of IgG (-1 
mg per experiment). Under these conditions, the derived 
binding affinity for the lower affinity class of sites (K0 ,2) is 
1.2 ,uM (Figure JB). 
Kinetic Differences between the Classes of FeRn Binding 
Sites for lgG. For each concentration of lgG, we analyzed 
the dissociation of lgG from immobilized FeRn. After the 
biosensor response reached an equilibrium level, dissociation 
of IgG was monitored for at least 2 min, and the dissociation 
phase was analyzed using single and biexponential rate 
equations. A two-exponential dissociation rate equation fits 
the data better than a single-exponential rate equation. The 
fast and slow dissociation rates are sufficiently different to 
calculate the contribution of each species to the total 
equilibrium biosensor response for each concentration of IgG. 
The components of the equilibrium response corresponding 
to the fast and slow dissociating populations were each fit 
to a model of one noninteracting binding site, demonstrating 
that the slow dissociating species binds with a high affinity 
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FIGURE 2: Analysis of the dissociation kinetics for the complex of 
lgG and immobilized FeRn. FeRn was coupled to a density of 2000 
RU, and the dissociation kinetics of FcRn/lgG complexes formed 
at different IgG concentrations were analyzed. For IgG concentra-
tions above 20 ,uM. the dissociation kinetics are best represented 
as a sum of two exponential decays: one with a fast rate constant 
and the other a slow rate constant. The contributions to the 
equilibrium response from the fast dissociating population (R1.,.) 
and the slow dissociating population (R.-) were determined and 
plotted as a function of lgG concentration. These data were fit to 
one-site binding models, and the total equilibrium response (Roou~) 
was fit to a two-site model. The derived binding affinities (below 
panel) show that the slow dissociating population binds with high 
affinity, and the fast dissociating population binds with low affinity. 
In ordc:r to determine whether the two populations equilibrate 
independently or one forms from the other, we examined the 
dissociation behavior after various equilibration periods for a single 
IgG concentration (2.2 ,uM). A single concentration of lgG was 
passed over immobilized FeRn and allowed to bind for various 
times. The total response at the time of dissociation was measured, 
and the components of this response dissociating with fast and slow 
kinetics were calculated. The biosensor response for each population 
is relatively constant for each equilibration period, supponing the 
hypothesis that the two populations of complexes equilibrate 
independently (data not shown). 
(Figure 2). Thus, both the equilibrium measurements and 
the dissociation kinetics are consistent with two populations 
of FcRn/lgG complexes: a high-affinity, slow dissociating 
species; and a low-affinity, fast dissociating species. 
Since most previous determinations of FeRn binding 
affinities included an equilibration step followed by a 
washing step [e.g., (/2, 22, 23)], we examined the depen-
dence of the observed affinity on the duration of a washing 
step. Different concentrations of IgG were passed over 
immobilized FeRn, and the response was measured at 
equilibrium, and at 30, 60, and 600 s into the dissociation 
phase (Figure 3A). The equilibrium data were fit to a model 
of two independent binding sites. The other curves were fit 
assuming the values derived at equilibrium for the high- and 
low-affinity binding constants. Because the low-affinity 
complex dissociates faster, the fraction of IgG bound to the 
high-affinity class of binding sites increases with washing 
time. Indeed, after 10 min of washing, the fraction of 
complexes in the low-affinity class becomes negligible, and 
the data can be modeled as a single class of noninteracting 
binding sites (Figure 3B; Scatchard plots of these data 
become progressively more linear with increased washing 
time). We conclude that experiments which include room 
temperature washing steps of several minutes or longer would 
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not detect either the biphasic nature of equilibrium Scatchard 
plots or the presence of a low-affinity class of binding sites. 
High-Affinity Binding of FeRn to lgG Requires Receptor 
Immobilization. In previous studies of the interaction 
between FeRn and IgG, we noted differences in binding 
affinities depending on which species was immobilized on 
the biosensor surface (7, 8). In order to characterize these 
differences, we immobilized the IgG used for the previous 
experiments (I B5) on the biosensor surface, and measured 
the equilibrium binding response for various concentrations 
of soluble FeRn (Figure 4). A best fit for each of the 
previously discussed five models was calculated. Using the 
criteria outlined above, the data are best modeled as two 
classes of independent FeRn binding sites on immobilized 
IgG. Comparing the affinities calculated for IgG im-
mobilized to those calculated for FeRn immobilized dem-
onstrates that, while the low-affinity binding constants are 
similar (Ko.l = 2.4 ,uM for IgG immobilized; Ko.2 = 1.2 
,uM for FeRn immobilized), the high-affinity class of binding 
sites interacts more weakly when IgG is immobilized (K0 .1 
= 210 nM for lgG immobilized; Ko.1 = 16 nM for FeRn 
immobilized). The dissociation kinetics for the FeRn 
interaction with IgG immobilized were also examined. As 
was the case with FeRn immobilized, the dissociation 
behavior is better modeled as two independently dissociating 
complexes than as a single species. Consistent with the 
comparison of the equilibrium binding results, the slow 
dissociating species dissociates faster when IgG rather than 
FeRn is immobilized (k.t,1 ~ O.Ql s-1 for IgG immobilized; 
k.t_, from 0.002 to 0.0002 s-• for FeRn immobilized), while 
the fast dissociation rates are similar (k.i.l ~ 0.0 l s-1 for either 
IgG or FeRn immobilized). 
In order to examine if the difference in the affinity of the 
high-affinity class of binding sites generally depends on 
which species is immobilized, we did a systematic study of 
the binding interactions of nine different IgG molecules at 
pH 6.0, and derived Ko values corresponding to the high-
affinity class of sites. For each monoclonal antibody. 
separate experiments were conducted with the antibody 
immobilized and with the receptor immobilized. For the 
interaction of each antibody with FeRn, the dissociation rate 
is slower and the affinity is higher when FeRn, rather than 
the IgG, is immobilized (Table 1). Because we see this effect 
for all of the IgG molecules tested, we conclude that these 
observed diffenences in affinity are a general property of 
the IgG/FcRn interaction. 
Comparison of the Interaction of FeRn with lgG versus 
Fe. The binding site for FeRn is located within the Fe region 
of lgG, but the effects of including the F.., arms of an intact 
antibody upon the FeRn interaction with Fe have not been 
systematically analyzed using biosensor technology. We 
therefore compared binding of several sets of IgGs and their 
corresponding Fe fragments to immobilized FeRn (Table 2). 
In each case, the binding data reveal the existence of high-
and low-affinity populations of FeRn. The affinities and 
dissociation rates for IgG and Fe binding are similar, although 
high-affinity (Ko.1) FcRnllgG complexes are slightly weaker 
interacting than the high-affinity FcRn/Fc complexes. This 
effect could be entropic (due to constraint of the IgG F.., 
arms upon FeRn binding) and/or because the bulky Fab arms 
interact unfavorably with FeRn. k.t,1 is faster for the Fe 
fragments (by a factor of -2) than for the corresponding 
intact antibodies. The combination of faster dissociation 
rates and higher affinities for the high-affinity FcRn/Fc 
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FtGURE 3: Effect of washing time on observed lgG affinity for immobilized FeRn. FeRn was coupled to a density of 2200 RU, and various 
concentrations of I B5 !gO were injected. The biosensor response at equilibrium and after various washing durations is plotted as a function 
of concentration for the interaction of lgG with immobilized FeRn (panel A). The equilibrium data were best fit to a two site binding 
model. The curves representing experiments employing washing steps of 30, 60, or 600 s were fit to a two-site model constrained to the 
binding affinities detennined using the equilibrium data. Because the low-affinity population dissociates with faster kinetics (Figure 2 and 
text), the washing step selectively depopulates the low-affinity site. Although biosensor methods allow equHibrium binding to be measured 
directly, many other methods employ a washing time of several minutes. For washing times of 10 min or longer, the Scatchard plots of 
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Best Frt Parameters Quality of F1t 
Ko.2 112 12 Ko.3 Is r2 rmsd Free rmsd 
11M % 11M % RU RU 
0.994 36 47 
0.11993 12 18 
2.4 34 0.99995 3 6 
0.7 0 .74 85 0 .11911117 2 6 
1.11 31 100. 13 0.11911118 3 21 
FtGURE 4: Soluble FeRn binding to immobilized lgG. IBS lgG was immobilized to a density of 3700 RU (for the experiment shown, and 
with similar results to densities from 1300 to 13000 RU, data not shown), and various concentrations of FeRn were injected. The biosensor 
response at equilibrium is plotted as a function of the concentration of IgG. Five binding models (see Figure I) were fit to the data; again, 
the two-site model best represents the data. Asterisk: the third binding affinity in the three site model was fixed at 100 pM. Without 
constraint, this affinity and the corresponding R.,.. both increased toward infinity. 
interaction compared to the high-affinity FcRnllgG interac-
tion implies that Fe fragment association rates must be faster 
(by a factor of - 4). 
DISCUSSION 
To achieve high-affinity binding comparable to that 
observed for cell surface FeRn, we find that the receptor, 
rather than its ligand, must be immobilized on the biosensor 
chip. Previously reported binding affinities for the interaction 
of lgG with rat FeRn on the surface of brush border, 
intestinal, or transfected cells are in the range of K0 = 8-55 
nM (7, 1 2). In the present study, we observe affinities 
ranging from 17 to 93 nM for a series of soluble lgGs binding 
to immobilized FeRn. For the complementary interaction, 
soluble FeRn interacting with the same IgGs, we consistently 
observed a lower affinity and faster dissociating class of 
FcRnllgG Binding 
Table I: Dependence of the High-Affinity Binding Mode on the 
Species Immobilized" 
FeRn immobilized lgG immobilized 
Ko.o A4.o Ko.o k...o 
(nM) (I0-3 s-•) (nM) (IO-l s-•) 
mlgGI 22 1.9 250 30 
mlgG2a 39 o.s 370 20 
mlgG2b 41 0.2 260 40 
rlgGI 34 0.7 180 40 
rlgG2a 1.5 0.3 80 10 
rlgG2b 93 0.7 • • 
rlgG2c 84 1.3 740 20 
anti-C04 (rlgG2a) 24 0 . .5 74 30 
IBS(mlgGI) 17 1.0 210 10 
• Equilibrium dissociation constants and dissociation rate constants 
are reponed for the interaction of FeRn with monoclonal lgGs. For 
each lgG studied, either FeRn or the lgG was coupled to the biosensor 
surface. FeRn was coupled to a density of 2600 RU (and several 
concentrations between 2000 and 4000 RU for the I BS measurements). 
The same protocol was followed for coupling each lgG, resulting in 
densities between SOO and 7000 RU (•: rlgG2b was not coupled 
successfully with this protocol). Regardless of the coupling density, in 
each case in which IgG is immobilized, the high-affinity interaction is 
weaker and shows faster dissociation kinetics than the corresponding 
interaction when FeRn is immobilized. Only the high-affinity Ko values 
are reponed for these experiments. The low-affinity K0 's could not be 
accurately determined because the quantities of most of the lgGs were 
limited, and we were not able to assay equilibrium binding at the high 
concentrations required to saturate the low-affinity binding mode. As 
can be seen by the close agreement of high affinity binding constants 
derived from three independent assays of I BS binding to immobilized 
FeRn (Figures 1-3), the high-affinity binding mode can be accurately 
measured in experiments in which the low-affinity mode is not saturated. 
The equilibrium and kinetic constants reponed for I BS binding to 
immobilized FeRn are the average of the three experiments involving 
I BS presented in this paper. 
Table 2: Comparison of Binding Affinities of Intact lgGs and 
Corresponding Fe Fragments for Immobilized FeRn• 
Ko.o k.. .o 
(nM) (10-l s-•) 
3F4 lgG (mlgG I) 49 0.6 
3F4 Fe II 2 . .5 
Hu lgG (polyclonal) IS o.s 
Hu Fe 9.7 0.9 
Rat lgG (polyclonal) 4. 1 0.6 
Rat Fe l.S 1.3 
• FeRn was coupled to a biosensor chip to a density of 2600 RU. 
Affinities were derived for a two-site binding model by nonlinear 
regression analysis. Rate constants reponed are an average for all 
concentrations of lgG injected. 
binding sites (Table I). The weaker affinities of immobilized 
lgGs for FeRn are comparable to the 500 nM Ko obtained 
by isothermal titration calorimetry for the interaction of 
soluble FeRn with human IgG (/4). We conclude that FeRn 
must be constrained to some sort of two-dimensional surface 
(a membrane or a biosensor chip) to achieve high-affinity 
binding of IgG. In vivo, FeRn is an integral membrane 
protein that interacts with soluble JgGs; therefore, the 
interaction of immobilized FeRn with soluble IgG should 
be more representative of physiological conditions than the 
reverse situation (immobilized IgG interacting with soluble 
FeRn). In the study of the interaction between cholera toxin 
and gangliosides, it was also noted that biosensor analyses 
with the normally membrane-associated gangliosides im-
mobilized reproduced whole cell assays more closely than 
free solution measurements, presumably because the bio-
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sensor measurements were performed on surfaces resembling 
the cell membrane (24). 
Several previous studies support the hypothesis that two 
FeRn molecules dimerize, as observed in FeRn and FeRn/ 
Fe crystals (3, 25), to form the high-affinity binding site for 
a single IgG. A 2: I receptor: ligand stoichiometry was 
observed for rat FeRn interacting with IgG in solution and 
in crystals of the receptor/Fc complex (14, 25). Site-directed 
FeRn mutants with alterations that specifically affect the 
interaction of IgG with FeRn dimers, but not with monomers, 
show reduced affinities in biosensor assays and in measure-
ments of labeled IgG binding to cell surface FeRn (7). 
Finally, the role of FeRn dimerization in its interaction with 
lgG was directly tested by introducing cysteines at positions 
that either facilitated or hindered receptor dimerization when 
FeRn was coupled to a biosensor chip using thiol chemistry 
(8). High-affinity binding (Ko = 22 nM) was observed when 
FeRn was coupled in the orientation facilitating dimerization, 
but the binding affinity was reduced to a K0 > 4 ,uM when 
receptor dimerization was hindered. In the present study, 
the Ko values derived for the high-affinity population of 
immobilized FeRn are similar to those observed for dimer-
ization-facilitated FeRn (8), implying that the high-affinity 
population represents lgG bound to receptor dimers. When 
FeRn is immobilized on a biosensor chip, it is attached to a 
long flexible dextran moiety at concentrations 2::-100 ,uM 
(26). This FeRn concentration is much higher than the 
concentration of soluble FeRn interacting with immobilized 
IgG, and therefore the equilibrium between monomeric and 
dimeric FeRn will be shifted to include a larger fraction of 
dimer when FeRn is immobilized. Immobilization of FeRn 
also reduces the loss of entropy associated with dimerization, 
the major energetic hindrance to dimerization (27). The 
entropy of the monomer and of the dimer is reduced upon 
immobilization to the dextran molecules because some of 
their rotational and translational movements are restricted. 
Since the loss of entropy upon immobilization occurs twice 
for monomers but only once for a dimer, the loss of entropy 
upon dimerization is lower for immobilized FeRn than for 
soluble FeRn. Both of these effects promoting dimerization 
(higher local concentration and reduction in the Joss of 
entropy) should increase the affinity for lgG for both 
membrane-associated FeRn and FeRn immobilized on a 
biosensor chip relative to the IgG affinity of soluble FeRn. 
Previous biosensor analyses of the interaction of im-
mobilized FeRn with IgG were complicated by nonlinear 
behavior in Scatchard analyses (6, 8). Here we show that 
two classes of noninteracting FcRnllgG complexes are 
sufficient to explain this nonlinear behavior, and characterize 
them as a slow dissociating population with a similar affinity 
to the range of values calculated in studies using membrane-
bound FeRn (7, /2), and a fast dissociating population with 
lower affinity. We have shown that it is the high-affinity 
mode that depends on which species is immobilized. 
The low-affinity (K0 .2) fast dissociating (k.u) binding 
component is similar with either IgG or FeRn immobilized. 
This binding mode could exist under physiologically relevant 
conditions or could result from some specific property of 
the biosensor analysis. Characteristics of biosensor meth-
odology that have been proposed to potentially alter a binding 
interaction include mass transfer properties of the soluble 
ligand and effects on the receptor due to its immobilization 
(26, 28, 29). Mass transfer considerations are imponant 
when evaluating kinetic data but irrelevant under equilibrium 
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conditions. Since the low-affinity populations are observed 
under equilibrium conditions, they cannot result from mass 
transfer effects. It is unlikely that the low-affinity FeRn 
population is an artifact of the amine coupling method 
because ldnetic analysis revea.led two classes of lgG binding 
sites for FeRn immobilized by thiol coupling methods (8). 
Using any coupling chemistry, steric hindrance of one 
immobilized FeRn molecule by another and/or occlusion of 
unoccupied binding sites by bound IgG molecules could 
introduce nonideal binding behavior. However. the excellent 
agreement of the equilibrium binding response to a two-site 
model suggests that this is not a significant effect in our case. 
If the low affinity-binding mode is not biosensor specific, 
then a population of FeRn molecules with low affinity for 
IgG could exist under physiological conditions. However, 
it would be difficult to detect on biological membranes 
because the techniques used to measure this interaction 
generally require a washing step that is long relative to the 
dissociation rate of the low-affinity complexes. and would 
therefore result in nearly complete dissociation of these 
complexes (Figure 3). Regardless of the origin of the low-
affinity population, we can separate the contributions of the 
high- and low-affinity binding interactions. Therefore, our 
observations about the high-affinity binding mode are 
independent of the existence of a low-affinity mode. 
Biosensor-based methods have been used to study the 
interaction between FeRn and IgG (6-8, 30), and these 
characterizations agree well with the results from in uiuo 
and cell binding studies (7, 12, 31, 32). Some of the lessons 
we have learned in our studies may be relevant in other 
biosensor-based investigations. We have calculated binding 
constants using equilibrium rather than ldnetic data because 
the Iauer can lead to incorrect results if the data are mass 
transfer limited or the reaction mechanism is unknown (26, 
28, 29). In these analyses, we used a best fit procedure that 
optimizes the agreement between the observed and modeled 
equilibrium binding response equally for all concentrations 
of ligand. This method is preferable to Scatchard analyses 
which overemphasize the poorly determined weaker binding 
responses. The use of cross-validation, which has been 
widely used in the refinement of crystallographically-derived 
protein structures (33), allowed us to detect instances in 
which the addition of extra parameters resulted in overfitting 
the data by modeling noise rather than the signal. This 
method should be generally applicable for biosensor analyses. 
The significant differences in affinities we observe depending 
on which species is immobilized highlight the imponance 
of characterizing a binding interaction in both orientations. 
Finally, for the special case of two noninteracting populations 
of binding sites with different dissociation rates, utilization 
of the dissociation phase of the measurement, either by 
delayed sampling or by modeling the dissociation phase and 
treating the components of the total response separately, 
could allow characterization of each population of binding 
sites. 
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Identification of critical lgG binding epitopes on 
the neonatal Fe receptor 
Daniel E. Vaughn, Christina M. Milburn, David M. Penny, W. Lance Martin, 
Jennifer L. Johnson and Pamela J. Bjorkman 
The neonatal Fe receptor (FeRn) binds maternal immunoglobulin G 
(IgG) during the acquisition of passive immunity by the fetus or newborn. 
FeRn also binds IgG and returns it to the bloodstream, thus protecting IgG 
from a default degradative pathway. Biosensor assays have been used to 
characterize the interaction of a soluble form of rat FeRn with IgG, and 
demonstrate that FeRn dimerization and immobilization are necessary to 
reproduce in vivo binding characteristics. Here we report the identification 
of several FeRn amino acid substitutions that disrupt its affinity for IgG and 
examine the effect of alteration of residues at the FeRn dimer interface. The 
role of these amino acids is discussed in the context of the previously 
reported structures of rat FeRn and a complex of FeRn with the Fe portion 
of IgG. 
Introduction 
The neonatal Fe receptor (FeRn) binds immunoglobulin G (IgG) in two important 
physiological processes (reviewed in (Junghans, 1997)). In the transmission of passive 
immunity from mother to offspring, FeRn mediates the transcytosis of maternal IgG across 
fetal and/or neonatal tissues, depending on the species involved. FeRn also binds IgG 
inside cells that degrade serum proteins and returns it to the bloodstream, thus rescuing it 
from a default degradative pathway. Each of these processes is facilitated by the pH 
dependence of the FeRn interaction with IgG (Rodewald, 1976; Rodewald & Kraehenbuhl, 
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1984). Under slightly acidic conditions (pH 6.0), FeRn binds IgG with a Ko of 
approximately 20 nM, while under slightly alkaline conditions (pH 7.5) there is no 
detectable binding for IgG concentrations of severalllM (Raghavan et al., 1995a). 
Unlike other known Fe receptors which are composed of tandemly repeated 
immunoglobulin-like domains, FeRn is homologous to class I major histocompatibility 
complex (MHC) molecules (reviewed in Raghavan & Bjorkman, 1996). The FeRn light 
chain is 132-microglobulin (132m) (Simister & Rees, 1985), the same light chain that 
associates with class I MHC heavy chains. The heavy chains of both FeRn and class I 
MHC molecules consist of three extracellular domains, a 1, a2, and a3, followed by a 
transmembrane region and a short cytoplasmic sequence (Simister & Mostov, 1989; 
Bjorkman & Parham, 1990). The extracellular region of FeRn and class I MHC heavy 
chains exhibit low but significant sequence identity (22-30% for the a 1 and a2 domains, 
35-37% for the a3 domain) (Simister & Mostov, 1989). The 2.2 A crystal structure of the 
extracellular region of rat FeRn revealed the expected structural similarity to MHC 
molecules and suggested the participation of a dimer of FeRn heterodimers in ligand 
binding (Burmeister et al., 1994a). In each of three crystal forms used in the FeRn 
structure determination, a dimer of FeRn molecules mediated by contacts between the a3 
and 132m domains was observed. The FeRn dimer was also observed in the crystal 
structure of a 2:1 complex of FeRn and the Fe fragment of rat IgG which was solved to a 
resolution of -6.5 A (Burmeister et al., 1994b). Although the limited resolution of this 
structure determination prohibited a detailed analysis of the molecular interaction, the 
approximate binding region on each molecule could be localized (Figure 1 ). 
Results from studies to map the binding sites on FeRn and IgG are consistent with 
the binding interaction observed in the FcRn/Fc crystal structure. Three sites on the IgG 
ligand have been identified as important for the binding of mouse and rat FeRn: Ile253, 
His310, and the region including His433, His435 and His436 (Kim et al., 1994a,b,c; 
Raghavan et al. , 1994; 1995a; Medesan et al., 1997; Figure 2A,B). Mutation of residues 
Il-3 
within each of these epitopes disrupts both binding to FeRn in vitro and FeRn mediated 
transport in vivo (Kim et al., 1994a,b,c; Raghavan et a!., 1995a; Medesan et al., 1997). 
There is less information available concerning the functional epitope on FeRn for binding 
IgG. Site directed mutagenesis was used to identify two regions on rat FeRn that exert a 
slight effect on its affinity for rat lgG: His250 and His251, and the a3 domain loop 
comprising residues 219-224 (Raghavan et al., 1994). Neither of these regions is at the 
direct interface between the "primary" FeRn molecule that shows the majority of contacts 
with Fe in the 2:1 FeRn complex involving the FeRn dimer (Figure 1 ). His 250 and His 
251 are at the FeRn dimer interface where they may exert their effect on IgG binding 
affinity either by modulating formation of the FeRn dimer, which is required for high 
affinity binding of IgG (Raghavan et al., 1994; 1995b), or by direct contact between Fe 
and the "secondary" FeRn molecule of the FeRn dimer (Figure 1) (Weng et al., 1997). 
Similarly, residues 219-224 of the secondary, but not the primary, FeRn molecule are in a 
position to contact Fe (Weng et al. , 1997). 
Because of the low resolution of the available FcRn/Fc cocrystal structure, we 
cannot identify specific FeRn residues at the IgG interface with certainty. To further 
characterize the epitope on FeRn, we designed, constructed, and expressed mutants of rat 
FeRn at the predicted interfaces with IgG and with the second FeRn in the receptor dimer. 
We have quantitatively characterized the IgG binding interaction for each of these FeRn 
mutants using a biosensor based assay (Raghavan et al., 1994, 1995a,b; Vaughn & 
Bjorkman, 1997). In this assay, soluble FeRn immobilized on a biosensor surface 
reproduces the affinity for IgG and the pH dependent interaction observed for membrane 
bound FeRn in vivo or on transfected cells (Mackenzie, 1984; Raghavan et al., 1994 ). We 
have used the assay to demonstrate that high affinity binding of IgG requires both FeRn 
dimerization and receptor immobilization (Raghavan et al., 1995b; Vaughn & Bjorkman, 
1997). Here we identify several residues on rat FeRn that exert a major effect on binding 
affinity for murine or rat IgG, discuss the implications for pH dependent FcRn/IgG binding 
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and FeRn dimerization, and compare the results to other known receptor-ligand and 
protein-protein interaction systems. 
Results 
82m mutants at the FcRn-Fc interface 
Using the FcRn/Fc cocrystal structure (Burmeister et al., 1994b), we identified 
FeRn residues predicted to contact Fe. Most are located on the a2 domain of the primary 
receptor, with fewer contributions from the al and B2m domains of the primary receptor 
and the a3 domain of the secondary (dimer-related) receptor. To verify the contacts 
between Fe and the primary FeRn predicted by the low resolution cocrystal structure, we 
constructed eight FeRn mutants. 
The cocrystal structure predicts that theN-terminal portion of B2m contacts the Fe 
CH2 domain (Figure I, 2A). To test this hypothesis we examined the binding of three 
mutants: BI 1 A, BQ2A, and B-1 Y (Table 1 ). In order to avoid potential exchange of mutant 
rat B2m for endogenous hamster B2m or bovine B2m in the medium, these mutations were 
introduced into a lipid-linked version of rat B2m that associates with the truncated FeRn 
heavy chain at the cell surface. This form of lipid-linked wild type FeRn was previously 
shown to bind IgG with the known physiological pH dependence (Gastinel et al., 1992). 
The affinity of these mutants for radiolabeled IgG was evaluated using a cell binding assay 
(Table 2) . The binding response at equilibrium was plotted as a function of the log of the 
concentration of IgG and fit to a model assuming one class of binding sites (Figure 3A). 
The binding behavior of FeRn at the cell surface may be more complicated (see Vaughn & 
Bjorkman, 1997 for a discussion), but the data from the cell binding assays are too noisy to 
reliably fit more complicated binding models. However, the affinity derived using the cell 
binding assay agrees with high affinity binding constants obtained using a biosensor assay 
(Kn = 24 nM, cell binding assay; Ko,J = 24 nM, biosensor assay (Vaughn & Bjorkman, 
1997); in both cases a rat IgG2a monoclonal antibody against CD4 was used). When the 
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mutants were examined using the cell binding assay, we find that substitution of theN-
terminal lie of B2m with alanine (BI I A), or extension of theN-terminus by one additional 
residue (B-1 Y), eliminates significant IgG binding at concentrations up to 0.9 IJ.M, 
corresponding to a MG of> 2 kcal/mol (Table 2). However, substitution of Gln-2 of the 
B2m domain with alanine (BQ2A) results in binding similar to wild type FeRn (Table 2; 
Figure 3A,B), although the total binding response is increased presumably because the 
BQ2A mutant is expressed at a higher level than the wild type construct as shown by FACS 
analysis (data not shown). 
FeRn heavy chain mutants at the FcRn-Fc interface 
In order to more completely characterize the binding, we used a surface plasmon 
resonance assay to measure the binding affinities between IgG and soluble forms of wild 
type and mutant receptors. Biosensor analyses of the interaction of IgG with soluble FeRn 
immobilized on a biosensor chip show non-linear behavior in Scatchard plots (Raghavan et 
al., 1995a,b). We recently demonstrated that the interaction oflgG with immobilized FeRn 
is best described as two classes of non-interacting FcRn/IgG complexes: a slow 
dissociating population with an affinity in the range of values calculated in studies using 
membrane-bound FeRn (Mackenzie, 1984; Raghavan et al. , 1994), and a fast dissociating 
population with lower affinity (Vaughn & Bjorkman, 1997). As previously described 
(Vaughn & Bjorkman, 1997), plots of the net equilibrium response versus the log of the 
concentration of injected ligand were analyzed using linear regression to derive the percent 
of FcRnllgG complexes comprising each population (f 1 and f2), the high and low affinity 
binding constants (KD,l and Kn,2 respectively), and the maximum combined binding 
response (Rmax,tot; Table 2). 
Two mutations to the FeRn heavy chain were made in order to test the importance 
of potential aromatic and/or aliphatic contacts predicted from the cocrystal structure: 
Wl33A and 84-86 (Table 1). FeRn Trp-133 is exposed to solvent in the structure of FeRn 
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alone (Burmeister et al., 1994a), and is in a position where it could interact with Ile-253 of 
Fe which was identified as a critical residue on Fe for interaction with FeRn (Kim et al., 
1994a,b,c; Raghavan et al., 1995a; Medesan et al. , 1997) (Figure 2A). We find that IgG 
binding to the W133A mutant is extremely weak even at J.I.M concentrations (Figure 4A). 
Thus the affinity of this mutant for lgG is > 8 11M corresponding to a MG of> 4 kcal!mol 
(Table 2). The 84-86 mutation (Table 1) encompasses three of the four amino acids in the 
at domain that are predicted to be within 5 A of the Fe ligand in the cocrystal structure 
(Figure 2A). We find that replacement of these residues with the corresponding residues 
from class I MHC molecules (Kabat et al., 1991) results in a binding affinity similar to 
wild type (Figure 4A; Table 2). 
Much of the pH dependence of the FcRn-Fc interaction has been assigned to the 
titration of histidine residues on the Fe ligand (Raghavan et al., 1995a). There are several 
acidic residues on the a2 domain of the receptor that could interact electrostatically with the 
protonated form of these histidines. Glu-117 is positioned near Fe His-310, Glu-132 and 
Glu- I 35 are near Fe His-435, and Asp- I 37 is in the vicinity of Fe His-435 (Figure 2B). 
Three mutations (E117S, El32Q&El35Q, and Dl37N) were constructed to test the 
functional importance of these acidic residues (Table I). Neither E 117S nor 
E132Q&E135Q bind IgG significantly at concentrations up to 8 11M (Figure 4B; Table 2). 
The DI37N mutant binds IgG slightly at J.lM concentrations, but the binding affinity is also 
> 8 11M (Figure 4B; Table 2). For each mutant, the calculated high affinity binding is 
reduced by greater than 1000-fold, corresponding to a MG of more than 4 kcal/mol. 
FeRn mutants at the dimer interface 
In order to examine the effects on IgG binding of mutations at the FeRn dimer 
interface, we made mutations at two additional positions within FeRn. Based on the crystal 
structures of FeRn alone and the FcRn/Fc complex (Burmeister et al., 1994a,b), Gly- I 9I 
is positioned such that side chains introduced at this position should interact with position 
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191 of the dimer related FeRn molecule (Figure 2C). We constructed two mutants (G 191E 
and G 191 H) to examine the effect of substitution at position 191 (Table 1). Both mutations 
have a slight (-4-fold) effect on the high affinity binding constant (Kn,I) when FeRn is 
coupled at densities greater than 2500 RU (Figure 5A; Table 2). Both mutants also show a 
reduction in the total number of binding sites (Rmax,tot) and the fraction of high affinity 
binding sites (ft) compared to wild type FeRn. IgG binding is further reduced when the 
FeRn concentration on the chip is lowered by coupling at lower densities. Under these 
conditions, high affinity binding is further reduced (6- to 10-fold) and the fraction of high 
affinity and total number of binding sites are again reduced relative to wild type FeRn 
(Figure 5B; Table 2). 
We next examined the effects of mutating B2m residue Glu-89. This residue is in 
position to form a salt bridge with either His-250 or His-251 of the dimer-related FeRn 
heavy chain (Figure 2C). We previously showed that mutation of His-250 and His-251 
results in a 6-fold reduction in affinity for IgG (Raghavan et al., 1994). Two mutations 
were constructed (BE89H and BE89K) to test the role of Glu-89 in dimer formation and 
IgG binding (Table 1 ). Similar to the mutations at Gly-191, substitution of Glu-89 with 
either a histidine or a lysine results in a slight reduction in high affinity IgG binding, and a 
reduction in the fraction of high affinity IgG binding sites (Figure 5C; Table 2). Unlike the 
Gly- I 91 mutations, however, the total number of binding sites is not reduced, and the 
effect on affinity is largely independent of coupling density (Figure 5D; Table 2). 
Discussion 
Functionally critical residues for protein-protein interactions can be mapped by site 
directed mutagenesis followed by determination of mutant binding affinities. This is an 
especially powerful method when high resolution structures are available to identify the 
residues at the receptor-ligand interface. One of the best characterized protein-protein 
interfaces is the interaction between human growth hormone (hGH) and its receptor 
Il-8 
(hGHR). Wells and colleagues have systematically changed all the residues that compose 
the crystallographically observed interface between the hormone and its receptor (DeVos et 
al., 1992) to alanines, and find that only a small subset of the amino acids at the interface 
(approximately 5 of the 24-31 residues) are responsible for most of the binding affinity 
(reviewed in (Wells & DeVos, 1996). Thus there is a distinction between the " functional 
epitope" (those residues that exert a major effect upon the binding affinity; 660 > 2 
kcal/mol for substitution of a single amino acid to alanine) and the "structural binding site" 
(all residues at the interface). 
In the case of the interaction between FeRn and IgG, the structural binding site 
cannot be identified with certainty using the available low resolution FcRn/Fc cocrystal 
structure (Burmeister et al., 1994b). The IgG binding site was tentatively identified as 
primarily formed from a surface of the cx2 domain with additional potential contributions 
from residues in the at domain, the top surface of the B2m domain, and/or the cx3 domain 
of a dimer related molecule (Burmeister eta/., 1994b). Because the complex structure was 
determined using crystals that diffracted to only about 6.5 A and a portion of the Fe CH2 
domains was disordered in the final electron density maps, we sought experimental 
confirmation of the IgG binding site on FeRn. The identification of several amino acid 
substitutions that substantially disrupt IgG binding within the structural epitope predicted 
from the low resolution cocrystal structure provides this confirmation. We have identified 
several amino acid mutations (W 133A, E117S, DI37N, El32Q&El35Q, BIIA and B-IY) 
that result in a decrease in the free energy of binding of more than 2 kcaJ/mol (Table 2). 
These mutants, and all mutants in this study, are correctly folded as assayed by monocJonal 
antibody reactivity and heterodimer assembly (see Methods). Thus FeRn heavy chain 
residues Trp-133, Glu-117, Asp-137, either Glu-132, Glu-135 or both, as well as Ile- 1 
and theN- terminus of B2m comprise much of the functional IgG binding epitope. 
Well characterized functional binding epitopes for protein-protein interfaces often 
include surface exposed hydrophobic residues that make important contributions to the free 
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energy of binding. For example, hydrophobic interactions contribute to the binding energy 
in several antibody-antigen interactions (Kelley & O'Connell, 1993; Tsumoto et al., 1995; 
Dall' Acqua et al., 1996). In addition, the binding affinity for the hGH/hGHR interaction 
arises primarily from hydrophobic interactions, with electrostatic interactions being Jess 
important (Wells & DeVos, 1996). For hGHR, the largest contributions to the free energy 
of binding come from Trp-1 04 and Trp-169. Replacement of either residue with an alanine 
results in a loss of binding free energy of more than 4.5 kcal/mol. The next three largest 
contributions also are made by hydrophobic residues (Ile-103, Ile-1 05, and Pro-1 06), each 
with loss of binding free energy of 1.5 to 3.5 kcal/mol. For the hormone, both polar and 
hydrophobic residues show significant decreases in binding free energy when substituted 
with alanine residues. Interestingly, several of the polar residues (e.g., Lys-172, Thr-175, 
and Arg-43) use the aliphatic portions of their side chains to contact the receptor. 
There is also a strong hydrophobic component to the interaction between FeRn and 
its IgG ligand. Previous reports have implicated Ile-253 as part of the ligand's functional 
epitope (Kim et al., 1994a,b,c; Raghavan et al., 1995a; Medesan et al., 1997). Here we 
have shown that Trp-133 is part of the receptor's functional epitope. From the crystal 
structure of the complex, these two hydrophobic side chains are known to be positioned 
near each other (Figure 2A). Thus Ile-253 of the ligand and Trp-133 of the receptor are 
likely to form the hydrophobic core of a binding interface similar to those seen for hGH-
hGHR and in several antibody-antigen interactions (Kelley & O'Connell, 1993; Tsumoto et 
al., I995;Dall'Acquaetal., 1996;Wells&DeVos, 1996). 
In addition to hydrophobic effects, the FcRn-Fc interface relies on strong 
electrostatic interactions to provide binding free energy. It was previously shown that His-
31 0 and one or more of Histidine residues 433, 435, and 436 of the Fe ligand are 
necessary for full binding affinity and in vivo function (Kim et al., 1994a,b,c; Raghavan et 
al., 1994; 1995a; Medesan et al., 1997). Here we have identified three FeRn mutations, 
El17S, D137N, and El32Q&EI35Q, that dramatically reduce binding affinity. Since 
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these substitutions are conservative, most replacing only the negatively charged carboxylate 
group with a neutral amide group, it is likely that the disrupted interactions are salt bridges. 
In the FcRn/Fc cocrystal structure, each of the mutated acidic residues from FeRn are near 
one or more of the implicated Fe histidine residues (Figure 2B), suggesting that the 
protonated histidines form a pH-dependent salt bridge to the corresponding acidic residues 
on FeRn. 
The approximately wild type binding of the 84-86 mutant, suggests that these 
residues within the FeRn cd domain do not contribute to the functional IgG binding site, 
while the substantially reduced binding of BilA and B-1 Y demonstrates that the B2m light 
chain does. The hydrophobic Ile side chain at theN-terminus of B2m is positioned near the 
side chains of Fe residue 309 (Leu, Val, Gin, or Met in rat, murine, and human IgG's; 
(Kabat eta/., 1991)) and Fe residue 311 (Gin or Arg in rat, murine, and human IgG's; 
(Kabat et al., 1991)), and could form a hydrophobic interaction with the aliphatic portions 
of one or the other of these sidechains. Extension of theN-terminus by one residue by the 
addition of a bulky tyrosine residue (B-1 Y) could reduce binding through a steric 
hindrance. Alternatively, the N-terminal extension could affect binding by blocking a 
specific interaction with theN-terminal amino group. In proteins, a-NH2 groups have a 
pKa that is generally -8 (Fersht, 1985). In FeRn, the presumably protonated a-NH2 
group of B2m is positioned where it can form a hydrogen bond with the backbone carbonyl 
of residue 115 on the heavy chain and also a pH dependent salt-bridge with Glu-117. Thus 
the protonated a-NH2 group of B2m could help position Glu-117 of the heavy chain to 
form an anionic binding site for His-31 0 of the Fe ligand. 
Inhibition studies using anti-B2m specific monoclonal antibodies previously 
suggested the involvement of the FeRn B2m domain in binding to lgG (Raghavan et al., 
1994). This suggestion is confirmed by the present demonstration that the N-terminal 
region of B2m constitutes a functional epitope for ligand binding. Crystal structures show 
that B2m interacts similarly with the heavy chains of class I MHC molecules and FeRn 
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(Bjorkman & Parham, 1990; Burmeister et al., 1994a). In both cases, the B2m and a3 
immunoglobulin-like domains of FeRn and class I MHC molecules are related by a 152• 
+1- T rotation followed by a -13 A translation that positions the B2m domain underneath 
the a l-a2 domain platform (Burmeister et al., 1994a and references therein). The 
conservation of this asymmetric a3-B2m interaction serves different functional purposes 
since the B2m position in FeRn is critical for interaction with its IgG ligand, yet the same 
B2m position is found in MHC molecules, which do not function as receptors for IgG. 
The present study extends the results from previous work indicating that two FeRn 
molecules dimerize, as observed in FeRn and FcRn/Fc crystals (Burmeister et al. , 
1994a,b), to form the high affinity binding site for a single IgG. We previously reported 
that FeRn mutants with alterations that specifically affect the interaction of IgG with FeRn 
dimers but not with monomers (residues 250 and 251 or the loop comprising residues 219-
224; Figure 1) showed reduced affinities in biosensor assays and in measurements of 
labeled IgG binding to cell surface FeRn (Raghavan et al., 1994). Here we report two 
additional regions that affect FeRn dimerization and/or the interaction of Fe with the FeRn 
dimer. Mutations at FeRn residue 191, which interacts with its counterpart on the dimer 
related receptor, result in a lower affinity and fewer high affinity binding sites. These 
effects are enhanced at lower receptor density, suggesting that mutation of this residue 
exerts its effect through interference with FeRn dimer formation. By contrast, mutation of 
B2m residue Glu-89 results in a slight reduction in binding affinity which is not dependent 
upon FeRn coupling density and is not accompanied by a significant reduction in the 
number of binding sites. These results suggest that B2m Glu-89 interacts primarily with 
the IgG ligand directly rather than the dimer-related FeRn heavy chain. Disorder of the Fe 
CH2 domain makes it difficult to identify potential contacts for Glu-89 from the cocrystal 
structure (Burmeister et al., 1994b). However, a direct interaction between the Fe CH2 
domain and residues at the dimer interface near B2m Glu-89 (FeRn His 250 and His 251) 
was suggested by modeling studies using a computational docking algorithm to predict the 
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orientation of the Fe CH2 domain when bound to FeRn (Weng et al., 1997). If Fe 
becomes distorted upon binding to the FeRn dimer as predicted by the modeling studies, 
B2m Glu-89 could contact the CH2 domain. 
Conclusions 
We have designed and constructed several amino acid substitutions on FeRn to map 
its binding site for IgG. The identification of several mutations that reduce the IgG affinity 
confirm and further define the IgG binding site on FeRn that was identified at low 
resolution in the FcRn-Fc cocrystal structure (Burmeister et al., 1994b). These 
functionally important IgG binding epitopes on FeRn complement previously reported 
binding epitopes on Fe (Kim eta/., 1994a,b,c; Raghavan eta/., 1994; 1995a; Medesan et 
al. , 1997). Ile-253 of Fe and Trp-133 of FeRn are likely to form the core of a strong 
hydrophobic interaction, while Glu-117, Glu-132, Glu-135 and Asp-137 on the receptor 
provide anionic binding partners for the protonated forms of His-310, His-433, His-435 
and His 436 of the ligand. Finally, amino acid substitutions for Gly-191 at the dimer 
interface display an FeRn concentration dependent effect on lgG affinity, providing 




IB5, a mouse IgGl monoclonal antibody against human Zn-a2-glycoprotein 
(Sanchez et al., 1997) whose interaction with wild type FeRn has been previously 
characterized (Vaughn & Bjorkman, 1997), was used for biosensor binding assays. Anti-
CD4 (rat IgG2a) used in the cell binding assays was purchased from Boehringer 
Mannheim. Its interaction with wild type FeRn has also been characterized in a biosensor 
assay (Vaughn & Bjorkman, 1997). Two mouse lgGl anti-FeRn monoclonal antibodies, 
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1G3 and 4Cll (Raghavan et al., 1994), were used for immunoaffinity chromatography, 
enzyme-linked immunosorbent assays (ELISAs), immunoprecipitations, and fluorescence 
activated cell sorting (FACS). Rabbit anti-human 132m and peroxidase-conjugated anti-
mouse, as well as goat FITC-conjugated anti-rabbit antibodies were purchased from 
Boehringer Mannheim. Iodobeads were obtained from Pierce. 125J (specific activity -100 
mCi/ml) was obtained from Amersham in the form of sodium iodide. N-ethyi-N' -(3-
diethylaminopropyl)-carbodiimide (EDC), N-hydroxysuccinimide (NHS), BIAcore 
surfactant P20, and CM5 sensor chips were obtained from BIAcore AB. CNBr-activated 
Sepharose and PD-10 columns were purchased from Pharmacia. 
Construction and expression of mutant FeRn molecules 
Locations for FeRn mutants were chosen using the crystal structures of FeRn alone 
(Protein Data Bank entry lFRU) and a complex between FeRn and Fe (Protein Data Bank 
entry 1 FRT). For expression of soluble mutant FeRn heterodimers, the cDNAs encoding 
the truncated FeRn heavy chain (residues 1-269) (Gastinel et al., 1992) or rat 132m were 
altered by site directed mutagenesis (Kunkel et al., 1987). After verifying the sequence of 
the altered cDNAs, the mutant cDNAs were subcloned into the expression vector pBJ5-GS 
which carries the glutamine synthetase gene as a means of selection and amplification in the 
presence of the drug methionine sulfoximine (Bebbington & Hentschel, 1987). 
Cotransfection of FeRn and 132m expression vectors into Chinese hamster ovary (CHO) 
cells, selection, and amplification were carried out as described (Gastinel et al., 1992; 
Raghavan et al., 1994). Cell supernatants were screened for FeRn heterodimer expression 
by a sandwich ELISA, using either the FeRn heavy chain-specific monoclonal antibody 
1G3 or 4C11 as the capture antibody and a polyclonal antiserum against human 132m to 
detect positive samples as described (Raghavan et al., 1995b), and confirmed by 
immunoprecipitation with the other antibody. Mutant proteins that retained functional 
binding to IgG were purified from the supernatants of the highest expressing clones by pH 
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dependent binding to a rat IgG column (Gastinel et al., 1992). Mutants that did not bind 
IgG sufficiently for IgG-affinity chromatography were purified using an immunoaffinity 
column constructed with an anti-FeRn monoclonal antibody. Purified 103 antibody was 
covalently attached to CNBr-activated Sepharose following the manufacturer's protocol. 
Binding and elution conditions for FeRn binding to the 1 G3 column were identified using a 
biosensor assay of wild type FeRn interacting with amine coupled 1 G3 at pH 8 (see 
below). Supernatants from cells expressing wild type or mutant FeRn proteins were 
passed over the IG3 column at pH 7.5, which was subsequently washed with -10 column 
volumes of 50 mM sodium phosphate (pH 7.5 - 8.5) and eluted with 50 mM sodium 
phosphate (pH 3.0). Eluates were immediately neutralized with l M disodium phosphate. 
These elution conditions did not affect the ability of wild type FeRn to bind again to the 
l G3 column or the behavior of wild type FeRn in subsequent biosensor assays (data not 
shown). 
For expression of membrane bound FeRn mutants, mutations were introduced into 
a previously described lipid-linked version of rat B2m that pairs with the truncated FeRn 
heavy chain at the surface of transfected cells (Gastinel et al., 1992). The lipid-linked B2m 
protein consists of the phosphatidylinositol anchoring signal of decay-accelerating factor 
(DAF) (residues 311 -347; (Caras et al., 1987)) fused to the final amino acid of B2m (B2m-
DAF). Altered B2m-DAF cDNAs were sequenced and subcloned into the PBJ5-GS 
expression vector, which was co-transfected into CHO cells along with the expression 
vector encoding wild type soluble FeRn. After two to four weeks, populations were 
screened for heterodimer expression by immunostaining at pH 8.0 with the anti-FeRn 
antibody 1 G3 and FITC-conjugated goat anti-mouse secondary antibody. High expressing 
lines were isolated by single cell FACS. Cell sorting and analysis was performed on a 
Coulter Epics Elite flow cytometer using Coulter Elite software version 3.0. 
The correct folding of each of the FeRn mutants used in this study was 
demonstrated by several experiments. First, each of the mutants is either expressed on the 
II-15 
cell surface or secreted, therefore none of the mutations results in intracellular retention as 
would be expected for mis folded proteins. Second, all mutants assemble into 
hete rodimers, as verified either by SDS-PAGE analysis of purified protein and in a 
sandwich ELISA for secreted mutants or by cell surface reactivity with an anti-FeRn heavy 
chain monoclonal antibody for the mutations introduced into lipid-linked B2m and 
expressed as heterodimers with soluble FeRn heavy chains (data not shown). Finally, each 
mutant retains the immunoreactivity of wild type FeRn for monoclonal antibodies generated 
against correctly folded wild type FeRn ( 4C 11 and I G3; Raghavan et al., 1994). All 
secreted mutants were selected using a sandwich ELISA and immunoprecipitation 
employing 4C II and I G3 , non-IgG binding mutants were purified on a I G3 
immunoaffinity column, and cells expressing lipid-linked mutants were isolated by flow 
cytometry using I G3. The correct folding of each mutant was expected since each of the 
mutations were introduced into residues that are solvent exposed in the crystal structure of 
FeRn (Burmeister et al., l994a). 
Purification and Iodination of IgG 
Purified anti CD4 was iodinated using iodo-beads according to the manufacturer's 
protocol. Briefly, one to two beads were rinsed in I ml of 100 mM sodium phosphate 
buffer pH 6.0, dried on filter paper and added to a mixture of 20 f..ll of 125J in 180 f..ll of the 
same buffer. After five minutes, 0.5 ml (0.4 mg) of purified IgG was added and the 
mixture was allowed to incubate for approximately 15 minutes at room temperature. 
Unreacted 125J was removed by gel filtration using a PD- 10 column. 
Cell binding assays 
Cells expressing wild type FcRn/B2m-DAF or mutant FcRn/B2m-DAF were grown 
to confluence in tissue culture plates and assayed for IgG binding as described (Raghavan 
et al. , 1994). Cells were detached , pe lleted, washed and resuspended in binding buffer 
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(Hank's balanced salt solution, lO mM HEPES, 0.25% bovine serum albumin, pH 6.0) to 
a concentration of approximately 3 X I Q6 cells/mi. In triplicate assays 3 X IQ5 to 5 X IQ5 
cells were mixed with various amounts of 125J labeled IgG and binding buffer to a total 
volume of 0.5 mi. The samples were incubated for at least 2 hours at room temperature, 
then pelleted and the supernatants removed and set aside. Cell pellets were washed with 
1.0 ml of cold binding buffer. The levels of radioactivity in the supernatants and cell 
pellets were measured using a Beckman gamma 5500 counter. Non-specific binding was 
determined by similar treatment of untransfected CHO cells. The concentration of free IgG 
was determined from the radioactivity in the supernatant and the specific activity of the 
labeled IgG. The binding response was similarly calculated from the radioactivity in the 
washed cell pellet. 
Biosensor experiments 
A BIAcore biosensor system (Biacore AB) was used to evaluate the interaction of 
secreted mutant and wild type FeRn proteins with IgG as previously reported (Vaughn & 
Bjorkman, J 997) and references therein). Briefly, wild type or mutant FeRn proteins were 
immobilized to a biosensor chip surface using standard amine coupling chemistry as 
described in the BIAcore manual, and different concentrations of purified IgG were injected 
over the immobilized FeRn. IgG concentrations were determined spectrophotometrically 
using an extinction coefficient at 280 nm of 216000 M-1 cm-1 (IgG; Fasman, 1989) . 
Sensor chip surfaces were regenerated by injecting a pulse of 50 mM phosphate, 150 mM 
NaCI, pH 8. Variation in coupling densities was achieved by varying the chip activation 
step from 4 to 7 minutes. 
Because systematic errors can contribute to the uncertainty of Ko determinations 
(including the slight variations in the pH of the binding buffer, the specifics of the coupling 
reaction, the concentration of the ligand, and the specific batch and purification state of the 
ligand), Ko values can be more accurately compared for experiments conducted in parallel 
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on the same chip. For each experiment, wild type FeRn, one or two mutants, and buffer 
without protein were coupled in one of the four available flowcells. The same dilution 
series of ligand and a buffer blank were passed over each flow cell, and the response at 10 
minutes (taken as the equilibrium response) was recorded after subtraction of the buffer 
response. A modest response was observed for higher ligand concentrations (> -62 nM) 
in mock-coupled flow cells, reaching a maximum of -200 RU at the highest ligand 
concentration of 8 11M. This blank response, most likely due to either the bulk refractive 
index contribution of the ligand and/or a nonspecific low affinity interaction with the 
dextran matrix of the chip, was subtracted from the equilibrium responses recorded for 
FeRn coupled flow cells to yield a net equilibrium response. 
Calculation of binding affinities and changes in the free energy of binding 
For both the cell binding and biosensor assays, the equilibrium binding response 
was plotted as a function of the log of the free IgG concentration. These data were fit to 
either a model of one or two noninteracting binding sites by nonlinear regression as 
previously described (Vaughn & Bjorkman, 1997). In each case in which a model of two 
non-interacting sites is used, the two site model produces a lower cross-validated residual 
(Vaughn & Bjorkman, 1997) than the one site model. Ko and Rmax (response 
corresponding to complete binding) values are presented when a single class of non-
interacting sites was modeled, and Ko, 1 (high affinity binding constant), Ko.2 (low affinity 
binding constant), f1 (fraction of total binding sites corresponding to the high affinity class 
of binding sites) and Rmax,tot (response corresponding to complete occupancy of both 
classes of binding sites) values are presented when two classes of non-interacting sites 
when modeled (Table 2). For each of these parameters, standard errors are also reported as 
determined in the KaleidaGraph implementation of the Levenberg-Marquardt algorithm, 
which reflect the precision of individual curve fittings (Table 2). The reproducibility of the 
derived affinities is+/- -20% as evaluated by comparing the six independent Ko values 
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reported for wild type FeRn from experiments conducted on different biosensor chips 
(Table 2). L\L\G values were calculated as 2.303RT log[KmutiKw.d for the high affinity 
binding constant (Kn,l) where R is the gas constant (1.99 x lQ-3 kcal mol-l K-1) and Tis 
the absolute temperature (295 K). Results from biosensor experiments in Table 2 
correspond to the interaction of wild type and mutant FeRn proteins with the 1B5 
monoclonal IgG. Similar results were obtained for experiments on FeRn mutants that 
interact directly with IgG using the anti-CD4 IgG (data not shown). 
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Table 1. FeRn mutants 
Mutant Domain Position(s) Mutation 
Fc-FcRn Interface 
BllA B2m-DAF 1 I ->A 
BQ2A B2m-DAF 2 Q ->A 
B-lY B2m-DAF N-terrninus addY 
W133A <X2 133 W->A 
84-86 al 84-86 NQI->GYY 
E117S a2 117 E -> S 
El32Q&E135Q a2 132 and 135 BothE-> Q 
D137N a2 137 D->N 
Dimer Interface 
G191E a3 191 G ->E 
G191H a3 191 G ->H 
BE89H B2m 89 E->H 
BE89K B2m 89 E-> K 
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Table 2. Characterization of IgG binding to FeRn mutants 
Mutant Ko,t ft Ko.2 Rmax,tot .:\.:\G F 
(nM) (%) (J.!M) (RU) (kcal/mol) 
Fc-FcRn Interface: 
Wild Type 24±4 0.129 ± o.oo8a 
BllA >> 900 N.B. >>2 
BQ2A 10±2 0.60 ± 0.04a -0.5 
B-lY >>900 N.B. >>2 
Wild Type 12±2 43 ±2 1.1 ± 0.3 910 ± 30 
W133A > 8000 13{)C >4 
84-86 6.0 ± 0.6 62±2 0.9 ± 0.2 1430± 30 -0.4 
Wild Type 4.9 ± 0.4 66±2 0.7 ± 0.2 1890 ± 30 
D137N > 8000 25{)C >4 
El17S >> 8000 N.B . >>4 
E132Q&E135Q >> 8000 N.B . >>4 
Dimer Interface: 
Wild Type 6.3 ± 0.4 60± 1 0.9 ± 0.1 1410 ± 20 
G191E 25 ± 5 41 ±3 2.2 ± 0.7 650 ± 40 0.8 
Gl91H 21 ±4 39±2 1.9 ± 0.5 740 ± 30 0.7 
Wild Type 10. ±I 54± 3 0.9 ± 0.2 580 ± 20 
GI91E 57± 5 41 ± 1 4.4 ± 0.9 370 ± 20 1.1 
Gl91H 90± 30 37±4 5±4 350 ± 60 1.4 
Wild Type 6.7 ± 0.6 54±2 0.8 ± 0.1 1250 ± 20 
BE89K I9±2 43 ± 3 1.2 ± 0.2 1180 ± 30 0.6 
BE89H 22±2 46±2 1.4 ± 0.2 1310 ± 20 0.7 
Wild Type 7 ±I 54± 3 0.6 ± 0.2 880 ± 20 
BE89K 27 ±2 38 ±2 1.7 ± 0.5 720 ± 30 0.8 
BE89H 22 ± 2 37 ± 3 1.5 ± 0.4 660 ± 20 0.7 
N.B. =no binding detected 
a Arbitrary units on the same relative scale 
b Affinity measurements done using lipid-linked FeRn at the cell surface 
c Observed binding response at highest IgG concentration (8 ~) 
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Primary FeRn Secondary FeRn 
Figure 1. Ribbon diagram of the cocrystal structure of the FeRn dimer binding to its Fe 
ligand. The high affinity binding site for IgG is formed by a homodimer of two FeRn 
molecules identified as the "Primary FeRn" (cyan and light green) and the "Secondary 
FeRn" (blue and dark green). Each FeRn molecule is composed of a multidomain heavy 
chain (cyan or blue) and a single domain light chain (~2m; green). The Fe ligand (red) 
interacts with the heavy chain a2 domain and ~2m domain of the primary FeRn, and the 
heavy chain a3 domain of the secondary receptor. Previously characterized FeRn heavy 
chain mutations that affect ligand binding (see text for details) are shown in magenta. The 
FeRn dimer interface shown as a close-up in Figure 2C is indicated by a black box. 
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Figure 2. Close-up views of the mutated amino acids on FeRn. Orientations are the same 
as shown in Figure 1 (panels A and B) or rotated by 45° about a horizontal axis (panel C). 
Substituted amino acids are highlighted in yellow (mutations described and characterized in 
this text) or magenta (previously characterized mutations). Other colors are as described 
for Figure 1. Highlighted positions are: (A) Ile-1 (11) and Gln-2 (Q2) of ~2m, amino acids 
84 to 86 (84-86) and Trp-133 (W133) of the FeRn heavy chain, and Fe Ile-253 (1253); (B) 
His-310 (H310), His-433 (H433), His-435 (H435), and His-436 (H436) of the Fe and 
Glu-117 (E117), Glu-132 (E132) , Glu-135 (E135), and Asp- 137 (D137) of the FeRn 
heavy chain; and (C) Gly-191 (Gl91) , His-250 (H250), His-251 (H251) of the FeRn 










































Figure 3. IgG binding to B2m mutants at the FcRn-Fc interface. Equilibrium IgG binding 
to membrane associated wild-type and mutant pQ2A FeRn is plotted as a function of the log 
of the IgG concentration. The best fit binding curves, modelled as a single class of non-
interacting binding sites, correspond to the values reported in Table 2. Two additional 
mutants (pi 12A and p-1 Y) showed no significant binding at IgG concentrations of~ 0.9 
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Figure 4. lgG binding to FeRn heavy chain mutants at the FcRn-Fc interface. Equilibrium 
IgG binding to wild-type and mutant FeRn proteins immobilized on a biosensor chip is 
plotted as a function of the log of the IgG concentration. The best fit binding curves, 
modelled as two classes of non-interacting binding sites, correspond to the values reported 
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Figure 5. lgG binding to FeRn mutants at the dimer interface. Equilibrium lgG binding to 
wild-type and mutant FeRn proteins immobilized on a biosensor chip is plotted as a 
function of the log of the lgG concentration. The best fit binding curves, modelled as two 
classes of non-interacting binding sites, correspond to the values reported in Table 2. 
Experiments were performed at high (panels A and C) and low (panels Band D) coupling 
densities. Values for coupling densities are indicated in parentheses. 
Structural basis of pH dependent antibody binding by 
the neonatal Fe receptor 
Daniel E. Vaughn and Pamela J. Bjorkman 
Background: The neonatal Fe receptor (FeRn) binds immunoglobulin G 
(lgG) with nanomolar affinity at pH 6, but shows no detectable binding at 
pH 7.5. At pH 6, FeRn is more thermally stable and the dissociation rate of 
its light chain is an order of magnitude slower than at pH 8.0. 
Results: We determined the structure of FeRn at pH 8 and compared it to a 
further refined version of the pH 6.5 structure. Extensive ordered 
carbohydrate is observed at both pH values. The two structures are very 
similar; thus the pH dependence of FeRn's stability and affinity for IgG can 
be attributed to chemical properties of the structures themselves rather than 
mechanisms that rely on conformational changes. 
Conclusions: FeRn dimerization, required for high affinity binding of 
lgG, is facilitated by reciprocal interactions in which carbohydrate from one 
receptor binds to protein residues from the dimer-related receptor to form a 
"carbohydrate handshake". The pH dependence of FeRn stability and 
binding to lgG are mediated by e lectrostatic interactions involving 
histidines. These interactions are more favorable for protonated histidines, 
which predominate at acidic pH values. 
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Introduction 
The neonatal Fe receptor (FeRn) binds immunoglobulin G (IgG) in two important 
physiological processes (reviewed in [1]). Mammals, and probably amniotes in general, 
transmit maternal lgG molecules to pre- or postnatal offspring in order to provide the 
newborn with humoral immunity to antigens encountered by the mother. This passively 
acquired lgG is critical during the first few weeks of life before the newborn develops a 
fully functional immune system. Depending on the species, FeRn mediates the 
transcytosis of maternal lgG across fetal and/or neonatal tissues in this acquisition of 
passive immunity. FeRn also functions in the adult, where it is involved in the 
maintenance of high serum lgG levels. FeRn rescues IgG from a default degradative 
pathway by binding lgG in endocytic vesicles of the cells that degrade serum proteins and 
mediating the return of IgG to the bloodstream. Both of these processes are facilitated by 
pH dependent lgG binding to FeRn [2,3]. At pH 6.5, FeRn binds IgG with nanomolar 
affinity while IgG binding to FeRn is not detectable at pH 7.5 [4]. 
The sharp pH dependence of FeRn binding to lgG is an unusual and characteristic 
feature of this protein-protein interaction. At least part of the pH dependence of the 
interaction comes from histidines at the CH2-CH3 domain interface of the lgG ligand [4-9]. 
Thus the FeRn binding site on IgG has evolved to interact in a pH dependent manner with 
FeRn. It is noteworthy that other Fe receptors (i.e., the various FcyRs of the 
immunoglobulin gene superfamily, none of which show pH dependent IgG binding) bind 
to a different region of lgG, involving the hinge and the hinge-proximal portion of the CH2 
domain (reviewed in [ 1 0]). This region is distant from the CH2-CH3 domain interface 
containing the conserved histidines implicated in FeRn binding. Several other proteins 
bind to lgG at the junction between the CH2 and CH3 domains. These include protein A 
[11], protein G [11,12], and rheumatoid factor autoantibodies [13]. One or more of the 
conserved histidines have been shown to be contact residues in complexes of these proteins 
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with IgG. Nonetheless, only the interaction of FeRn shows a sharp pH dependent binding 
profile. 
In addition to the pH dependence of IgG binding, FeRn shows other pH dependent 
properties. FeRn is more stable at pH 6 compared to pH 8 as assayed in thermal 
denaturation profiles [ 14]. Furthermore, the dissociation rate of the FeRn light chain from 
the heavy chain is an order of magnitude slower at pH 6 than at pH 8 [14]. Taken together, 
these results suggest that the interaction between the two chains of the FeRn heterodimer is 
altered over this narrow pH range. 
FeRn shows structural and sequence similarity to class I major histocompatibility 
complex (MHC) molecules (reviewed in [I 0]). The FeRn light chain, 62-microglobulin 
(B2m), is the same polypeptide that associates with class I MHC heavy chains [ 15]. The 
heavy chains of both FeRn and class I MHC molecules consist of three extracellular 
domains, a 1, a2, and a3, followed by a transmembrane region and a short cytoplasmic 
sequence [ 16, 17]. The 2.2 A crystal structure of a soluble form of rat FeRn corresponding 
to the ligand-binding extracellular region was solved at pH 6.5 [18]. In each of three 
crystal forms used in the FeRn structure determination, a dimer of FeRn heterodimers 
mediated by contacts between the a3 and B2m domains was observed (hereafter referred to 
as the "FeRn dimer"). FeRn dimerization is required for the formation of the 
physiological high affinity IgG binding site [19]. The FeRn dimer was also observed in 
the crystal structure of a 2:1 complex of FeRn and the Fe fragment of IgG determined at an 
effective resolution of 6.5 A [20]. The low resolution FcRn/Fc cocrystal structure revealed 
the approximate IgG binding site on FeRn, which was further defined by evaluating the 
IgG affinities of a series of FeRn mutants [21]. 
Here we report the structure of rat FeRn at pH 8. This structure determination 
reveals an extensive carbohydrate mediated interaction between the dimer related FeRn 
molecules that was not originally interpretable at pH 6.5 [18]. We also present a further 
refined structure of FeRn at pH 6.5 that includes the additional carbohydrate structure, and 
III-4 
discuss the physiological relevance of this interaction. The pH 8 and 6.5 structures are 
compared with specific attention to the pH dependence of FeRn stability and affinity for 
IgG. We propose a mechanism for pH dependent antibody binding to FeRn based on 
these structures and the body of structure/function literature concerning this interaction. 
Results & Discussion 
Solution of the pH 8 FeRn structure and refinement of pH 6.5 and pH 8 structures 
FeRn crystallizes in space group C222t both at pH 6.5 and at pH 8, although the 
unit cell dimensions are slightly different (Table 1). The pH 8 and pH 6.5 crystals both 
diffract weakly and suffer from extensive radiation damage when data are collected at room 
temperature, therefore data for the new pH 8 structure were collected from cryopreserved 
crystals using synchrotron radiation, as had been done previously for the pH 6.5 crystals 
[18]. The pH 8 crystals diffract to approximately 2.7 A resolution (effective resolution is 3 
A for F > 3cr), as compared to a 2.2 A nominal and 2.4 A effective resolution limit for the 
pH 6.5 crystals (Table 1 ). 
The pH 8 structure was solved by molecular replacement using the pH 6.5 
coordinates. The asymmetric units in both crystals include two FeRn molecules forming 
the FeRn dimer, and a third unpaired FeRn molecule referred to as the FeRn monomer. In 
both crystal forms , the FeRn monomer is not as well ordered as the FeRn molecules that 
form the dimer, as evidenced by higher average B factors (Table 1 ). To facilitate 
comparison of potentially small differences between the new structure at pH 8 and the 
previously determined structure at pH 6.5, the pH 6.5 structure was re-refined using more 
stringent application of non-crystallographic symmetry (NCS) restraints as recently 
recommended [22]. NCS restraints were set at 300 kcal moJ-1 A-2 for the whole molecule 
until regions that did not obey the NCS were identified manually. Later in the refinement, 
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the NCS unrelated regions were not restrained, while the restraint weight for the NCS 
related regions was optimized to minimize the freeR factor. The NCS unrelated regions are 
mainly interdomain linkers, at crystal contacts, or at the FeRn dimer interface. The 
conformations of the three NCS related FeRn molecules are similar ( 1.0 A and 0.8 A 
r.m.s. difference for all protein atoms in the pH 6.5 and pH 8 structures respectively). 
Within each domain, the regions which obey the NCS are nearly identical (0.3 A and 0.1 A 
r.m.s. difference for all protein atoms in the pH 6.5 and pH 8 structures respectively). 
In both structures, all 269 heavy chain and 99 light chain residues are observed in 
each of the three NCS related molecules, as well as a total of 18 sugar residues and three 2-
mercaptoethanol molecules covalently bound to the proteins. The newly refined pH 6.5 
structure includes 480 water and two sulfate molecules, while the pH 8 structure includes 
189 water and two sulfate molecules. Both structures have good model geometry, 
including >80% of the main chain phi-psi angles in the most favored regions of a 
Ramachandran plot and no residues in disallowed regions as defined in Procheck ([23]; 
Table 1). Both structures also adequately account for the observed diffraction data, with 
Rrree values less than 30% (Table I). 
Comparison of FeRn crystal structures at pH 6.5 and pH 8 
The structure of FeRn at pH 8 is similar, but not identical, to the pH 6.5 structure. 
The two crystal forms are not isomorphous; each refined model having an R-factor >50% 
when calculated using the diffraction amplitudes of the other data set. Rigid body 
refinement, treating the FeRn dimer and the unpaired FeRn molecule as separate rigid 
bodies to account for differences in the crystal packing interactions, reduces the R-factor 
from 53% to 41% for the pH 6.5 structure refined against the pH 8 data. When each of 
three domains (al plus a2, a3 and B2m) is treated as a separate rigid body, the R-factor is 
further reduced to 34.6%. When the pH 6.5 and pH 8 FeRn dimers have been 
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superimposed to align corresponding ex I ex2 platforms, the B2m and ex3 domains of the 
same FeRn are rotated 1.2· and 1.1 · respectively and the dimer related FeRn is rotated 3.o· 
(Figure 1) . Thus, there are minor differences in both the interdomain and intermolecular 
packing. Within each domain the structures are very similar (less than 1 A r.m.s. 
difference for all protein atoms within each domain), although there are a few sidechains 
that adopt alternate rotamers, most notably His-250 in the FeRn dimer (discussed below). 
Implications for pH dependent FeRn stability and ligand binding 
Although FeRn is more stable at pH 6 than at pH 8 [14], the crystal structures 
determined under acidic and alkaline conditions are very similar. The absence of large 
structural differences eliminates explanations that rely on conformational changes, allosteric 
effects or induced fits, and suggests that the pH dependent differences in stability and 
affinity for IgG are properties of the residues within the structures themselves. Histidines 
are likely to be involved in pH dependent protein interactions at pH values near neutral. 
The pKa for histidine in model compounds is 6.6 [24]. However, the actual pKa depends 
on the environment of the histidine side chain, most significantly on the solvent 
accessibility and the proximity of charged species (reviewed in [25]). Thus an imidazole 
group buried in the hydrophobic interior of a protein tends to have a pKa > 6.6, whereas 
proximity to a negative charge generally lowers the pKa. The usual range of pKa values 
observed for histidines in proteins is 5 to 8 [24]. 
FeRn contains ten histidine residues, six located on the heavy chain and four on 
B2m [16]. Electrostatic interactions between histidines and neighboring electronegative 
oxygen atoms are listed in Table 2. Within an FeRn molecule, there are two interdomain 
salt bridges (His-168 of the ex2 domain to Glu-54 of the ex I domain, and His-237 of the ex3 
domain to the C-terminal carboxylate group of B2m), and numerous other interdomain 
electrostatic bonds involving histidines (Figure 2). In these electrostatic bonds, the Na I or 
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Ne2 proton of histidine interacts with an oxygen atom carrying either a formal or partial 
negative charge. These interactions are more favorable for fully protonated histidines and 
thus stabilize FeRn at pH 6.5 relative to pH 8. Four of the interactions are between B2m 
and the FeRn heavy chain (His-10, His-237, B2m His-13, and B2m His-31; Table 2) thus 
directly stabilizing the association of the FeRn heavy and light chains at acidic relative to 
alkaline pH. This subset of histidine-mediated interactions accounts, at least in part, for the 
observed pH dependent difference in the rate of B2m exchange [14], while all the 
interactions listed in Table 2 potentially contribute to increased FeRn stability at pH 6. 
FeRn and class I MHC molecules share the same light chain, B2m. Only one of the B2m 
histidines forms an inter-subunit salt bridge. Of the six histidine residues on the FeRn 
heavy chain, only His-258 is conserved in class I molecules, which do not show pH 
dependent differences in stability [14]. Thus distinct structural features of FeRn cause its 
pH dependent properties, and these features involve interactions with specific side chains 
rather than a major rearrangement of domains or a large conformational change. 
The pH dependence of FeRn's interaction with IgG can also be attributed to 
chemical properties of the FeRn and Fe structures themselves rather than mechanisms that 
rely on conformational changes. The structures of the FeRn dimer at pH 6.5 and at pH 8 
are essentially the same as the structure of the Fc-bound FeRn dimer in the low resolution 
FcRn/Fc cocrystal structure [20]. Although IgG is flexible in solution [26] and 
presumably undergoes a loss of entropy upon FeRn binding due to trapping FeRn-bound 
Fe in one of its many solution conformations [27], there is no evidence that Fe undergoes a 
pH dependent conformational change [14]. As is the case for the pH dependent stability of 
FeRn, the pH dependence of IgG binding also appears to be mediated primarily by 
histidines. We propose the following mechanism for pH dependent IgG binding by FeRn 
(Figure 3a). At pH 8, most solvent exposed histidine residues will be deprotonated and 
carry no net charge, while at pH 6.5 and below, these residues will generally be protonated 
and carry a net positive charge. For each positively charged histidine, there is a 
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complementary anionic binding pocket, and thus these histidines form several pH 
dependent salt bridges. Specifically, there are three anionic binding sites on FeRn that 
accomodate histidines on Fe, and two anionic binding sites (one on each B2m molecule) 
that accept histidines on the dimer related FeRn molecule. We believe that the cooperative 
effect of these several pH dependent salt bridges are sufficient to explain the dramatic 
difference in IgG affinity between FeRn at pH ~ 6.5 and FeRn at pH ;?:: 7.5. 
On IgG, histidine residues critical for FeRn binding have been identified by 
mutagenesis and subtype studies. One of these is His-31 0. A triple site directed mutant of 
human IgG4 (Leu-309, His-3 1 0, and Gln-311 each to Gly) decreases the affinity for IgG 
from 22 nM to 1.9 !J.M [4], and a murine lgG 1 mutant (His-31 0 to Ala) shows greatly 
reduced transcytosis and protection from catabolism [9]. Histidine residues within loop 
433-436 of IgG have also been implicated, although the specific residues appear to vary 
among lgG isotypes. For human lgG4, His-433 but not His-435 is necessary for high 
affinity IgG binding [4] , while for murine IgG I both His-435 and His-436 but not His-433 
are necessary for both optimal in vitro FeRn binding and in vivo FeRn function [9]. 
FeRn res idues that are critical for lgG binding line three negatively charged pockets 
(Figure 3b). Critical residues were identified by site directed mutagenesis of FeRn side 
chains that are near Fe in the low resolution structure of the FcRn/Fc complex [20]. 
Substitution of FeRn heavy chain residues Glu-117 with Ser, Trp- 133 with Ala, Asp- 137 
with Asn, or both Glu-132 and Glu- 135 with Gin, reduces the affinity for a monoclonal 
murine lgG 1 from a Ko of 5 nM to a Ko more than 8 J.!M, a change in the free energy of 
binding of> 4 kcal/mol [2 1]. Similarly, substitution of 132m Ile- 1 with Ala, or extension 
of the B2m N-terminus one residue by addition of a tyrosine reduces the binding affinity to 
levels that are undetectable for I J.!M lgG (Ko >> 1 J.!M) [21]. The pockets lined by these 
residues are negatively charged, and could form anionic binding sites for protonated 
histidines. Although the resolution of the FcRn/Fc cocrystal structure is insufficient to 
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visualize the interaction of individual Fe histidines with anionic pockets on FeRn, they are 
in positions where they could form pH dependent salt bridges [20]. 
Formation of the FeRn dimer is also required for high affinity binding of IgG ( 19]. 
The interaction of FeRn residues His-250 and His-251 with Glu-89 on B2m of the dimer 
related molecule stabilizes this interaction, and can be directly compared in the structures of 
FeRn at pH 6.5 and pH 8 (Figure 3c, d). Mutation of His-250 and His-251 to the 
corresponding MHC class I residues (Gin and Asn) decreases IgG affinity -6 fold, while 
replacement of Glu-89 of B2m with either His or Lys decreases IgG affinity -3 fold, 
corresponding to changes in the free energy of binding of 1.1 and 0.7 kcal/mol respectively 
[7,21]. Thus the dimer related histidine salt bridges are less critical for IgG binding than 
the salt bridges between histidines on the ligand and anionic sites on the receptor. 
Nonetheless, these interactions are necessary for optimal lgG binding even though FeRn 
forms essentially the same dimer at pH 6.5 and at pH 8. There are slight differences at 
these sites between the pH 6.5 structure and that at pH 8 that might account for these 
effects. At pH 6.5, both histidine 250 and 251 extend across the dimer interface and 
interact with Glu-89 of B2m (Figure 3c), while at pH 8 only His-251 extends across the 
dimer interface (Figure 3d). At pH 8, the alternative conformation of His-250 allows it to 
form a salt bridge with the terminal carboxylate of the same heavy chain (Figure 2), and 
this conformation is seen in the FeRn monomer at both pH 6.5 and 8. 
Carbohydrate mediated dimer interface 
Several studies show that the FeRn dimer is required to form the high affinity 
binding site for a single lgG. A 2: I receptor: ligand stoichiometry was observed for rat 
FeRn interacting with IgG in solution and in crystals of the receptor/Fc complex [20,28]. 
Site directed FeRn mutants with alterations that specifically affect the interaction with FeRn 
dimers, but not with monomers, show reduced affinities for IgG [7,21]. The role of FeRn 
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dimerization in its interaction with IgG was directly tested by introducing cysteines at 
positions that either facilitated or hindered receptor dimerization when FeRn was coupled to 
a biosensor chip using thiol chemistry [ 19]. High affinity binding (Kn = 22 nM), similar 
to the affinity observed under physiological conditions [29], was found when FeRn was 
coupled in the orientation facilitating dimerization, but the affinity was reduced over 100-
fold when receptor dimerization was hindered [ 19]. 
There is an extensive interface between dimer related FeRn molecules. The a3 
domain from each molecule interacts with both the a3 and B2m domains from the dimer 
related molecule, while the only direct interaction between B2m domains is made between 
the side chains of Glu-74. The dimer is approximately two-fold symmetric with each 
molecule interacting through the loops connecting strands A and B and strands E and F of 
the a3 domain , and the G strand of B2m. However, the dyad symmetry is not exact; e.g., 
two sulfate molecules bind to one a3 domain of the dimer but not the other. 
In addition to the protein-protein interactions, much of the FeRn dimer interface is 
formed by interactions involving carbohydrates. We originally calculated that FeRn 
dimerization buries approximately 2100 A2 of surface area (1068 A2 contributed from 
each FeRn monomer) using the pH 6.5 structure that included three sugar residues from 
each molecule [ 18]. After interpretation of additional carbohydrate density at the dimer 
interface, we now calculate that dimerization buries 2600 A2 of surface area in the pH 6.5 
structure, of which 1100 A.2 are buried by carbohydrate. N-linked carbohydrate from one 
a 3 domain binds to an otherwise exposed hydrophobic surface on the dimer related a3 
domain (Figure 4a,b). Combined with the reciprocal interaction, this forms a 
"carbohydrate handshake" that could rationalize previously reported results that are in 
apparent contradiction. While the stoichiometry of rat FeRn with Fe or IgG is 2: I [20,28] , 
presumably reflecting the interaction of Fe with the FeRn dimer, the stoichiometry of 
mouse FeRn interacting with Fe in solution was observed to be I: I [30]. In the latter 
study, a soluble form of mouse FeRn was expressed in insect cells in which N-linked 
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carbohydrate structures differ from their mammalian counterparts. Proteins expressed in 
mammalian cells undergo additional processing steps on N-glycosides to add complex 
carbohydrate antennae relative to proteins expressed in insect cells, which stop 
carbohydrate processing at an earlier high man nose step [31 ,32] (Figure 4c ). The rat FeRn 
structure, which was solved using protein expressed in Chinese hamster ovary (CHO) 
cells, reveals intimate contacts between the a I ,6-linked antennae and dimer related 
hydrophobic amino acids that would not be possible if the carbohydrate moiety was of the 
high mannose type: e.g., the glucosamine group of Nag-509 penetrates into a pocket in the 
a3 domain formed by residues Arg-216, Ser-22I, Leu-242, Val-244, and Tyr-252 (Figure 
4b). Thus differences between the high mannose N-glycoside of mouse FeRn and the 
complex carbohydrate of rat FeRn could affect the propensity of FeRn to dimerize. Indeed, 
we observe that soluble mouse FeRn expressed in CHO cells interacts with Fe with a 2: I 
stoichiometry (L.M. Sanchez and P.J.B., unpublished results). Thus, it is likely that the 
complex carbohydrate antennae make specific contacts that facilitate formation of the high 
affinity 2: I FcRn/IgG complex. 
Although ordered N-glycoside sugars have been observed on other glycoprotein 
structures, it is unusual for more than about three sugar residues to be ordered. Exceptions 
include the structures of (i) a legume lectin, in which a plant-specific heptasaccharide is 
ordered at a crystal contact [33], (ii) the adhesion domain of CD2, in which a high 
mannose N-glycan stabilizes the protein fold [34], and (iii) the Fe fragment of IgG, in 
which complex oligosaccharides occupy the space between the dimer-related CH2 domains 
[II]. In both Fe and FeRn, theN-glycoside core and much of one antenna (Figure 4c) are 
modeled in each structure, with the other antenna being disordered. For Fe, it is the al ,3-
linked antenna that is ordered, while the a I ,6-linked antenna is seen in FeRn. 
Amongst these examples of ordered carbohydrate in protein structures, the FeRn 
carbohydrate is the only glycoside that facilitates a physiologically relevant dimerization. 
The ordered carbohydrate on Fe is the most comparable to that of FeRn, because in both 
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cases the carbohydrate includes residues specific to complex oligosaccharides, and is at a 
homodimer interface that obeys approximate two-fold symmetry. However, the Fe 
carbohydrate is not required for dimerization or function, as nonglycosylated Fe expressed 
in bacteria forms dimers that retain full in vivo function [5 ,6], perhaps because the 
glycoside in Fe primarily contacts other carbohydrate molecules on the dimer related 
molecule [11]. By contrast, the carbohydrate at the FeRn dimer interface makes contacts to 
dimer related protein residues (Figure 4a,b). Binding of the distal sugar residues to the 
dimer related FeRn presumably stabilizes the carbohydrate structure and allows its 
visualization in the electron density maps. Indeed, these sugars are disordered at both pH 
6.5 and pH 8 on the FeRn monomer that lacks a dimer-related partner. 
Biological implications 
The pH dependent interaction between FeRn and lgG is necessary forin vivo 
transport of IgG between acidic and basic pH environments. The structure of FeRn does 
not change significantly between pH 6.5 and 8, even though FeRn shows decreased 
stability at alkaline versus acidic pH [14]. A network of electrostatic bonds between the 
Nd I or Ne2 proton of histidines and oxygen atoms carrying either a formal or partial 
negative charge makes a set of interactions that are more favorable under acidic conditions 
that favor protonation of the histidine residue. We propose that these interactions 
contribute to the observed pH dependent stability of FeRn. Thus for FeRn, structural 
changes that lead to increased or decreased stability can be explained by subtle features 
rather than major conformational changes. As a second example of a system in which 
stability differences are not revealed as large conformational changes, class II MHC 
molecules that bind the CLIP peptide of the invariant chain are less stable than class II 
complexes with conventional peptide antigens, yet the crystal structures of both types of 
complexes are nearly identical [35]. 
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The characteristic feature of the FcRn/IgG interaction is its sharp pH dependence, 
which allows FeRn to bind IgG in early endosomes (pH -6.2) and release IgG at the cell 
surface (pH -7 .5). The use of titratable salt bridges by FeRn to bind IgG at pH 6.5 but not 
pH 8 is a simple but elegant mechanism that provides the necessary pH dependent affinity 
for FeRn to carry out its IgG transport functions in vivo. The lack of a conformational 
change between the FeRn structures solved at permissive and non-permissive pH 
conditions for ligand binding is in contrast to the classical pH dependent binding interaction 
of oxygen to hemoglobin. Hemoglobin undergoes a conformational transition between an 
"R" and "T" state that is influenced by the binding of numerous small molecules. Thus 
FeRn's pH dependent IgG affinity illustrates a molecular mechanism for sharply pH 
dependent binding that does not involve allosteric effects or conformational changes. 
To our knowledge, the FcRn/IgG interaction is the first detailed molecular 
mechanism of a receptor binding to a protein ligand with physiological pH dependence. 
Many other receptor-ligand pairs also make use of sharply pH dependent affinities to 
achieve the desired intracellular routing. For example, low density lipoprotein binds its 
receptor extracellularly at pH -7.5 and is released under the slightly acidic conditions of the 
early endosomes (pH - 6.2) [36]. Similarly, ape-transferrin binds to the transferrin 
receptor in acidic endosomes, but is released at the cell surface [37]. In the case of FeRn, 
most of the affinity for its ligand is achieved by the interactions between protonated 
histidines and anionic binding pockets [21 ]. By contrast, for other well-characterized 
protein-protein interactions, hydrophobic contacts provide much of the free energy of 
binding [38-41]. The predominance of electrostatic interactions involving titratable 
histidines in the binding of IgG by FeRn provides a mechanism to achieve sharply pH 
dependent receptor-ligand affinity that might be generally applicable. 
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Materials and Methods 
Crystallization and cryopreservation 
FeRn was expressed and purified as previously described [42]. Crystals were 
grown at 22·c in hanging drops by combining 2 Ill protein solution ( -20 mg/mL FeRn, 20 
mM PIPES pH 6.5, and 0.02% NaN3) with 2 Jll reservoir solution (15% PEG 3000, 100 
mM Tris pH 8.0, 100 mM (Nlf4)2S04 pH 8.0, and 30% ethylene glycol). Crystals grew 
to a mature size of about 0.5 mm x 0.5 mm x 0.3 mm in approximately two weeks. The 
crystals belong to space group C222J with unit cell dimensions a= 122.6, b = 193.1, c = 
149.0 A. These crystals suffered from severe radiation damage at room temperature, so 
diffraction data were collected at cryogenic temperatures. The crystal could be flash cooled 
either in liquid nitrogen or in a -17o·c nitrogen stream, although better results (higher 
resolution diffraction and lower mosaic spread) were obtained by initially cooling the 
crystals in a -120 to -14o·c nitrogen stream and slowly (over about 10 minutes) reducing 
the temperature of the nitrogen stream to -17o·c. 
Data collection and processing 
X-ray diffraction data of the pH 8 FeRn crystals were collected on beamline A 1 at 
the Cornell High Energy Synchrotron Source (CHESS) on the Princeton IK CCD detector 
(Table 3). Despite cryopreservation, the FeRn crystals decayed noticeably over the course 
of a data collection and therefore data were collected from five crystals. All data processing 
was done with version 1.5 of the HKL suite [43] . Several alternate data reduction 
strategies were examined (inclusion of different subsets of the five crystals, various 
statistical criteria for the rejection of individual observations and/or exclusion of invididual 
data frames) and assayed by the merging statistics of Friedel mates. Strategies that 
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improved traditional measures of data quality (i.e., Rmerge) without a corresponding 
reduction in the agreement between Friedel mates were abandoned. The final scaled data 
set includes data from three crystals, and while several whole images were discarded 
because of beam drift or crystal decay, no observations were discarded based on statistical 
assays or because of negative intensities. The average redundancy of 3.4 was comparable 
for all resolution bins. 
Structure solution and refinement 
Electron density fitting was done using the program "0" [44] . All 
crystallographic refinement was done using X-PLOR [45] with a maximum likelihood 
target function [46], a flat bulk solvent correction, and no low resolution or sigma cutoff 
applied to the data. As previously done for the pH 6.5 structure [ 18], a randomly selected 
5% of pH 8 structure factor amplitudes were excluded from automated refinement and 
used to compute a "free" R factor (Rrree) [47] throughout refinement. The chemical 
restraints included only repulsive terms with weights chosen to minimize the Rrree value; 
no electrostatic terms were included. Thus the refinement was independent of the assumed 
protonation state of each titratable residue. 
FeRn packs similarly in the pH 8 and pH 6.5 crystals, but there is a significant 
change in the pH 8 unit cell (Table I ). The initial search model for the pH 8 crystals was 
the pH 6.5 structure without solvent molecules that had been subjected to simulated 
annealing (3000 K) [48] with strong NCS restraints (300 kcal mol-l A-2). Initial molecular 
replacement maps revealed carbohydrate structure that was not modeled in original pH 6.5 
structure [18]. The pH 8 structure was built to include theN-glycoside, refined against the 
high pH data, and the model was then returned to the acidic pH crystal form by rigid body 
refinement. The additional sugar residues showed strong density, and the higher resolution 
data provided significant new information. Several rounds of rebuilding and refinement 
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against the pH 6.5 data were carried out. At this point the final pH 6.5 structure without 
water molecules was again rigid body refined against the pH 8 data. This structure was 
than subjected to positional and individual B-factor refinement, and water molecules were 
placed to generate the final pH 8 structure. For both structures, ordered water positions 
were identified by selecting peaks within hydrogen bonding distance to polar or charged 
atoms at 1.5cr above the average density in a 2Fo-Fc SigmaA weighted map. Throughout 
refinement of both pH 8 and pH 6.5 structures, NCS restraints were applied to each 
domain separately with weights chosen to minimize the Rrree value. Residues that do not 
obey the NCS were identified manually during map interpretation and not restrained. 
Specifically, these regions are the four N-terminal residues of the heavy chain, the two N-
terminal residues of the light chain, the interdomain linkers (residues 84-89 and 177-182 of 
the heavy chain), residues 39-45 (involved in a crystal contact), and residues that comprise 
the dimer interface ( 177-182, 189-193, and 246-252 or the heavy chain and the side chain 
of Glu-74 on B2m). 
The programs "0" [44] and Procheck [23] were used for model assesment. 
Figures were generated using Molscript [49] and Raster-3D [50] (Figures 1, 2, and 4a), 
"0" (Figures 3c,d and 4b), and GRASP [51] (Figure 3b). 
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Table 1 
Data collection and refinement statistics. 
Crystal 
Unit Cell (C222t) 
Resolution 
Effective resolution (F > 3cr)* 
Rmerge 
Completeness 
Number of observations 












R.m.s. deviation from ideality 
Bonds 
Angles 






r.m.s .d . bonded 
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*As defined in [52], the resolution at which a complete data set would have the same 
number of reflections as the number of observed reflections with an amplitude greater than 
3cr. 
tAs previously reported [18] 
:f:As defined in Procheck [23] 
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Table 2 
pH dependent electrostatic interactions. 
Proton Donor Distance Proton Acceptor 
Residue Domain Atom (A) Residue Domain Atom 
His-10 al NiH 3.5 Ser-55 B2m Oy 
3.5 Phe-56 B2m 0 
His-168 a2 Nat 3.5 Glu-54 al Oel 
2.8 Glu-54 a l Oe2 
His-237 a3 Ne2 3.2 Met-99 B2m OT 
His-250 a3 Ne2 2.7 GJu-89 B2m* Od 
His-250t a3 N£2 3.2 Leu-269 a3 OT 
His-251 a3 Ne2 3.1 Glu-89 B2m* 0£1 
His-25Jt a3 Nc2 2.7 Glu-89 .fJ2m* Oel 
2.9 Glu-89 .fJ2m* Oe2 
His-258 a3 Nat 3.9 Glu-180 a2-a3 0 
Ne2 2.9 Pro-207 a3 0 
His-13 B2m Nat 4.0 Ser-204 a3 Oy 
His-31 B2m Ne2 3.0 Gln-93 a2 Oel 
His-67 B2m Ne2 4.0 Glu-50 B2m 0£1 
His-84 B2m Ne2 2.9 Pro-32 B2m 0 
* Interacts with the dimer-related molecule. 
t Interactions shown are for the pH 6.5 structure. Interactions that are different (> 0.5 A) 
for the pH 8 structure are shown in italics. 
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Figure 1: pH dependent domain movements in the FeRn dimer. Co. traces of the pH 6.5 
(black) and pH 8 (grey) FeRn dimer superimposed to optimize the alignment of the a l a2 
platform of the top FeRn molecule show small domain movements. Every twentieth Co. 
position for the pH 8 structure is represented as a black sphere. 
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Figure 2: Histidine mediated stabilization of FeRn. FeRn is stabilized in part by a 
network of pH sensitive electrostatic interactions (see text for details), many of which occur 
between the FeRn heavy chain (blue) and light chain (green). All ten histidine residues and 
their electrostatic bonding partners are shown. The isolated glutamate at the bottom of the 
figure is Glu-89 from the dimer related FeRn. 
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Figure 3: Mechanism for pH dependent IgG binding. a) Schematic representation of the 
association (pH 6; left) and dissociation (pH 7.5; right) of the high affinity FcRn/Fc 
complex. At pH 6.0 to 6.5, positively charged histidines on Fe (top) interact favorably 
with negatively charged residues on FeRn (bottom). High affinity binding is additionally 
facilitated by stabilization of the FeRn dimer through the interaction between positively 
charged histidines on the FeRn heavy chain with a negatively charged residue on the dimer 
related B2m subunit. At pH 7.5 and above, the histidines are neutral, destabilizing the 
FeRn dimer and allowing dissociation of the Fc/FcRn complex. b) Stereo figure of the lgG 
binding surface on FeRn. Negatively charged regions are red and positively charged 
regions are blue. Three anionic binding pockets for the protonated Fe histidines (A, B, and 
C) are lined by amino acids that are required for lgG binding (see text for details). c) The 
pH 6.5 interaction of His-250 and His-251 with the dimer-related B2m Glu-89 shown with 
electron density from a 2Fo-Fc SigmaA weighted electron density map contoured at 1.5cr. 










Figure 4: Ordered carbohydrate at the dimer interface. a) Ribbon diagram of the FeRn 
dimer including the ordered carbohydrate. At the center of the figure, ordered glycoside 
covalently attached to one monomer interacts extensively with the dimer related molecule. 
b) Two sugar residues (Nag and Gal of the complex carbohydrate antenna) are shown 
binding to a hydrophobic patch on the dimer related FeRn at pH 6.5. The electron density 
for a 2Fo-Fc SigmaA weighted map is contoured at lcr for the carbohydrate (pink) and at 
1.5cr for the protein (blue). There is clear electron density for the N-acetyl group on the 
Nag that interacts with Ile-242, Val-244, and Tyr-252. c) Schematic structures of typical 
complex and high mannose carbohydrates. 
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Cells need to adhere specifically to cellular and extracel-
lular components of their environment to carry out di-
verse physiological functions. Examples of such func-
tions within the nervous system include neurite 
extension, synapse formation, and the myelination of 
axons. The ability to recognize multiple environmental 
cues and to undergo specific adhesion is critical to each 
of these complex cellular functions. Recognition and 
adhesion are mediated by cell adhesion molecules 
(CAMs), which bind to macromolecules expressed on 
neighboring cells or in the extracellular matrix (ECM). 
A detailed understanding of how CAMs mediate cellu-
lar adhesion will ultimately require site-directed muta-
genesis to identify critical amino acids involved in spe-
cific recognition, quantitative functional assays to 
evaluate binding interactions, and high resolution three-
dimensional structures to provide a context for the inter-
pretation of these data. Three-dimensional structures 
of macromolecules are obtained by protein crystallo-
graphic or multidimensional nuclear magnetic reso-
nance (NMR) techniques. In the case of adhesion mole-
cules, structural biologists have adopted a "divide and 
conquer" approach in which structures of stable protein 
fragments are determined. These structures, which are 
the focus of this review, Illustrate the basic architecture 
of several CAM building block domains and, in some 
cases, provide information about inter- and Intramolecu-
lar interactions. There are several reasons why it is diffi-
cult, It not impossible, to determine the three-dimen-
sional structure of an entire CAM. First, no one has 
succeeded in growing crystals of a protein with charac-
teristics of a typical CAM (a large extracellular region 
connected to a cy1oplasmic domain by a single mem-
brane-spanning region). For this reason, crystallogra-
phers generally concentrate on the soluble extracellular 
portions of CAMs. However, the extracellular portions 
of most neural CAMs contain multiple copies of one or 
more domain motifs organized into long flexible struc-
tures that are too large to tackle using current NMR 
technology (Wagner et al., 1992) and generally do not 
produce well-ordered crystals (Kwong et al., 1990). 
These constraints combine to preclude structure deter-
minations of the entire extracellular regions of larger 
CAMs. 
Here we review the structures of the CAM domains 
relevant to cell adhesion events in the nervous system, 
focusing on the three motifs for which three-dimensional 
structures are available: Immunoglobulin (I g) superfam-
ily domains, fibronectin type Ill (Fn-111) domains, and 
the domains found In cadherins. In the nervous system, 
members of the lg superfamily mediate calcium-inde-
pendent homophilic and heterophilic binding. Their ex-
tracellular regions Include one or more domains with 
sequence similarity to antibodies (Williams and Barclay, 
1988; Yoshihara et al., 1991 ). Many neural CAM lg super-
family members Include Fn-111 domains arranged in tan-
dem with lg-like domains (Figure 1 ). Three-dimensional 
structures are available for domains of several classes 
of lg-llke domains and for Fn-111 domains; thus, one can 
mentally (or using computer graphics; e.g., see Figure 
4) piece together the likely structures of the extracellular 
regions of many neural CAMs. Cadherins are also impor-
tant neural CAMs, forming homophilic adhesion inter-
faces in the presence of calcium (Geiger and Ayalon, 
1992). Two recent structures of cadherin domains pro-
vide a clue about how the adhesive interface is formed. 
The classification of lg-like domains has evolved since 
the first description of the lg superfamily (Williams and 
Barclay, 1988) because of many recent structure deter-
minations. Studies by Chothia and colleagues (e.g., Har-
paz and Chothia, 1994) suggest that some of the original 
classifications of lg superfamily domains need to be 
reconsidered. We review this work briefly and present 
a structure-based sequence alignment of lg superfamily 
domains (Figure 2; Tables 1 and 2) to allow the reader 
to classify lg-like domains correctly. Alignments based 
on structurally equivalent residues often differ from 
those generated using sequence information alone, es-
pecially when the sequences share a low percent iden-
tity, as is the case for alignments of lg-like domains. 
Thus, when analyzing a sequence for the design and 
interpretation of mutagenesis experiments, one should 
use a structure-based sequence alignment such as that 
provided in this review. Consultation of this sort of align-
ment is also the most accurate method for identi fying 
conserved sequences in a family of related proteins. 
Molecular biologists often use such Information in the 
design of primers for polymerase chain reaction-based 
experiments to probe for new members of a family. 
In this review, we also present the tertiary structures 
of lg superfamily, Fn-111, and cadherln building blocks. 
These structures share a common 13-sheet folding topol-
ogy called a "Greek key." We introduce this protein fold 
using topology diagrams of representative members of 
each domain family (Figure 3). Topology diagrams are 
representations of protein structures commonly used 
for illustrating the connectivity between individual sec-
ondary structural elements (I.e., 13 strands and a helices). 
Figure 3 is designed to allow the reader to compare the 
variations in 13-strand topology that result in different 
structures for the various members of each family. In 
addition, conserved features of each domain type are 
Indicated on the topology diagram, allowing the reader 
to correlate the location of particular residues in the 
sequences of related domains with their likely positions 
in three-dimensional structures. The topology diagram 
for each type of domain can be compared to the sche-
matic ribbon diagram directly below it. Ribbon diagrams 
are constructed by fitting a smoothed curve through the 
position of a single atom representing each residue, and 
stylistic features (such as depicting 13 strands as arrows 
and helices as spirals) aid the viewer in interpreting the 
structure. Figures 1 and 3 thus depict the structures of 
CAMs with Increasing levels of complexity and realism: 
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JUre 1. Domain Organization of Neural lg Superfamoly CAMs 
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liko and Fn·lll domains are Indicated for the extracellular regions of vertebrate CAMs; structural homologs in insects are listed in parentheses. 
e domains are classifiod based upon a comparison of their sequences to the structure-based aequence alignments in Figure 2. No 
LSsification is listed for those domains that do not show a clear agreement to one of the consensus sequences. 
at is, many of the domains that are commonly schema-
ad as ovals, rectangles, or loops (e.g., Figure 1) have 
own three-dimensional structures. 
Structures of individual domains, however, do not re· 
al how domains are arranged within the whole mole· 
le. Because of the necessity of the divide and conquer 
proach, we know less about this aspect of CAM struc· 
·e. Figure 4 summarizes the available structural infor-
ttlon about the relevant interactions of tandem do· 
1ins within a CAM. In the case of most neural CAMs, 
we understand even less about intermolecular recogni· 
tion, since the ligands for many neural adhesion mole-
cules are unknown and there Is little available informa-
tion about particular residues involved In homotypic and 
heterotypic adhesion. Thus, the Interpretation of many 
ofthe structural studies related to neural adhesion mole· 
cules awaits the gathering of additional data on their 
func tional interactions. However, clues from some of 
the individual structures provide hints about the likely 
nature of a few of these interactions. We describe these 
Review: Neural CAM Structu<es 
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Structure Based Alignment of Ig V-like Domains 
A' B c D E F G 
H C02 LETWGALGQDINLDIPSFQMSODIODIKIIE K II OTYKLFK ,,,, •. NGTLKIKHLKTOOQDIYKVSIYOTKGKNVLEK . I .FDLKIQE 
R COZ GTVWGALGHGINLNIPNFQMTOOIOEVRWER II MElLA .• ,, , . NGOLKIKNL TROOSGTYNVTVYSTNGTRILHK . A. LDLRILE 
(04 01 KVVLGKKGOTVEL TCTASQ .• KKSIQFHIIKN I I qRAOSRRSlWOQGNFPLIIKNLKIEOSOTYICEVE •• , , • • DQKE. E. VQLL VFGL T 






LDMOVVEGSAARFOCKVE . GYPD . PEVIAIIFK I I HFQIOYOEEG •• NCSL TISEVCGOOOAKYTCKAVNSLG , .EATC . T .AELLVET 
GPGL VRPSQTLSL TCTVSGTSFOOYYIITWVR I I GRVTNL VNTSK . NQFSLRL SSVTAAOTAVYYCARNLIAGGIOVIIG . QGSLVTVS 
PSVSGAPGQRVTISCTGSSSGAG . HNVKIIYQ I I ~RFSVSKSG . , • TSATLAITGLQAEOEAOYYCQSYOR •• SLRVFGGG . TKL TVL 
LORTWNL GETVELKCQVLLSNPT SGCSIILF I I RFSGKRL , , • GDTFVL TLSDFRRENE GYYFCSALSN , • SIMYFSHF . VPVFLPA 
SRYLAQIGOSVSL TCSTT . GCES . PFFSWRT .LL.J1KVTNEGT ,. • • TSTL HIHPVSFGNE HSYLCTATCE •• SRKLEK. G. IQVEIYS 
Consensus •xw .. lx • xx • xxxDx#xYxC 
Structure Based Alignment of Ig C2 Domain s 
A B c C' E F G 
H C02 02 SKPKISI'ITCINT . • . TTL TCEVIAN , , GTOPELNL YQDG . KHLKLSQ , , • RVITHKWTTQ ... LSAKFKCTAGNKV •. SKESSVEPVSCPE 
R COZ 02 SKPMIYWECSNA •.•. ATLTCEVLE. , . GTDVElKLYQGK. EHLRSLR ., . KTMSYQWTN . .. • LRAPFKCKAVNRV • • SQESEMEVVNCPE 
V(AM 02 KOPEIHLSGPL EAGKPITVKCSVAOVYPFORLEIOLLKGO . HUotKSQE .//KSLEVTFTPVI EOIGKTLVCRAKLHI//TVRQAVKELQVYI 
(04 OZ FGL TANS . OTHLLQG . QSL TL TL ESP . PGSSPSVQCRSPR, GKNIQGG •.• KTLSVSQLELQ . , OSGTWTCTVL QNQ, • KKVEFKIOIVVLA 
C04 04 VIIMKVTQPOS . • • . • NTL TCEVIAGP . TSPKIARL ILKQENQEARVSRQ , , . KVIQVQAPE •. , , . AGVWQCLLSEGE. , EVKMOSI(!QV 
Consensus •x• +x • x•x •xcx• 
Figure 2. Structure-Based Sequence Alignments 
Structural alignmeot of residues is based upon the pairwise superpositlon of V-llke and C2 domains (Tables 1 and 2). Gaps In one sequence 
compan>d with the others are Indicated by dots. 11 strands are =lored red (ABE-containing sheel) or blue (GFC-<>OO!aining sheet). Structu<ally 
consetVed loops characteristic of V-like domains (connecting strands A" to 8 and E to F) are colored yellow. Sequeoc:es between strands C 
and 0 are not Usted in the lg-like domain sequonces ftndicated by double slashes and colored g"""'l because the high degree of variabnity 
between structures makes all~t impossible. Consem;"" primary sequence patterns are Identified at lhe bottom of lhe sequences: an 
asterisk indicates a hydrophobic amino acid; a plus sign represents a bask: amino acid; a number sign indicatos a glycine, alank'ta, or aspartate; 
and an •x• indicates any amino acid. 
structures to give the neurobiologist a glimpse of what 
will eventually become a structural framew<X"k for under-
standing the molecular basis of neural adhesion. 
The Greek Key Folding Topology 
f;l-pleated sheets are a common structural element in 
globular proteins. Within a sheet, f3 strands adopt an 
almost fully extended confonnation, aligned so that hy-
drogen bonds form between main chain atoms of resi-
dues within adjacent strands. When fl strands are ar-
ranged in an antiparallel fashion, as is the case for the 
neural CAM building blocks reviewed here, the result is 
Table 1. Suparposilion of lg V-like Domains 
VCAM 01 C04 01 C04 03 
CD201 1.5 {65) 1.6 (75) 2.0 {15) 






usually two t:1 sheets that are packed against each other. 
Side chains from both sheets contribute to a hydropho-
bic core at the interface between the sheets, and be-
cause every second residue of a t:1 strand points to the 
same side of the sheet, hydrophobic residues tend to 
occur at every second position in the primary sequences 
of fl strands arranged In a two-sheet structure (Figures 
2 and 3). 
A common folding topology for domains containing 
one or two antiparallel fl sheets is called a Greek key 
because of the similarity in the connectivity of the 1=1 
strands to a repeating unit of an ornamental pattern 
COB Telokln v. v, 
1.3 {64) 1.5 (62) 1.3 (67) 1.3 (67) 
1.6 (63) 1.6 (75) 1.8 (71) 1.5 (76) 
1.5 (74) 1.5 (76) 1.4 (78) 1.5 (78) 
1.5 (54) 1.2 (66) 1.9 (73) 1.6 (63) 
1.6 {71) 1 .3 (93) 1.3 (83) 
1.4 {70) 1.6 (83) 
1.3 (83) 
The rms deviations (A) lor difrerent pairwise supeo positicus of cart>cn-u atoms of lg V..fika domains ""' lste<l. Fer each comtMnaticn, the 
number of c:alt>oo-« atoms used In the calculation of the nns deviation Is listed in pan>ntheses. Regions ccntainmg ftw cr more adjacent 
carbon-a atoms that superimposed within 3.8 A were used to ~ta the rms deviatlons listed. V" and V, domain coordinates were obtained 
11om - protMn database file 7fab. 
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The rms deviations (A) for different pairwise superpositions of car-
bon-a atoms of lg C2 domains are listed. For each combination. 
the number of carbon-n atoms used In the calculation of the rms 
deviation is listed in parentheses. Regions containing five or more 
adjacent carbon-a atoms that superimposed within 3.8 A were used 
to generate the rms deviations listed. V" and v ... domain coordinates 
were obtained from the protoin database fifo 7fab. 
used in ancient Greece (Richardson, 1 977; middle of 
Figure 3). The presence of a Greek key fold in a protein 
does not imply a common evolutionary origin or function 
with another Greek key protein. For example, lg variable 
domains and the enzyme superoxide dismutase have 
the same folding topology, but no sequence or func-
tional similarity (Richardson et al., 1 976). 
We use the lg constant domain depicted in Figure 3 
as the archetypal Greek key fold. 13 strands are labeled 
with consecutive letters starting with the N-terminal 
strand. For other domains, extra strands are labeled 
with primes (e.g., C' and C" of lg variable domains) 
to preserve the nomenclature for analogous 13 strands. 
Throughout all figures, the 13 sheet including strands A, 
B, and E is red, and the sheet containing strands G, F, 
and C is blue. Throughout the review, we refer to the 
different sheets by the letters of the strands they contain; 
for example, an lg C1 domain contains an ABDE sheet 
(or ABDE face) and a GFC sheet. 
The lg Superfamily 
Many cell-cell interactions in the nervous system are 
mediated by lg superfamily members, which are defined 
as molecules that contain domains with sequence simi-
larity to the variable or constant domains of antibodies 
(Williams and Barclay, 1988; Yoshihara et al., 1991). 
Many lg superfamily molecules consist of tandem lg-
like domains connected in series with multiple copies 
of a second building block domain called an Fn-111 repeat 
(shown schematically in Figure 1). Current structural in-
formation about domains in lg superfamily members 
comes mainly from structures of molecules that function 
in the immune system. However, to date, any two mole-
cules that share detectable sequence similarity have 
Figure 3. Structuros of Building Block Domains 
A-4 
been found to adopt the same folding topology. Thus, 
one can use the structures of the immunologically rele-
vant molecules as first order models for the structures 
of lg superfamily domains in neural CAMs. In this sec-
tion, we describe the three-dimensional structures of 
some of the CAM domains depicted schematically in 
Figure 1. 
Structures of lg Superfamily Domains 
lg-like domains have traditionally been identified at the 
primary sequence level by the presence of two cysteine 
residues separated by 55 to 75 amino acids (which form 
a disulfide bond in the folded structures), and a so-
called "invariant" tryptophan residue located 1 0-1 5 resi-
dues C-terminal to the first conserved cysteine (Davies 
and Metzger, 1983; Williams and Barclay, 1988; Kabat 
et al., 1991 ). However, some lg superfamily domains 
lack these features but still adopt an lg-like fold (e.g., 
CD4 domain 3; Brady et al., 1 993). 
On the basis of sequence and structural similarities, 
lg superfamily member domains were divided into three 
sets; C1, C2, and V-like (Williams and Barclay, 1988). 
The C1 set includes antibody-constant and topologically 
equivalent domains. The C2 set has a slightly different 
organization of 13 strands within the two sheets as com· 
pared with the C1 set. The V-like (variable-like) set in-
cludes lg variable and structurally similar domains. Re-
cently, Harpaz and Chothia defined another structural 
set called the "I" set (Harpaz and Chothia, 1 994), which 
can be regarded as a shortened V-like domain (Wagner 
and Wyss, 1 994). For the purposes of this review, we 
will group the I set of superfamily members together 
with other V-like domains. Because of the presence of 
Fn-111 modules in a number of lg superfamily neural adhe-
sion molecules (Yoshihara et al., 1 991), we include a 
discussion of Fn-111 domain structure in this section al· 
though these domains are not part of the lg superfamily. 
lg C1 Domains 
C1 domains consist of seven 13 strands arranged into 
two antiparallel sheets: one consisting of strands A, B, 
D, and E (red in Figure 3), and the other consisting of 
strands G, F, and C (blue In Figure 3; Davies and Metzger, 
1 983). The two sheets are connected by a disulfide bond 
between strands B and F. In an antibody, constant do-
mains are found in the F. region and the C-terminal 
domains of the F..,. Constant-like, or C1 set domains, 
are also found in the membrane proximal domains of 
major histocompatibility complex antigens and T cell 
receptors (Chothia et al., 1988; Bjorkman and Parham, 
The border separatong diagrams of antibody domains (top) end from neural CAM doma1ns (bottom) ohows a typical Greek key pattern as seen 
In vases and other earty Greek art. Topology (above the told name) and nbbon {below the fold name) d1agrams arc presented for each building 
block structure. Tho ABE·containing sheets are rod and the GFC·containing sheets are blue. In the topology diagrams, strands are identified 
by letters. Amino acids that have equivalent positions in all structures of the domain type are indicated by a closed circle, by the one·letter 
code If the identity of the amino 3Cid Is conserved, by the symbol </> tor hydrophobic residues. or by the symbol "' for hydrophiliC residues. 
fl.-sheet hydrogen bonding Is lndtcated by dashed lines. Reg1ons of irregular secondary atructure are indicated by open rectangles. Yellow 
highlights the antigen binding loops in the lg variable domain, the structurally conserved loops in the V-like domains (A• to B and E to F 
loops). the integrin-binding AGO loop present In some Fn·lll domains, and the A strand of N-cadherin domain 1 th3t mediates formation ol 
the strand dimer. The part of the V·like domain that shows the most variability between structures (connection between strands C and 0) Ia 
highlighted in green. A1bbon diagrams were prepared using Molscript (K,..,ulis. 199t) and rendered wilh Raster 30 (Merritt and Murphy. 1994) 
from coordinates available rrom the PHB (7fab for lg constant and variable domains, 1ten for Fn-111) or provided by the authors (VCAM-1 
coord1nates from E. Y. Jones for V-llke and C2 domains. and N-cedherin domain 1 coordinates from L. Shapiro for Cad). 
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VCAM-1 NgFn 1,2 
Ribbon diagrams are shown for tandem domain structures. The ABED sheet Is red and the A'GFCC'C" sheet is blue. In the two diagrams of 
C04, the strand that continues from the first domain into the second domain is highlighted In green. For the C02 and VCAM-1 diagrams, the 
short interdornaln connecting sequence is highlighted in green. A metal ion between the neurogllan Fn-111 domains (NgFn1 ,2) Is shown In 
green. The lntegrin binding loop In VCAM-1 and residues within the metal binding site in NgFn1 ,2 are highlighted in yellow. These figures 
were prepared with Mol script (Kraulis, 1991) and rendered with Raster 30 (Merritt and Murphy, 1994) from coordinates obtained from the 
protein database (3cd4 for C04 01,2; 1cld tor C04 03,4; 1hgf tor C02, and 1ctb for NgFn1 ,2) or provided by E. Y. Jones for VCAM-1. 
1990; Bentley et al., 1995). To date, this fold has not 
been found as a component of a CAM (Wagner and 
Wyss, 1994). 
lg C2 Domains 
The C2 and C1 folding topologies are similar, except for 
the "sheet switching" of one 13 strand (strand 0 of the 
ABED sheet [red] in a C1 domaln becomes strand C' in 
a C2 domain to form a GFCC' sheet; blue). 13 strands in 
lg C2 domains are somewhat shorter than in C1 domains 
("-'6 compared with "-'9 residues) and lack many of the 
conserved sequence patterns at the N-terminal end of 
the 13 barrel (see Figure 2). C2 domains have been seen 
in the structures of three lg superfamily members (Table 
2): the second domain of the immune system adhesion 
molecule C02 (Jones et al., 1992; Bodian et al., 1994), 
the second domain of vascular cell adhesion molecule-1 
(VCAM-1; Jones et al., 1995), and the second and fourth 
domains of the T cell coreceptor C04 (Ryu et al., 1990; 
Wang et al., 1990; Brady et al., 1993). 
Jg V-like Domains 
Variable domains of immunoglobulins are the prototype 
for the V-like domains of adhesion molecules. This fold 
is found In the VH and VL domains of antibodies (Davies 
and Metzger, 1983) and the N-terminal domains ofT cell 
receptor a and 13 chains (Chothia et al., 1988; Bentley 
et al., 1995). The folding topology is similar to the lg 
constant fold or C1 set. However, two additional 13 
strands (C' and C" ) extend the GFC face (blue). For 
antibodies and T cell receptors, two variable domains 
pair to form an antigen binding site composed of resi-
dues within the loops connecting strands B and C, 
strands C' and C ' ' ,and strands F and G (yellow in Figure 
3). Close examination of the hydrogen bonding patterns 
in lg variable domains shows that the C-terminal portion 
of the A strand is hydrogen bonded to the GFC-con-
taining sheet (blue). This portion of the strand is called 
A' (Figure 3). 
V-like domains in lg superfamily members are folded 
similarly to lg variable domains (Table 1). V-like domain 
structures do not always include the C' and C" strands 
that distinguish lg variable from lg constant domains. 
Structures with V-llke domains include the T cell core-
captors C04 (first and third domains; Ryu et al., 1990; 
Wang et al., 1990; Brady et al., 1993) and CDS (Leahy 
et al., 1992a), theN-terminal domains of two adhesion 
molecules (C02 and VCAM-1; Jones et al., 1992; Bodian 
et al., 1994; Jones et al., 1995), and telokin, the C-termi-
nal domain of the myosin light chain kinase (Holden et 
al., 1992). 
Primary Sequence-Based Classification 
of lg-like Domains in CAMs 
One way to compare three-dimensional structures of 
proteins is to superimpose the coordinates of their car-
bon-« atoms. For proteins adopting the same fold, a 
structural core of residues can be identified as one 
whose carbon-« atoms superimpose upon their coun-
terparts. The overall rms deviation among core residues 
of related proteins varies inversely with the percent se-
quence identity: i.e., core residues in proteins related 
by a high percent identity (;>60%) superimpose well 
(generally within 1 A rms deviation), whereas core resi-
dues in more distantly related proteins (20%-30% se-
quence identity) superimpose with a larger average rms 
deviation (~2 A; Chothia and Lesk, 1986). For pairwise 
superpositions of lg V-like and lg C2 domains, we pres-
ent the number of core residues and their rms deviations 
in Tables 1 and 2. A large structural core of residues 
superimpose well within each subset of lg-like domains, 
whereas a much smaller structural core is identified 
when lg V-like domains are superimposed upon lg C2 
domains. 
We generated structure-based sequence alignments 
for lg V-like and lg C2 domalns by aligning residues 
within the appropriate structural cores (Figure 2). The 
alignments reveal a consensus of primary sequence fea-
tures that can be used to predict if a protein will adopt 
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a C2 fold versus a V-like fold. Many neural CAM domains 
were Initially classified as C2 primarily on the basis of 
the number of residues separating the cysteine residues 
(Yoshihara et al., 1991). However, an examination of the 
sequences in light of the consensus sequences of V-like 
and C2 domains indicates that many neural CAM do-
mains are more likely to adopt a V-like fold (Harpaz and 
Chothia, 1 994). For example, the sequences of all of the 
lg-llke domains of the NCAM, L1, and contactlnfTAG-1 
families match the V-like consensus sequence better 
than the C2 consensus sequence (Figure 1). 
The differences between lg V-like and C2 domains at 
the primary and tertiary structure levels can be summa-
rized as follows: first, in V-like domains, the C-terminal 
portion of the A strand (A') is part of the GFC face (blue) 
and connects to the B strand via a conserved type II p 
tum (yellow In Figure 3; Harpaz and Chothia, 1 994). This 
turn is usually identifiable in the primary structure by a 
sequence motif that includes a glycine seven residues 
before the first of the characteristic cysteines (Fig-
ure 2). Another distinguishing sequence motif is found 
at the region connecting the E and F strands of V-like 
domains compared to C2 domains (yellow In Figures 2 
and 3). 
Fn-111 Modules 
Fn-111 domains were originally identified as a repeating 
motif of ~90 amino acids in the ECM protein fibronectin 
(Hynes, 1 990). This common structural motif has been 
estimated to occur in up to 2% of all animal proteins 
(Bork and Doolittle, 1 992). Structures of single Fn-111 
modules from the ECM proteins tenascin (Leahy et al., 
1 992b) and fibronectin (Main et al., 1992), as well as a 
tandem pair of domains from the Drosophila neural CAM 
neurogllan (Huber et al., 1994) and domains 7-10 of 
fibronectin (Leahy et al., 1996) have been reported. The 
p-sheet domain topology of the Fn-111 motif is identical 
to lg C2 domains (Figure 3), although domains with these 
folds are not related by primary sequence. This topology 
is also shared by the bacterial chaperone PapO (Holm-
gren and Brdnden, 1989) and the human growth hor-
mone receptor (De Vos et al., 1992); thus, a number of 
proteins with diverse functions have converged upon 
this common fold. 
Arrangements of Domains within a Molecule 
Recognition of a ligand may not be confined to a single 
CAM domain; thus, multidomain structures are impor-
tant for understanding ligand binding. The structures of 
tandem lg-like domains from C04, C02, and VCAM-1 
and a structure of tandem Fn-111 repeats provide exam-
ples of how adjacent domains within a neural CAM can 
be arranged (Figure 4). 
Crystals of the entire extracellular domain of CD4 dif-
fract poorly (Kwong et al., 1 990); thus, separate struc-
tures of domains 1 and 2 (01 02; Ayu et al., 1 990; Wang 
et al., 1990), then domains 3 and 4 (0304; Brady et al., 
1 993), were determined. In both the 01 02 and 0304 
structures, the G strand of the first domain continues 
to become the A strand of the second domain (G to A 
strand Is green: Figure 4). The relative orientation of 
domains 1 and 2 in human CD4 is conserved in multiple 
crystal forms, suggesting there is little segmental flexi -
bility between the first two domains (Ryu et al., 1994). 
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The 0304 interface is also likely to be rigid (Brady et 
al., 1 993). Thus, the available structural data for CD4 
suggests that segmental flexibility is mostly restricted 
to the junction between 02 and 03 (Kwong et al., 1990). 
In the crystal structures of the two-domain extracellu-
lar regions of rat and human C02, however, strand G 
from domain 1 does not continue directly Into strand A 
of domain 2 (Jones et al., 1 992; Bodian et al., 1994). 
Instead, the two domains are separated by a linker of 
six amino acids that adopts an extended conformation 
(green In Figure 4). There are significant differences in 
the relative domain orientations when the various struc-
tures of C02 are compared, suggesting lnterdomaln 
flexibility (Jones et al., 1 992; Bodian et al., 1 994). Simi-
larly, an extended linker connects domains 1 and 2 of 
VCAM-1 (green in Figure 4), and the domain association 
is believed to be somewhat flexible (Jones et al., 1 995). 
The structure of a two-domain proteolytic fragment 
of neuroglian provides an example of the relative orien-
tation of tandem Fn- 111 domains (Huber et al., 1994). 
The interface between the two Fn-111 modules that were 
crystalized Is believed to be rigid, consistent with the 
Insensitivity of the two-domain fragment to proteolytic 
digestion. The hydrophobic interface includes a metal 
binding site, presumably involved In stabilizing the rela-
tive orientation between domains (Figure 4). Although 
metal binding may not be a universal feature at Fn-111 
domain Interfaces (and was not seen in the recently 
determined crystal structure of domains 7-10 of fibro-
nectin; Leahy et al., 1 996), an interdomain metal site at 
the analogous position is predicted by sequence com-
parisien to be present in the homologous vertebrate 
neural CAM L 1 (Huber et al., 1 994). 
The two Fn- 111 domains in neuroglian are related by 
a near perfect twofold screw axis along the longest 
molecular dimension (~70 A). Assuming this relative ori-
entation is a general property of tandem Fn-111 repeats, 
the tandem Fn-111 domains in neuroglian and other neural 
CAMs can be modeled as a thin straight rod with two-
domain zig-zag repeats (Huber et al., 1 994). When com-
bined with the dimensions of pairs of tandem lg- like 
domains from C04, C02, and VCAM-1 (60-80 A long, 
20-30 A wide), the model suggests that neuroglian Is a 
long narrow molecule (20-30 A In diameter) that could 
extend up to 400 A from the cell surface if there were 
no significant bends between domains (Figure 5). How-
ever In photomicrographs, rotary-shadowed whole neu-
roglian (six lg-like domains plus five Fn-111 domains) ap-
pears to be a flexible rodlike molecule containing about 
four bends (Huber, 1 994; H.P. Erickson, A. H. Huber, A.J. 
Bieber, and P.J.B., unpublished data). The mean total 
length is ~390 A, consistent with a head-to-tail packing 
of the lg-like domains and with the dimensions assumed 
for the neuroglian lg-like and the Fn-111 domains. The 
five-domain Fn-111 portion of neuroglian is observed to 
bend In at least two positions. Analysis of the electron 
microscopy data supports a model in which the domain 
Interface joining the first two Fn-111 modules of neuro-
glian (the ones in the crystal structure) is rigid, but some 
of the other Fn-111 interdomain interfaces are flexible 
and appear to exhibit considerable rotational freedom 





Figure 5. Hypothetical Model for the Alignment of Six lg-like and 
Five Fn-111 Domains in Series, as In Molecules of the L 1 Family 
Space-filling model in which atoms in lg-iike domains are b lue (side-
chain atoms) and green (main 4 chain atoms). Main-chain atoms in 
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Thus, we have seen that the body of current structural 
knowledge is sufficient to piece together a general idea 
of the structures of neural CAMs in the lg superfamily. 
The C04, VCAM-1 , and C02 structures provide starting 
models for the structures of lg-like domains in neural 
CAMs. The available structures of Fn-111 modules pro-
vide the starting model for the remaining portion of neu-
ral CAMs that include these motifs. Both lg-like and Fn-
111 modules in CAMs interact in a head-to-tail fashion, 
producing an extracellular region that is much longer 
than it is wide (e.g., Figure 5). Structural data on lg-
like as well as Fn-111 repeats suggest that connections 
between domains can be rigid (as in the interface be-
tween the first two domains of C04 or the first two Fn-
111 modules of neuroglian) or flexible (as in the first two 
domains of C02). For each individual CAM, some inter-
domain connections are probably rigid while others are 
likely to allow adjacent domains to adopt multiple orien-
tations with respect to each other. Presently, there is 
no way to predict which domain interfaces will be flexible 
or rigid based upon primary sequences alone, and even 
CAMs with related domain organization and sequences 
may show different points of flexibility. Although the 
functional significance of flexibility in neural CAM mole-
cules is unknown, flexibility could allow molecules on 
different cells to adopt the specific conformations re-
quired for adhesive binding. 
lg Superfamily Adhesive Interactions 
Neural CAMs of the lg superfamily are involved in a 
variety of adhesive interactions, including hemophilic 
binding, recognition of other lg superfamily members, 
recognition by integrins, and binding to components of 
the ECM. 
In hemophilic adhesion, for example by NCAM or L 1 
family members, CAMs on one cell bind to partner mole-
cules expressed on an adjacent cell (Rutishauser and 
Jessen, 1988). There are no structural data that directly 
address how this interaction occurs. However, packing 
in the crystals of rat and human C02 provides a hint of 
what a hemophilic interaction between V-like domains 
may resemble (Jones et al., 1992; Bodian et al., 1994). 
Although multiple crystal forms of rat and human C02 
show different crystal packing arrangements, a head-
to-head interaction between the N-terminal V-like do-
mains is conserved across space groups and species 
(Bodian et al., 1994). In this interac tion, the A'GFCC'C" 
faces (blue) from molecules packed head-to-head form 
a tightly packed interface (Figure 6). This interaction is 
consistent with molecules on different cells binding in 
an extended orientation, and could be a model for how 
hemophilic adhesion is accomplished between V-like 
domains of lg superfamily members. 
Fn- 111 domains are gray and side-chain atoms are pink (first two 
domains) or green (domains 3-5). Potential points of flexibility sug-
gested by electron microscopic studies of neurogllan (see text) and 
by crystallographic and biochemical data on lg superfamily mole-
cules (e.g., Kwong et al., 1990) are noted by arrows. No structural 
information concerning the potential flexibility of the interface be-
tween lg-like and Fn- 111 domains (indicated by a question mark) Is 
available. This figure was generated using the program SETOA (Ev-
ans, 1993) and coordinates for CD4 01 02 (3cd4) as a model for the 
six lg-like domains and NgFn1 ,2 (1 cfb) as a model for Fn-111 repeats. 
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Membrane of Cell 2 
Figure 6. Models of Hemophilic Adhesive Interactions for lg V-llke and Cadherin Domains 
(Left) Ribbon diagram of the head-to-head interaction observed in crystals of C02 domains 1 and 2 (Jones et al., 1992) serves as a model 
for hemophilic and heterophilic interaction between lg superfamily members. 
(Right) The zipperlike structure observed In crystals of N-cadherin domain 1 (Shapiro et al., 1995a) as a model for cadherin-medlated cell-<:ell 
adhesion. Strand A, which interdlgltates into the partner domain of the strand dimer, Is highlighted In yellow. 
Many lg superfamily CAMs bind heterophilically to 
other superfamily members. In fact, C02 itself binds 
to C058, another lg superfamily member. Site-directed 
mutagenesis studies (Withka et al., 1993) have mapped 
the C058 binding site on C02 to the same face observed 
in the crystallographic interaction between opposing 
C02 molecules (the A 'GFCC'C" face; blue). Thus, the 
packing in the C02 crystals may also be illustrative 
of heterophilic interactions between lg superfamily 
members. 
Structural information about the interaction of lg su-
perfamily domains with integrins comes from the VCAM-
1 crystal structure (Jones et al., 1995). Mutagenesis 
studies implicate six residues of VCAM-1 domain 1 as 
critical for binding to the VLA-4 integrin (Osborn et al., 
1994). Other leukocyte lg superfamily integrin-binding 
molecules have been shown to bind to integrins via 
a similar sequence motif (hydrophobic, followed by a 
negative charge). The critical residues for VLA-4 binding 
are part of the GFC face (blue; Figures 3 and 4) and 
occur at the N-terminal portion of the loop connecting 
strands C and D (yellow; Figure 4). The GFC face of 
VCAM-1 is comparable to the GFCC'C" face of C02, 
which is implicated in heterophillc interactions (Jones 
et al., 1992; Bodian et al., 1994). It has therefore been 
suggested that the face containing 13 strands C, F, and 
G of the first domain of lg superfamily members may be 
a site of intercellular adhesive interactions, regardless of 
the nature of the ligand (Jones et al., 1995). This detailed 
structural analysis of the VCAM-1/integrin interaction is 
relevant to nervous system molecules such as tel-
encephalin, a VCAM-1 homolog expressed on a re-
stricted set of dendrites that is predicted to bind inte-
grins (Yoshihara and Mori, 1994). 
In addition to lg superfamily domains, integrins are 
also recognized by some Fn-111 repeats in ECM proteins. 
This interaction is mediated by an Arg-Giy-Asp (RGD) 
sequence motif (Hynes, 1990). The RGO sequences of 
the Fn- 111 modules from the ECM proteins tenascin and 
fibronectin are located in a 13 hairpin loop between 
strands F and G (Leahy et al., 1992b, 1996; Main et al., 




of a negatively charged residue in the midst of a flexible 
loop, the conformation of the RGD loops in these ECM 
proteins does not resemble the conformation of the CD 
loop in the first domain of VCAM-1 , which is critical for 
the interactions of V-like domains with integrins. How-
ever, both types of loops contain a negative charge, 
which could facilitate adhesion by completing a divalent 
cation-binding site on the integrin (Jones et al., 1995). 
Significant progress has been made in the field of inte-
grin structure with the solution of the structure of the A 
domain of the a subunit of an integrin (Lee et al., 1995). 
However, further information about interactions be-
tween integrins and lg superfamily or Fn-111 domains 
awaits the solution of the structure of a heterodimeric 
lntegrin and/or a complex between an integrin and its 
ligand. 
The Fn-111 modules of most neural CAMs do not con-
tain RGD sequences (Bork and Doolittle, 1992), and the 
function, if any, of the comparable loop in the Fn-111 
modules of CAMs is unknown. However, RGD se-
quences are found in what appears to be the F-to-G 
loop of a few neural CAMs such as TAG-1 (Furley et al., 
1990), Ng-CAM (Brugoon et al., 1991 ), and neurofascin 
(Volkmer et al., 1992). In the case of neuroglian, the only 
neural CAM for which structural information Is available, 
the Fn-111 domains do not contain RGD sequences 
(Bieber et al., 1989). However, both FG loops are solvent-
accessible 13 hairpin turns and are therefore available 
for intermolecular recognition (Huber et al., 1994). 
Cadherins 
Cadherins are single-pass transmembrane proteins that 
include an extracellular region formed by five repeats 
of 100 amino acids and a conserved cy1oplasmic do-
main. The extracellular region functions In calcium-
dependent homophilic cell adhesion, with the adhesive 
specificity residing primarily within the first repeat. The 
cy1oplasmic domain meditates connections with actin 
filaments via catenin proteins. The combination of cad-
herin-mediated hemophilic recognition and catenin-
mediated cy1oskeletal anchoring has been Implicated 
in cell sorting and cell condensation events during mor-
phogenesis. Different cadherins, such asP-, N-, R-, T-, 
and E-cadherln, are expressed in a wide variety of cell 
types. Since each member binds homophilically to the 
identical type, cells preferentially adhere to other cells 
bearing the same cadherin member (Takeichi et al., 
1990; Geiger and Ayalon, 1992). In addition to the "clas-
sic" cadherins found in the zonula adherens cell-cell 
junctions of vertebrates, a protocadherin family with de-
velopmentally regulated expression is found in the brain 
(Sano et al., 1993), and proteins with tandem cadherin-
like repeats are found in Drosophila (Mahoney et al., 
1991) and in vertebrate desmosome junctions (Wheeler 
et al., 1991 ). Other proteins, such as the proto-oncogene 
c-ret (which functions In differentiation and/or prolifera-
tion in peripheral nerve cells and hematopoietic cells), 
consist of a cadherin-like extracellular region and an 
intracellular tyrosine kinase domain (Iwamoto et al., 
1993). 
The Cadherin Fold 
The NMR structure of the first domain of E-cadherin 
and the crystal structure of the comparable N-cadherin 
domain were recently reported (Overduln et al., 1995; 
Shapiro et al., 1995a). Although there Is no significant 
sequence similarity between cadherins and members 
of the lg superfamily, the cadherin domain adopts a 
Greek key fold with ABED (red) and A'GFC (blue) 13 
sheets, a topology similar to that of lg V-like domains 
(Figure 3). However, unlike lg V-like domains, the BC 
and CD loops include helical regions, and the AB and 
EF connections differ from their V-like counterparts. The 
cadherin domain is topologically similar to lg V-like do-
mains without showing the primary sequence character-
Istics that would make cadherins members of the lg 
superfamily, much as Fn-111 domains are topologically 
similar, yet not related by sequence, to lg superfamily 
C2 domains. An analysis of lg superfamily and cadherin 
sequences and lntron patterns suggests the two types 
of structures converged upon a similar stable folding 
topology, rather than diverged from a common ancestor 
(Shapiro et al., 1995b). 
The first domain of N-cadherin d imerizes in solution 
and In the crystal structure (Shapiro et al., 1995a). The 
dlmer-related domains are oriented parallel to each 
other; thus, the same dimer could be formed on a cell 
surface. This dlmer is called the "strand dimer" because 
the first four residues of each domain (A strands; yellow 
in Figures 3 and 6) Interdigitate into the partner domain, 
forming hydrogen bonds with strand B. In particular, the 
tryptophan side chain at residue 2 is inserted into the 
hydrophobic core of the dimer-related molecule. An 
analysis of cadherln domain 1 sequences shows a nota-
ble conservation of residues at the strand dimer inter-
face, and it therefore seems likely that all cadherin extra-
cellular regions function as dimers (Shapiro et al., 1995a, 
1995b}. Domain 1 of E-cadherin, however, is reported 
to be monomeric (Overduin et al., 1995}, a surprising 
result given the conservation of residues, including Trp 
2, within the A and A ' strands of the two structures. 
Further studies will be required to assess the generaliz-
ability of the cadherin strand dimer as the functional 
unit for formation of adhesive interfaces. 
Arrangements of Cadherin Domains 
within a Molecule 
In addition to requiring calcium for adhesive interac-
tions, cadherins show a calcium-dependent resistance 
to proteoly1ic degradation. A single amino acid change 
is sufficient to abolish calcium-mediated adhesion and 
protection from proteolysis, implying that calcium acts 
indirectly to regulate hemophilic adhesion by modulat-
Ing the protein structure (Ozawa et al., 1990). In both 
the NMR and X-ray cadherin structures (Overduin et al., 
1995; Shapiro et al., 1995a), a calcium binding site Is 
identified near the carboxyl terminus of the domain. The 
metal ions are incompletely coordinated in the single 
domain structures; thus, it is speculated that residues 
within the second domain complete the coordination. 
This hypothesis is supported by results of NMR and 
site-directed mutagenesis studies (Ozawa et al., 1990; 
Overduin et al., 1995). Homologous calcium binding 
sites are predicted at the interfaces between each tan-
dem pair of cadherin domains (Overduin et al., 1995; 
Shapiro et al., 1995a), which could stabilize the interdo-
main junctions and thereby account for the observation 
of calcium-dependent resistance to proteolysis (Ozawa 
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et al., 1990). A model for the five-domain extracellular 
region of cadherins was constructed based upon the 
structure of the domain 1 strand dimer, with the relative 
positioning of successive domains dictated by the cal-
cium ion coordination (Overduin et al., 1995; Shapiro et 
al., 1995a). 
Homophlllc Adhesion by Cadherins 
Three different crystal forms of N-cadherin contain a 
linear zipper of cadherin dlmers thought to reflect adhe-
sive interactions between two cadherin-expressing cells 
(Figure 6) (Shapiro et al., 1995a). The zipper Is formed 
by the combination of the strand dimer twofold symme-
try axis with another twofold axis orthogonal to the first. 
The result is a continuous ribbon of cadherin protomers, 
in which the C-terminl of successive dimers project in 
opposite directions, as if the dimers were emanating 
from two interacting cells. Thus, the packing in these 
crystals may be providing us with the first atomic resolu-
tion view of celkell adhesion. It is therefore instructive 
to examine the features of the interaction interface be-
tween cadherin protomers related by the antiparallel 
twofold symmetric interaction (termed the "adhesion 
dimer''). 
The main contact areas within the adhesion dimer 
interface include an interaction between the related C 
strands, the related CD loops, and the DE loop of one 
protomer with the FG loop of the partner. The interaction 
interface includes residues within strand F that had been 
implicated in cadherin subtype recognition. In general, 
the regions involved in adhesive contacts are distant 
from the Ca2 • binding site, another indication that the 
calcium dependence of cadherin adhesion arises from 
its stabilizing influence, rather than through a direct ef-
fect on the adhesive interface. 
The adhesive interface is assumed to be relatively 
weak, since domain 1 of N-cadherin forms only dimers 
in solution, rather than higher order oligomers (Shapiro 
et al., 1995a). (The dimers formed in solution are as-
sumed to correspond to the strand dimer rather than 
the adhesion dimer.) Indeed, a portion of the adhesion 
dimer interface is mediated by water molecules, as com-
pared with the strand dimer interface, in which a strand 
from one domain interdigitates into the hydrophobic 
core of the partner. The adhesion zipper observed in the 
cadherin crystals illustrates a mechanism to overcome 
weak Individual adhesive interactions through the coop-
erative binding of rows of molecules on each cell. 
Conclusions 
The Greek key J3 sandwich structure is a common motif 
in cell surface proteins Involved in adhesive interactions. 
This folding topology serves as the building block for 
domains in neural CAMs, such as cadherin domains and 
the lg-like and Fn-111 domains of lg superfamily mem-
bers. Structure-based sequence alignments for do-
mains from these proteins (Figure 2) (Leahy et al., 1992b; 
Huber et al., 1994) provide an important tool for relating 
primary sequences to three-dimensional structures. 
The Greek key structural motif is usually found as 
an array of tandem repeats, arranged in a head-to-tail 
fashion to create a long rodlike structure in which some 
domain interfaces allow rotational freedom, while others 
are relatively rigid. The available structures of tandem 
repeats have demonstrated ways that serially arranged 
lg-like domains can form rigid (e.g., CD4) or relatively 
rigid (e.g., C02) interfaces. However, because only fairly 
inflexible interactions are amenable to structure deter-
mination, we have yet to visualize the domain interac-
tions that provide CAMs with their greatest flexibility. 
To date, this inherent flexibility has hindered crystalliza-
tion of entire multidomain extracellular regions. Simi-
larly, intact antibodies resisted formation of well-
ordered crystals for many years, and the "divide and 
conquer" approach was used to elucidate the mecha-
nism of antibody function (Davies and Metzger, 1983). 
However, with the Improvement of crystallization tech-
niques, even a highly flexible intact antibody has been 
crystallized and used for an atomic resolution structure 
determination (Harris et al., 1992); thus providing hope 
that similar advances will allow crystallization of whole 
extracellular regions of large neural CAMs. 
By combining the results of site-directed mutagenesis 
and structural studies, the molecular mechanism by 
which CAMs achieve homophlllc and heterophilic adhe-
sion is beginning to be elucidated. The face of V-like 
domains that Includes strands G, F, and C has been 
implicated in two different adhesive interactions (Jones 
et al., 1992, 1995; Bodian et al., 1994), and this face 
was suggested to be the site of intercellular adhesive 
interactions, Irrespective of the ligand that binds (Jones 
et al., 1995). In this regard, it is interesting that the loca-
tion of the cadherin adhesion interface involves residues 
from the G, F, C, and D strands. However, adhesion 
by N-cadherin domain 1 is more of an edge-to-edge 
interaction than the face-to-face interaction observed 
In crystals of C02 (Figure 6) (Jones et al., 1992; Shapiro 
et al., 1995a). The adhesive interface observed in the 
cadherin crystals illustrates one way in which cell adhe-
sion is accomplished even with a very weak affinity ad-
hesive interaction (i.e., mM or weaker). This example 
also suggests that weak adhesive interactions will be 
difficult to study biochemically, because they are stable 
only under conditions of high valency. However, in some 
cases, crystallization can overcome this difficulty, so 
that the weak adhesive interactions that normally occur 
only on the cell surface can exist within the crystal, 
owing to the high protein concentrations required for 
crystallization. 
Many questions remain to be answered. At present, 
very little is known about the strength of different homo-
philic and heterophilic interactions. As more neural 
CAMs are available In purified forms, the affinities of 
specific homophllic and heterophilic interactions can be 
measured and the effects of Introduced mutations can 
be quantitated. Complexes between partner molecules 
involved in heterophilic interactions can be crystallized, 
which will allow a visualization of the atomic specificity 
involved in different cellular recognition events. Indeed, 
some proteins that do not form well-ordered crystals by 
themselves can be induced to crystallize as a complex 
with another protein; thus cocrystallization may be one 
method to obtain the structures of entire neural CAM 
extracellular regions. As the powerful tools of molecular 
biology are combined with the knowledge of the binding 




approach an atomic resolution understanding of how 
the neural CAM building blocks are used by cells to 
accomplish their diverse adhesive interactions. A num-
ber of interesting structures are undoubtedly on the hori-
zon, and we can look forward to a more complete picture 
of the mechanism of cell adhesion. 
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Expression and Crystallization of a Soluble Form of 
Drosophila Fasciclin III 
Roland K. Strong•t, Daniel E. Vaughn', Pamela J. Bjorkman2 
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3 Depa rt ment of Biologiwl Sciences 
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A truncated form of Dro'iophila fasc irl in ITT has been eng ineered by si te-dit·ected 
mutagenesis. Secreted fascic lin IT I is cxpresseci a t 3:3 to 40 mg/1 in insect <'ells wit h 
bnculo,·irus cntTy ing the recombina nt gene. Sing le c rystals of ptu·ifieci soluhle fns<'i<'iin I II 
hn,·e been g t·own l>y \ 'n por dittiusion t'ff8 11.~ po ly e thy l('ne glycol 8000 jsocl ium l'itm t<' tit low 
pH . The s pnc<' gmup is 1'6 1:!:! or its enant iomorph P6 522. with uni t <·1.'11 dimt>nsions 
a= /, = 140 A. r = :!60 A. ('ryo· pt'('Sel'\'('cl Cl'ystn ls cliffmet to reciprocal la ttice spacing;; 
beyond :Hl .\ . 
A'eyu'Ord8: b:wulo,·irus ex prt'ssion: imm unoglobul in supe rfnmi ly: cell ttd hcsion molt•t·u le; 
homoph ili<· binding: crysta lliza tion 
Fasciculnt ion is t\ process in which nt>u ronn I 
g rowth cones extend a lo ng specific axonnl surfac·es. 
con tributing to the d!',·eloprncnt of nppro pria te 
axonal pnthways in t he embrvonic ner·,·ous s\·stc rn 
(r-e,·iewed by Grenningloh et 'at .. 19!l0). Stuciil's o f 
g rowth cone guida rH'l' in t he <'l'nt rnl nPn·ous 
systl'ms of insects (Raper· et a/.. 19H3a .b.r: Bastiani 
eta/. , I !l84: Goodman el at .. I !l84 : Raper et a/ .. I !l84) 
suggested tha t s pecific nxon pathways >U't' dentnr· 
ca ted by diffPrent cell·surfn<'e recognition mo lecules. 
Fom· d iffe rent mcrnbmne·a~;;ociat NI g lytopr·oteins, 
iden tified on subs<'ls of fnscicnlnting axons nnclasso-
ciated g lia , ht\ \'C h<•en impl icated in nenm nal recog· 
n it ion nncl adhl'sion. Fascie lin f , I I ( Bnstia ni et a/. , 
I 987) and T\' (l;:olodkin PI ol., I !l92). Pnch initial !\• 
ident ified in t he g rnsshopper; fas<'iclin ITT (P a te l ; I 
a/. , 1987) and ncuroglin n (Bieber et at .. lfiS!l) . both 
origina lly charnctc rizecl in Dro.~ophila . The genes 
encoci ing en <'I t of t hese prote ins were su bsequcn t l\· 
t· loned (llnri'Pison & Goodman , 1988: Snow PI rJ, 
Hl88: Zinn et al., I fl88; Pa tel et al., 19Si ; Bieh<•r el 
a/., l!lS!l; Finow et a/., l!lS!l: Kolodkin et a/., 1002). / n 
!'itm ns.~avs ha,·c d pmonstrnted thnt f:tsc·idin T nnrl 
TTT nrc ca-pable of nll'cl iating homophilic nclht'sion as 
demonstrn ted by cell aggregat ion nnd cell sorting 
(Snow e./ al. , I !lS!l; E lkins el al., 1900). 
The extracelluln r region of fasric lin TT I has been 
predicted to be com posed of th ree highly di,·erged 
t J' re,..,nt ndrln:·s•: Frw l H utch in;;on Cnnc<•r· Jlt:'S('t\I'Ch 
('t·nr ... -. 11 24 ('olumhin Sti'Pt•t . St-tH! It• . \\',.\ 118 1114. 
L'.~ .A . 
immunoglobulin domnins based upon limited 
sequence sim ilnrity wit h other mr rnbcrs of the 
immunoglobulin super family (\\'ill iams & B.uc·lny , 
I !l88). The most t\mino-tcn nin>tl of the~e domains 
( DI) is proposed to he \ '-type. while t he two rnorl' 
carboxy·terrnina l domai ns ( D2 nml O:J) a re 
proposed to be of t he C:!·type (Grt'nning loh et al .. 
l!l!lO). 
The physical basis fo r inte ra<·tions het wt'en cell 
su rfnce ad hr sion moleeules has not been well 
cha mcterir.ed . l'n·stal st rnctu reM tu·e :wailable fo r 
(; Dt und C' D4, t w'o nwrnbers o f tlw immunoglobulin 
su perfa mi ly ( Hy u PI rtl .. 1900: \\'nng et al .. 19!l0: 
.Jones et al., I O!l:!). R<·gions of these t wo pm teins 
im·oh·ed in media ting rnolpcuh\1' in t t> raC'tions have 
been icien tified U\' mutational nnah ·sis. For 
exam ple. in t ht- c·nse.of CD2. the OFC(;'C" ·fat-e of t he 
am ino ·terrninnl \ '-type domain has been implicated 
in mediat ing homophilic fllS WPII us hl'lt>rophilic 
interaction~ with il" <·oun tcr·rl'o: .. ptor'tl (.Jones el rtf., 
I !l9t ). It has been suggested thnt such an inte r·· 
a ction may r·cprc•scnL a structnrnl pamdig m for 
intcmctions between members of the immuno-
g lobulin super·fumily (.Jones et al ., l!l!l2). 
In o rder to further undcrstnnd homophili<' inter· 
actions bet ween adhesion molecules in the de,·e· 
loping nen·ou:~ syst Prn , we ha,·e inititltl'd n Sl'ri t>s of 
stud ies to c(pfinc t he regions of fnsl'id in Ill im por·-
tnnt for homophilic spcdficity. On tlw hnsis of n 
computer-gencmtl'd model of the nmino· tcrm innl 
d omain ( I •. A. Castonguay, S. ll. Bryunt , P . )f . S. & 




s<'t of replacement mutants that w:U sen ·e to 
crudely ddine those regions of the molecule impor· 
tnnt in mediating homophilic interactions. The 
crn;tal structure of the extracellular domnin of 
fa~ci<'lin II I would pro,•ide a context within which 
to inte-rpret the effects of specific mutations in the 
Jli'Ot<'in. and pro,·ide a structural basis for· under· 
~tanding the mechanism of homophilic adhesion . Tn 
addition , clE>ter·minntion of the crvstal s tructure 
would nllow n direct compar·ison with the model of 
the amino-terminal domain , a llowing an assessment 
of the utility of the threading a lgorithm (Bryant & 
Lawrence. 1993). used in its construction . Here we 
des<•ribe the constru<'lion of n soluble form of the 
l'Xtrneellular· domains of fasciclin HI. its expression. 
pur·ifietllion. and cr-ystallization. 
(a) ('onslruction of a .soluble form offa8rirlin I I I 
A clorl<'d C'O:\A erwoding the 80 kOa form of 
fnsei<'lin Ill (Snow PIal .. 1989) was inserted into the 
p lliUl'S<·ripl (Stn\trtgene) \'ector. Site-dircc·ted mula· 
w·m•sis \\'liS JWr·fomwd (Kunkel e/ al.. l!l8'i) using ,, 
l·o mpleml'ntnr,\· o ligonul'll'otide that eneoded n slop 
r·odon following the lust residue of the l'XtnH'l'llulnr 
domain (.-\sp2:lG). F ollowing transformation of thl• 
mutagenesis r'l'IH'Iion into a wild-typ<· haete rial 
st ruin (X L·l Blue. Strntngenl'). mutant nwler·ulr•s 
\\'('r'l' idr•nt ifi<'cl by T · t rack nnnl,,·sis (And<·r·son . I !lSI ) 
and suhsl'qucntly ro nfimwd h.'· sNJIIl'n<·r· analysis of 
pula I i\'1' mulnnls . 
Tlw nllt•r·t•cl fitsl'i<'liu fll r·D:\A \\'as cx<·ist•cl from 
pHhrr•sr·ript h,\' cligPst ion with El'oR \ 'and llrJil r and 
inst•r·tt·cl iuto a p\'LJ:l!l:l har·ulodrus lmnsfpr \'l'<·tor 
(n gift fmrn :\1. D. Strrnnwrti) that had l>et'n digestt'd 
"ith Smal nnd fly/fT . Th<' eo rr·ect orient•tlion wns 
r·ontirtued by restril·tion mapping of the inscr·t. and 
suhst-qut•ntly l'O·trans fel'led into Sffi cells with \\'ild· 
l~' ))(' hat'ulo ,·inrs as dcseribecl (~urnrners & Smith. 
19::11) . Reeornhinant ,·iru:<es l'ncocling tnrrwnted 
fns<·i<·lin Ill \\'Crl' initiall.' · enriched hy plaque 
)1\·hrirlization. and incli,·idual r·er:ornbiuanls suh:<e· 
q;rently irll'nl itied hy ,·isual in:<peC'lion of plaque 
rnorphoiO){.\' (Surnnwrs & !-;mith. l!l8'i) . Thr idE'ntity 
of r·t·<·nmhrnnnl ,· iml isolates was eoutirnwd In· 
11'stri t·tion nutpping and Southem-blol nnal,\·sis t;f' 
\' iral )):\,.\ isolated fr·orn infe{'(ecl sm l't'lls. 
(h) E.rJJre.~,;ion of a ,;a/able form offnsricliu I I I by 
recombi 110111 !Jaculol'inc.s 
!-;f'!) c·PIIs \\'l'l'(' infP<·ted \\'ith rrc·o mhimtnl \' irus al 
multipl icitil's of inft•Nion ,·arying hN\\'l'C'n I and 10. 
and Jr,·c ls of filst·il'lin TTT sel'reted into tlw media 
nssPssrrl hy irnrnunonffinity purifkation (s<'<' hclow) 
uf I rnl a liquots at ~~ hour iniPr'\'ak Ehralr•s fmm 
thr• altinit\' matrix \\l'r<' anal\·zecl h\· !-;J)S. J>.\(:E 
aud ('uom.assil' hlu<' staining. · Prott'{n )pn•ls Wl'rl' 
Pstirnntf'cl hy <'Oill)Htriso n with ~tandards of knm\ n 
<·on<:t-ntrntion . Expr·ession ll'\'els r·enc·ll<'d n plateau 
of npproximatel~· :l.) to ~0 mg/litCI' at n multiplic·ity 
of infpc•tion of.) (chlla not s hown) . 1..<',-cJs of fu:;ei<'lin 
Ill t•:>.pr·<•ssio n \l'l'r·e rnnxirniz!'d at 1~0 hours post 
infection , with longer times resulting in increased 
protein degradation, presumably due to the high 
Je ,·els of cell death and ly~is obsen·ed at longer 
periods. 
As seen in Figure lA, secreted fasciclin liT 
produced in Sf9 cells migrates on an SDS-PAGE gel 
us n broad band (which can be resol\'ed into fi,·e 
disl'retc species; data not s hown) rnnging in 
molel'trla•· moss from 38 kDa to 42 kDn. This 
heterogeneity \\'1\S shown to be due to ,·nriable 
glycosylntion by treatment of the protein with 
peptide :'\ -glycosidase F (Xew Englund Biolabs). 
which cle•wes X· linkcd sugars (Plummer el nl .• 
198~). Sueh trentment results in a major s pecies of 
molecular weight 36 kOa wh<'n nnnln.cd IH' 
SDS-PAGE (Figure lA). This re:sult i;; ;onsisler;t 
with the obser·,·ation that fnsciclin Tll posst•s>!('s four 
potential sites for ::\-linked g lycosylation Plars hall. 
I !li2; <.:a,·el & ,·on Heijne. 1900). nnd s uggest:; that 
sm c·c ll:; differentially glyeo:>ylate the protein hac·k · 
hone. \\'ith each of the species of int·reusing 
rnoiN:ular mass l·orresponding to a form glyco:;y 
lnted nl o ne ndditional :site. \re hu,·e ohsen·l'd 
simi lar g lycosylation pattNns with othc•r. but no t 
all. Sl·<·rt'led proteins expressed in sm C'l' lls (P.:\I.S .. 
unpublislwd ohscr'\'ations). It is interesting to nott• 
t llllt the 80 kDn transmembrane form of fascic·lin 
ITT , when expr·cssrd in l-;ffi cells . d ot·s not show this 
lwterogerwity of glyco:;ylation (P.:\I.S .. unpuhlis lwd 
ohst·n·ntions) . strg)!esting a lternnl in• pror·r•ssing 
pathways for intc•gntl mcmhrant• prott•ins und al 
least ~orne seer·eted protc•ins. 
(t·) l'urijimtimt of.,urPINIJo.w·irliu I I I Jr1r 
8/rur/um/ .~/utlirs 
.-\ monodonal antihoth· dirt'l'tl'll ll"ainst t lw 
c•xtl'lll'<'lluhu· d omain of fa~<"il'lin Ill (~ l ).'i : l'atr•l £/ 
ttl .. I !lSI) was r:uupled to a l'r·otc•in· ,\ . :-;<•pham~c· 
matrix as rll•sc·r·ihed (Sl·hrwidl·r P/ ol.. IllS:!) . 
SUJK'r' rHttants from r<'<·omhinant luwu lonnrs· 
inf'l•l'lc•cl sm ('(•lis wer·e pas~c·cl 0\'l'l thi~ allinily 
matri x. e ltnc·cl with huffc· r·s mn~in~ from p ll ~·.) tu 
pll II ·.). and m·utmliZl'd immPcliat <'l.' · . \liq11ot ~ of' 
ear·h <'luntc• \\'C' r'l' tt·~ted for tlwir c·orltr·nt of' :-t•t·n·tprJ 
lits<·il'lin Ill ll\· SI>S- 1'.-\C: E. Eluall·~ "hit·h '"'"'' 
dr•ll'l'rnirwd to' c·onlain fa~t·ic·lin Ill "'''''' t h•·n 
nssa.n•d for llw ~truc·tural inte~rit .'· oft hi' JH'orl'in hy 
na I in• polyac·r.\'lam irlr• ~c·l r•lr•t·l rnphon•sk Elu ll'rl 
fast·it·lin Ill thnt had rwt hc·r·n dt·natun·d II\ till' 
!'lut ion t·onditions would lw ••xpr·•·tc·cl lo ,\·i·t·ld a 
disr·n·tc• hand ur· Sl'l'i<'s of hands wlu·n >truth·zr·d 
llrult•r· nnn-rlc•n•tl uring c·orulit ions. Tilt• rr·~ull ~ 
indi .. atc•d that l'itht'l' pH ~·ij o r· pH II ·.) \l'r•rc• 
r·t•quin•d for quantitati\'(• l'lution of ftt~l·i l'lin Ill 
fmm llw rtHtll'ix . anrl that nl•itiH'r of th•·~•· t·oruli· 
lion~ cli~r·uptNI thl' strul'lural intl'~rit.'· of till' I'"" 
tr•ir1. As sholl'n in Fi~trr·r · I B. t ht• purifi,•d JII 'Otl'i n 
rnigratl's as a singlt• hand nfu•r· l'hrtion at pll ll ·.i 
nncl nt•utmlizatiun. Till' purilir•rl prolt·in •·•trl hr· 
irnllllllltl)II'I'C'ipil ;ltc•tl with tlw :!J>.i mnnor·lunalanr i· 
hod.\ ' (cia lit not sh0\\'11). ofti·rin)! furl hr•r· 1'\·idt•nr·t· of 
tlw str·ur·ttrl'lll intl'gr·it ,\· oftlw )li'Oic-in . Frnall,\ "l11•u 
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purified fasciclin ITT was anulvzecl b,· isoelectl'ic 
focusing under m•th·e comlitio~s. a single species 
migrnting with a pT between ~-0 and 5·0 was 
ohsen·ecl (clnta not ~hown). further n~~umnce that 
the r·platin·l~· harsh treatment at clc,·uted pH 
n•quirecl for remond from the affinit\· column did 
not clenatur·e the protein. This result also demon-
strates that the extracellular domain of fasciclin III 
is acidic. and that the heterogeneous glycosylntion 
noted abm·e appea:·s to contribute no charge heter·o-
geneity to the pi'Otein. 
l~ased upon these r·esults, the following conditions 
were devised for purilieation of the secreted form of 
fasciclin III from baculo,·irus supernatants. After 
passage of the supemutant o,·er the column mutl'ix. 
the matl'ix was washed sequPntially with 5 to 10 
column ,·olumes of 10 m:.\ I triethano lamine 
(pH 8·:!). 0·5 :.\1 XaCI. I m:.\I phenylmethylsulfonyl 
fluoride followed b\· 5 to 10 column ,·olurnes of 
50 m:.\1 triethylam{np (pH 10·0) , 150 rn:.\1 XaCI. 
Bo und pr·otein was eluted with 5 column ,·olumes of 
50 m:.\1 triethylamine (pH 11·5), 150 m:.\1 KaCI , and 
neutralized immediately with 0·1 volume I :\I 
sodium phosp hate (pH 6·0). The e luate was sub-
sequently dialyzed against 10 m:.\[ He pes (pH 7·5) , 
and concentrated by ultmfiltration . 
(d) Crystallization of the secreted form of 
fascicl in I I I 
1=iingle cn·stals of the secreted extr·acellular 
domains of . fasciclin II I were grown as follows. 
Purified protein, concentrated to 20 mgfml in 
10 m:\1 Hepes (pH i·5). was mixed I : I with a pre-
cipitant solution: 5 to 100,0 (wfw) polyethylene 
glyeol 8000 (• 'igmn). 2·5 to 50,0 saturated sodium 
eitrnte. 50 m:\1 sodium acetate (pH ~ ·5) and with or· 
without I m:.\1 dithiothreitol. D r·ops (2 to .1, J.ll) of 
thi~ solution were suspended on siliconized cover 
s lips O\' er· wells containing 1·0 ml of the precipitant 
solution in a ,·apor diffusion experiment 
(:\ lcPher·son. 1982) at 22•c. Crystals appeared in 
one to six weeks: earlier in the highest precipitant 
concentmtions. wi th larger·, better formed cryst>\ls 
genemlly appearing later in the lower pr·ecipitant 
concentrations. T hese crystallizn.t ion conditions 
were initially identified on the basis of results gener-
ated from lhe use of a cn·;;Lallization factorial 
(Carter & Carter, 1979) using n.n "in-house" set of 
solutions. The crystals grow n~ smoothly cur,·cd, 
hexagonally faceted ellipsoids, with the long n.xis as 
long as 1·0 mm. Precession photograph~ show the 
space group to be ?6122 or its enantiomorph P6,22. 
with unit cell dimensions a= b = 1-Ul A. c = 260 A 
as determined from data reduction (r is parallel to 
the long axis of the c r·ystals). The soh•ent content of 
the~e crystals would range fi'Om 71 to 32~0 , 
ns;;mning from two to four molecules per asym-
llll'trir unit; thr·l'e molerules per asymmetl'ic unit 
gi,·es a soh·enL <'Ontent of ~6°0 , which is in the 
middle of the range ohscn·cd for most protein 
crystals (:'vlatthews, 1968). P.xperiments to enzyma-
tically remove thP ~'<-linked oligosn.cchn.ricles wPre 








Figure 1. Purified secreted fasciclin TIT is hetero· 
geneously gl~·rosylated and maintains its nati,·e con-
for·nHltion nftt·r· trentment with high pH. A. SDSfl 2·5 0 0 
PAGE analysis of' pur·ified l'nsciclin HI (I ,ug) before 
(lane I) and after (lane 2) treatment with N-glycosidase F 
(New England Biolubs). The positions of migmtion of 
molecular mass ><tnmhll'lls (~!,) nre indicated in kilodal-
tons. B. Purified fnscidin ITT (2·5 pg) nnalyzecl on a native 
10°0 polyacrylamidP gPI (larw 1) with non-d!'na.tured pro· 
tein markers (fr·om top to bottom: human carbonic 
anhydrase, bo,·ine cat·bonic anh.wlruse If (t·uns as 2 
bands). P-lnctulbumin. nnd so,,·beun trypsin inhibitor: 
Sigma) for comparison (lnne :!). The pH of thP gel buffer 
was 8·8 and the gel was r·un from tlw negative to the 
positive electrode. 
conducted in t\n at tempt to obtain impro,·ed 
crystals. Thiil treatment. while significantly 
reducing the amount of oligosaccharicle, has so far 
failed to yield any l'r~·stals (data not shown) . 
T he crystals cliffr·aet to r·eciprocal lattice spacings 
of 3·25 .. l. nt 1'00111 temper·atur·e in experiments 
conducted at the Stanford Synchrotron Radiation 
Ln.bomtory (hPamline 7- 1 ), but are particular·ly 
sensith·e to mdit<tion . The degree of the radiation 
clarnage is extr-eme enough to preclude data collec-
tion ><t room temperature. I n an effort to ove rcome 
this difficulty , the crystt<ls were flash -cooled (Hope , 
1990) in a stre><m of nitrogen gas at - 160°C 
(:\ lolecular Structure Systems ht\l'dware). Effecti,·c 
cryo-preticn·ation of n. crystal could not be achieved 
in the mother liquor lhat the crystals gro\1' in due to 
the formation of crystalline ice during cooling. 
Instead. crystn.ls were fi rst transferred to " holding 
solution of 10°0 (\1'/ W) polyethylene glycol 8000. 
2·5% saturated sodium citrnte. 50 m:\1 sodium 
acetate (pH ~·:3) t<nd I m:.\1 rlithiothreitol. The 
crystt<ls \l'er·e then progr·c;:si,·ely tmnsferred to solu -
tions that incor·por·ntNl higher and higher conccn-
trations of polyethyiPne glyeol ~00. tPrrninnting nt 
30°0 (wfw) after l\ period of fh·p hour,;. The t·r·ystals 
were then picked up in a myon loop mounted on a 
magnetic pin (Teng. 1990) and flash-cooled in thc 
gas-stream. This process reliably yields cryo-
pr·esen·ed crystals tht\t diffract to reciprocal lattice 
spacings beyond :~·0 .l. using synchrotron radiation . 
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Data collcction is in progress on nath·c crystals and 
one potential hea\·y-atom derinlti,•e (umnyl 
acetate). 
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